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THE DISEASE  
 
DEFINITION 
Infectious bursal disease (IBD) is a highly contagious, immunosuppressive infection of 
immature chickens caused by the infectious bursal disease virus (IBDV) (Fig. 1). The 
disease is characterised by the destruction of the lymphoid organs, in particular the 
bursa of Fabricius where the virus infects actively dividing and differentiating 
lymphocytes of the B-cell lineage. The infection, when not fatal, causes an 
immunosuppression, in most cases temporary, depending on the dose and 
virulence of the strain, the age and breed of the animals, and the presence or 
absence of passive immunity.  
No evidence exists of transmission of IBDV to non-avian species, including 
humans; the disease thus has no direct impact on public health. 
 
 
A
B
 
Figure 1. Structure of the IBDV virion (Bottcher et al., 1997; 
with kind permission of R.A. Crowther). (A) Electron 
micrograph of purified IBDV virions; bar, 100 nm. (B) Three-
dimensional map of the IBDV capsid; the outer (left) and 
inner (right) surfaces of the particle are viewed along a 
threefold axis of icosahedral symmetry. 
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SHORT HISTORY AND EPIDEMIOLOGY  
The syndrome, which emerged in 1957 (Cover, 1960), was formally documented in 
1962 by Cosgrove (Cosgrove, 1962) in broiler flocks near the town of Gumboro, 
Delaware (USA). Later outbreaks were subsequently referred to as ‘Gumboro 
disease’ after the geographic location. Originally the condition was named 
‘nephritis-nephrosis syndrome of chickens’ because of prominent kidney lesions. 
After it became evident that an enlarged bursa of Fabricius with endematous 
swelling and haemorrhagic lesions is the prominent feature of this disease, the term 
‘infectious bursal disease’ has become commonly accepted. Despite confusion 
regarding the identity of the causal agent, which was originally isolated by 
Winterfield et al. (1962), Koch’s postulates were satisfied by Snedeker et al. (1967), 
who isolated a virus from the bursa of Fabricius of affected birds and subsequently 
produced an attenuated vaccine. Based on its morphology, IBDV was tentatively 
classified sequentially as a picornavirus (Cho & Edgar, 1969), an adenovirus 
(Almeida & Morris, 1973), a reovirus (Lukert & Davis, 1974; Kosters et al., 1972) and an 
orbivirus (Hirai & Shimakura, 1974; Harkness et al., 1975), until the essential structural 
features of purified virus were determined. The IBD agent became then designated 
a birnavirus (Dobos et al., 1979) based on the presence of two double-stranded 
RNAs (dsRNA) (Muller et al., 1979a) and unique biophysical characteristics (Dobos et 
al., 1979).  
Between 1960 and 1964, the disease spread to most regions of the USA 
(Lasher & Davis, 1997), reaching Europe in the years 1962 to 1971 (Faragher, 1972). 
From 1966 to 1974, the disease was detected in the Middle East, southern and 
western Africa, India, the Far East and Australia (Faragher, 1972; Firth, 1974; Jones, 
1986; Lasher & Shane, 1994; van den Berg, 2000; van der Sluis, 1999). Infectious bursal 
disease is currently an international problem: 95% of the 65 countries that responded 
to a survey conducted by the Office International des Epizooties (OIE) in 1995 
declared cases of infection (Eteradossi, 1995), including New Zealand which had 
been free of disease until 1993 (Jones, 1986).  
 
ANTIGENETIC AND VIRULENCE VARIATIONS 
Until 1985, the IBDV field strains (classical strains) isolated were of relative low 
virulence, causing only 1-2% of specific mortality, and outbreaks were satisfactorily 
controlled by vaccination. However, since 1985 antigenic and pathogenic variant 
strains of IBDV, distinct from these classical strains, with increased specific mortality 
have been described in different parts of the world (reviewed in van den Berg, 
2000). In the USA, new strains responsible for up to 5% of specific mortality were 
described (Rosenberger & Cloud, 1986). These virus isolates were designated 
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antigenic-variant viruses since they were antigenically different from the classical 
strains isolated before 1985. They infected broiler chickens possessing relatively high 
levels of maternal antibodies and were highly immunosuppressive (Box, 1989).  
Later on, after 1988, in Europe (Chettle et al., 1989), and subsequently in 
Japan (Nunoya et al., 1992; Lin et al., 1993), a new class of pathotypic variants with 
high mortality rates (50-60% in laying hens and 25-30% in broilers) were observed. 
These isolates caused up to 100% mortality in specific-pathogen-free (SPF) chickens 
(Nunoya et al., 1992; van den Berg et al., 1991) and were therefore designated very 
virulent IBDV (vvIBDV) strains. They rapidly spread all over Asia and to other major 
parts of the world (reviewed in Eteradossi, 1995; van den Berg, 2000). Australia, New 
Zealand, Canada and the north of USA, however, have so far remained unaffected 
(Snyder, 1990; Proffitt et al., 1999; Sapats & Ignjatovic, 2000; Nevalainen et al., 1999; 
Czifra & Janson, 1999) by these acute forms of vvIBDV (Fig. 2).  
 
 
Figure 2. Worldwide geographical distribution of the two forms of IBDV 
(updated from van den Berg, 2000). In gray, countries where both acute 
and immunosuppressive forms have been reported. In black, countries 
where no acute but only immunosuppressive forms have been reported. 
In white, countries with no reported cases of IBDV (van den Berg, 2000, 
with kind permission of T.P. van den Berg, N. Eterradossi and Avian 
Pathology).  
 
 
These vvIBDV strains caused disease even in the presence of protective maternal 
antibody against the classical vaccine strains, similar to the antigenic-variant strains 
(Chettle et al., 1989). However, in contrast to the latter, the vvIBDV strains exhibit an 
enhanced virulence while having the same antigenic structure as classical IBDV 
isolates (Brown et al., 1994). The underlying molecular mechanism for the enhanced 
virulence of vvIBDV has not been elucidated.  
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TAXONOMY AND CLASSIFICATION     
Infectious bursal disease virus is a member of the birnavirus genus, family Birnaviridae 
(Leong et al., 2000). This family was established in 1986 to describe and classify a 
group of animal viruses that carry a bisegmented dsRNA genome as their 
distinguishing characteristic (Dobos et al., 1979). The two main representatives of this 
virus family are the infectious pancreatic necrosis virus (IPNV) of young salmonid fish 
and the causative agent of infectious bursal disease of chicken (IBDV). Other virus 
members belonging to this family are the tellina virus (TV), oyster virus (OV) and crab 
virus of bivalve molluscs, and the Drosophila X virus (DXV) of the fruit fly (Drosophila 
melanogaster) (Leong et al., 2000). A virus with birnavirus characteristics has been 
isolated also from European eels (EV) affected by stomatopapillomas. Tumors could, 
however, not be induced by EV, although the virus causes 50% mortality in young 
eels. In mammals the only birnavirus-like agents have been observed in faecal 
samples of several species of vertebrates (Chandra, 1997). Differences from true 
birnaviruses have been noted in size, length of genome segments and buoyant 
density; the designation ‘picobirnaviruses’ has therefore been proposed (Pereira et 
al., 1988; Chandra, 1997). The role of these agents in outbreaks of diarrhoea is 
uncertain.    
The name birna highlights the most important feature of these viruses: bi 
signifies the bisegmented nature of the viral genome as well as its double-
strandedness and rna indicates the nature of the viral nucleic acid. The family 
contains three genera: Genus Aquabirnavirus (type species: IPNV), Genus 
Avibirnavirus (type species: IBDV) and Genus Entomobirnavirus (type species: DXV) 
(Table 1).  
Chickens are the only avian species known to exhibit clinical symptoms 
upon an IBDV infection. Turkeys, ducks, and ostriches are susceptible to infection 
with IBDV but are resistant to clinical disease (Lukert & Saif, 1997; McNulty et al., 
1979). Two serotypes of IBDV have been described, distinguished by cross-
neutralisation and cross-protection tests. All viruses capable of causing disease in 
chickens belong to serotype I. Serotype II virus, on the other hand, has been isolated 
from turkeys having coryza and diarrhoea, but it remains unclear whether this 
serotype has any true pathogenic significance (Cummings et al., 1986). Infections of  
chickens with serotype II virus do not cause clinical manifestations or noticeable 
lesions. 
In addition to serological classification, the viral strains of IBDV may be 
classified according to virulence. The serotype II strains may be considered 
apathogenic and the pathogenic serotype I strains can be subdivided into classical 
virulent, antigenic-variant or very virulent isolates.  
CHAPTER 1  GENERAL INTRODUCTION 
 16
 
Family  Genus Type Species Acronym 
Birnaviridae Aquabirnavirus infectious pancreatic necrosis virus IPNV 
 Avibirnavirus infectious bursal disease virus IBDV 
 Entomobirnavirus Drosophila X virus DXV 
 
Genome: dsRNA  
Host: Invertebrates; Vertebrates  
Derivation of Name:  Aqua: from Latin aqua, “water” 
Avi: from Latin avis, “bird” 
Bi: from Latin prefix bi, “two”, signifies the bisegmented 
nature of the viral genome as well as the presence of 
dsRNA 
Entomo: from Greek entomon, “insect” 
Rna: from ribo nucleic acid, indicating the nature of the 
viral genome 
 
Table 1. Taxonomic Structure of the Family Birnaviridae 
 
 
PATHOGENESIS AND CLINICAL SIGNS 
The preferred host of the virus is young chickens in which a clinical disease develops, 
while the infection is essentially subclinical in older birds. The incubation period is 
very short: two to three days. Under natural conditions, the most common mode of 
infection appears to be via the oral route. From the gut, the virus is transported to 
other tissues by phagocytic cells, most likely resident macrophages. The target 
organ of  IBDV is the bursa of Fabricius at its maximum development, which is the 
specific source for B-lymphocytes in avian species. In vivo and in vitro studies have 
shown that the virus has a predilection for actively dividing immunoglobulin M (IgM)-
bearing B-lymphocytes (Ivanyi & Morris, 1976; Kaufer & Weiss, 1980). Bursectomy can 
prevent illness in chicks infected with virulent virus (Hiraga et al., 1994). The severity of 
the disease is directly related to the number of susceptible cells present in the bursa 
of Fabricius; therefore, the highest age at which the animals are susceptible is 
between 3 and 6 weeks, when the bursa of Fabricius is fully developed. This age 
dependent susceptibility is broader in the case of vvIBDV strains (van den Berg et al., 
1991; Nunoya et al., 1992). By 13 h post-infection, virus-containing cells appear in the 
bursa and the virus spreads rapidly through the bursal follicles. Virus replication leads 
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to extensive lymphoid cell destruction in the medullary and the cortical region of the 
follicles (Tanimura & Sharma, 1997). The cellular destructive process may be 
accentuated by apoptosis of virus-free bystander cells (Tanimura & Sharma, 1998). 
At 16 h post-infection, a second and pronounced viraemia occurs with secondary 
replication in other organs leading to disease and death (Muller et al., 1979b). 
Similar kinetics are observed for vvIBDV strains but replication at each step is 
amplified. T lymphocytes are resistant to infection with IBDV (Hirai & Calnek, 1979). 
Although the thymus undergoes marked atrophy and extensive apoptosis of 
thymocytes during the acute phase of virus infection, there is no evidence that the 
virus actually replicates in thymic cells (Tanimura & Sharma, 1998; Sharma et al., 
1989). Gross and microscopic lesions in the thymus are quickly overcome and the 
thymus returns to its normal state within a few days of virus infection. 
Clinical signs associated with acute disease include anorexia, depression, 
ruffled feathers, diarrhoea, prostration and death. The incidence of mortality is 
highly variable ranging from 100% to negligible. The most conspicuous lesions 
concern the bursa of Fabricius. The organ is enlarged, endematous and in some 
cases haemorrhagic. Petechial or diffuse haemorrhages may be found in muscular 
tissue. Lymphoid follicles of the bursa of Fabricius are totally necrotic, and in surviving 
birds the follicles are devoid of lymphoid cells (Fig. 3). Mortality commences on the 
third day of infection, reaches a peak by day four, then drops rapidly, and the 
surviving chickens recover a state of apparent health after five to seven days. 
Disease severity depends on the age and breed sensitivity of the infected birds, the 
virulence of the strain and the degree of passive immunity. Schematically, the 
global situation can be divided into three principal clinical forms, as follows: 
a) the classical form, as described since the early 1960s and caused 
by the classical strains of IBDV, where specific mortality is relatively 
low, and the disease is most often subclinical, occurring after a 
decline in the level of passive antibodies (Faragher, 1972). 
b) the immunosuppressive form, caused by the pathogenic antigenic-
variant strains, with an increased mortality and which partially resists 
neutralisation by antibodies against the classical IBDV strains 
(Jackwood & Saif, 1987; Snyder, 1990). 
c) the acute form, caused by vvIBDV strains, which is characterised by 
an acute rogressive clinical disease, leading to high mortality rates; 
mortality occurs even in the presence of a moderate level of 
maternal antibodies (Chettle et al., 1989; Stuart, 1989; van den Berg 
et al., 1991). 
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M ock D6948
 
Figure 3. Hematoxylin-eosin-stained sections of the bursa of Fabricius at day 13 post 
infection of SPF chickens either mock infected (Mock) or infected with wild-type vvIBDV 
D6948 (D6948). The mock-infected chickens show no damage of the follicular structure 
of the bursa, while the vvIBDV infected chickens show that the virus completely 
destroyed the bursa follicles and induced cystic formation. 
 
Recovery from disease or from subclinical infection is followed by 
immunosuppression with more serious consequences if infection occurs early in life. 
The most severe and long-lasting immunosuppression occurs when day-old chickens 
are infected by IBDV (Faragher et al., 1974; Sharma et al., 1989; Allan et al., 1972; 
Sharma et al., 1994). In field conditions, this rarely occurs since chickens tend to 
become infected later at approximately two to three weeks of age, when maternal 
antibodies decline. It has been reported that the virus has an immunosuppressive 
effect at least until the age of six weeks (Giambrone, 1979; Lucio & Hitchner, 1980; 
Wyeth, 1975). 
 
ECONOMIC IMPACT 
Economic losses in the poultry industry result from high mortality and morbidity rates 
due to the acute form of the disease and from a subclinical infection in chickens 
below 3 weeks old characterised by B-cell dependent immunodeficiency (Kibenge 
et al., 1988a; van der Sluis, 1999). The latter condition enhances the susceptibility of 
chickens to other infections and depresses the response of infected chickens to 
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vaccines against other diseases such as Newcastle disease, Marek’s disease and 
infectious bronchitis. Because vaccination is the principal method of viral disease 
control in commercial poultry worldwide (Lasher & Shane, 1994), IBDV should be 
considered as one of the most important viral pathogens of the commercial poultry 
industry. 
 
PREVENTION AND CONTROL  
IBDV is a highly stable virus under different environmental conditions. It can persist in 
poultry houses for several weeks even after thorough cleaning and disinfection 
(Lukert & Hitchner, 1984). It is more resistant to heat and ultraviolet light than reovirus 
(Petek et al., 1973) and is resistant to ether and chloroform. It is inactivated at pH 
12.0, but remains infectious at pH 2.0 (Benton et al., 1967). This complicates attempts 
to control infections by hygienic means and makes vaccination inevitable. 
In the past, a combination of live and inactivated vaccines used in the 
parent breeder flocks was sufficient to induce the production of high levels of 
maternal antibody in the broiler progeny, which prevented early infections and 
therefore immunosupression. However, most intermediate vaccines are presently 
inadequate in providing protection against vvIBDV. Some of the less attenuated 
(‘hot’) vaccine strains with acceptable reduction of virulence are given after 
determining the optimum age of vaccination using a formula which predicts the 
decline in maternal antibody (Kowenhovan & van den Bos, 1993). With the increase 
in knowledge about the molecular structure and immunology of IBDV, better 
attenuated and genetically engineered vaccines are being developed.  
 
THE VIRUS 
 
VIRUS STRUCTURE AND GENOMIC ORGANISATION 
IBDV is a small, non-enveloped virus with a bisegmented dsRNA genome. The virion 
has a single capsid shell of icosahedral symmetry with a diameter of 60-70 nm (Fig. 
1). Electron cryomicroscopy and image processing analysis showed that the 
structure of the virion is based on a T=13 lattice formed by trimer-clustered subunits 
(Bottcher et al., 1997; Caston et al., 2001). The external surface of the virion is 
composed of 260 protruding trimeric subunits formed by VP2 (Bottcher et al., 1997). 
The inner capsid is built of 200 Y-shaped trimeric subunits formed by VP3 (Bottcher et 
al., 1997). Five different classes of trimers can be distinguished according to their 
different local environment (Bottcher et al., 1997; Caston et al., 2001).  
The viral genome structure and organisation are presented in figure 4. The 
larger segment A (approximately 3,260 base pairs [bp]) contains two open reading 
CHAPTER 1  GENERAL INTRODUCTION 
 20
frames (ORFs). The larger ORF encodes a 110 kDa polyprotein (pVP2-VP4-VP3) that is 
autocatalytically cleaved by the viral protease VP4 to yield the viral proteins pVP2 
(also known as VPX; 48 kDa), VP3 (32 kDa) and VP4 (28 kDa) (Sanchez & Rodriguez, 
1999; Birghan et al., 2000; Lejal et al., 2000). During in vivo virus maturation pVP2 is 
further processed, by site-specific cleavages at its carboxy end, most likely by VP4 
protease activity, generating mature VP2 (40 kDa) and four small peptides (Da 
Costa et al., 2002). A small ORF preceding and partially overlapping the larger ORF 
of Segment A encodes VP5 (17 kDa) (Mundt et al., 1995). The smaller genome 
segment B (approximately 2,827 bp) contains one large ORF encoding VP1 (90 
kDa), the viral RNA polymerase which exists both as a free protein and as a 
genome-linked protein (VPg), covalently attached to the 5’ end of the RNA (Muller 
& Nitschke, 1987; Spies et al., 1987). 
 
Segment B (2827 bp)S egment A (3260 bp)
VPg pVP2 VP4 VP3
VP5
VPg VP1
IBDV genome
VPg pVP2 VP4 VP3
VP5
VPg VP1
mRNA
VPg VPg
trans cription
translation
proteinspVP2 VP4 VP3VP5 VP1
co-translational 
processing
pVP2 VP4 VP3
post-
translational 
processing
VP2 VP4
3’ 3’5’ 5’
small 
peptides
48 kDa 32 kDa28 kDa
40 kDa
17 kDa 90 kDa110 kDa
28 kDa
polyprotein
 
 
Figure 4. Schematic representation of the genomic organization of IBDV. The gene 
arrangements of both genome segments A and B are shown. VPg denotes the genome-
linked form of VP1 that is covalently attached to the 5’ end of the RNA. The molecular 
masses of the proteins (in kDa) are indicated.  
 
The VP1 ORFs and proteins of pathogenic serotype I and nonpathogenic serotype II 
strains share an 89% nucleotide and 93-98% amino acid sequence homology, 
respectively (Brown & Skinner, 1996). The RNA-dependent RNA polymerase (RdRp) 
consensus sequence motifs (Bruenn, 1991; Shwed et al., 2002) are conserved in the 
VP1 proteins of both IBDV serotypes. In segment A, lower nucleotide (83-84%) and 
amino acid (90%) sequence identities occur between coding regions of serotype I 
and II strains (Kibenge et al., 1991). This is mainly attributed to a hypervariable region 
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corresponding to the serotype-specific epitope(s) in the structural protein VP2 
(Bayliss et al., 1990).  
The 5’ and 3’ noncoding termini of the IBDV genome segments resemble 
those of other segmented RNA viruses such as reovirus (Antczak et al., 1982) and 
influenza virus (Stoeckle et al., 1987), where both 5’ and 3’ termini are homologous 
between the genome segments. The 5’ noncoding terminal sequence in both 
genome segments of IBDV consists of a 32-nucleotide consensus sequence, the 3’ 
noncoding terminal sequence of a conserved pentamer (Kibenge et al., 1996; 
Mundt & Muller, 1995). These segment-specific 5’ and 3’ end conserved regions also 
contain perfect inverted terminal repeats (ITRs) of 6 and 12 nucleotides in segment 
A and B, respectively (Mundt & Muller, 1995). Furthermore, the 5’ and 3’ noncoding 
termini of the IBDV genome segments have the potential to form stem and loop 
secondary structures (Boot et al., 1999; Kibenge et al., 1996; Mundt & Muller, 1995). 
 
VIRAL PROTEINS 
VP1, the RNA-dependent RNA polymerase of the virus, is present in small amounts in 
the virion (≈ 3% of the virion protein mass; Dobos et al., 1979), both as a free 
polypeptide and as a genome-linked protein (VPg) (Muller & Nitschke, 1987; 
Kibenge & Dhama, 1997). In IPNV, VP1 is linked to the 5’ ends of both genome 
segments by a serine-5’-GMP phosphodiester bond (Calvert et al., 1991). Since IBDV 
and IPNV behaved similarly during in vitro guanylylation reactions (Dobos, 1993), VP1 
of IBDV is also considered to be attached to a guanine residue at the 5’ terminus of 
the genome segments. Whether the 5’ termini of the noncoding strands also have 
this covalently linked VPg is not known. Furthermore, as has been shown to occur in 
vitro, VPg may act as a primase in the generation of viral mRNAs, and as a result 
becomes part of these mRNAs through covalent linkage at their 5’ ends (Dobos, 
1995; Magyar et al., 1998). Notably, the VPg protein of IBDV is unusually large 
compared to other VPg’s (e.g. adeno- and picornavirus) and its functioning both as 
a primer and as a polymerase is without precedent. Thus, by their genome-linked 
protein and their protein-primed RNA synthesis birnaviruses are unique among the 
double-stranded RNA viruses. Recently, it has been demonstrated that VP1 forms 
complexes with the capsid protein VP3, when expressed in a heterologous 
mammalian expression system, suggesting an additional role of VP1 in virus 
morphogenesis (Lombardo et al., 1999). 
VP2 and VP3 are the major viral structural proteins, forming the outer and 
inner layers of the proteinaceous capsid of the virion, respectively. VP2 contains the 
antigenic region responsible for the induction of neutralising antibodies and for 
serotype specificity (Fahey et al., 1989). This protein is highly hydrophobic and 
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conformation dependent, as demonstrated by the observation that all neutralising 
monoclonal antibodies (Mabs) react in immunoprecipitation but not in Western blot 
(Oppling et al., 1991; Schnitzler et al., 1993; van den Berg et al., 1996). Furthermore, it 
has been reported that transient expression of VP2 in vitro leads to the induction of 
apoptosis (Yao & Vakharia, 2001; Fernandez-Arias et al., 1997). VP3 has group-
specific antigens that are recognised by non-neutralising antibodies (Oppling et al., 
1991; Becht et al., 1988). The protein contains charged residues at its carboxy-
terminal domain, a domain suggested to be involved in either packaging or 
stabilising the RNA genome within the interior of the viral capsid (Hudson et al., 1986; 
Bottcher et al., 1997). Expression of the IBDV structural genes in various expression 
systems revealed the production of virus-like particles (VLPs) of IBDV. Extensive 
studies of these particles has given more insight into capsid morphogenesis. Single 
expression of VP3 does not yield any type of particle (Martinez-Torrecuadrada et al., 
2000b). The expression of pVP2 alone, leads to the formation of twisted tubular 
structures and isometric particles (Caston et al., 2001; Chevalier et al., 2002). Single 
expression of VP2 results in the spontaneous formation of dodecahedral particles 
which may assemble into larger, fragile icosahedral capsids built up by 12 
dodecahedral capsids (Caston et al., 2001). Only expression of the polyprotein gives 
rise to the formation of virus-like particles (VLPs) with a size and shape very similar to 
those of authentic IBDV particles. It has also been demonstrated that co-expression 
of the polyprotein with VP1 results in the formation VLPs in which VP1 becomes 
incorporated (Lombardo et al., 1999). The final processing of pVP2 to VP2, however, 
does not occur in VLPs. Recently, it was shown that the environment of the C-
terminal domain of VP3 functions as an important switch controlling virus 
morphogenesis. The fusion of an exogenous protein to the C-terminus of the inner 
VP3 capsid protein appeared to trigger efficient VLP formation and processing of 
pVP2 to VP2 in a recombinant expression system (Chevalier et al., 2002). 
VP4 is a non-structural protein associated with the formation of specific 
microtubules present in infected cells (Granzow et al., 1997). This is in contrast with 
previous studies describing this protein as a minor structural component present in 
mature virions purified by various methods (reviewed in Kibenge et al., 1988a). 
However, Granzow et al. (1997) demonstrated that VP4 is not a constituent of 
mature virions but that its presence in virion preparations was due to a 
contamination with the VP4-containing type II tubules. VP4 is the virus-encoded 
protease that shares some characteristics with bacterial Lon proteases (Sanchez & 
Rodriguez, 1999; Birghan et al., 2000; Lejal et al., 2000). It is involved in the auto-
processing of the polyprotein producing pVP2, VP3 and itself (Azad et al., 1987). The 
amino acids responsible for this proteolytic activity have recently been 
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characterised as a serine-lysine catalytic dyad (Birghan et al., 2000). In addition, the 
primary cleavage sites at the pVP2-VP4 and VP4-VP3 junctions of the polyprotein 
have been identified (Sanchez & Rodriguez, 1999; Lejal et al., 2000). Previously, the 
polyprotein cleavage sites were assumed to be located at the dibasic residues R(452)-
R(453) and K(722)-R(723), as predicted by Hudson et al. (1986). The corrected processing 
sites were, however, redefined as being located at amino acid residues A(512)-A(513) 
and A(755)-A(756) and these sites are characterised by the (Thr/Ala)-X-Ala↓Ala motif 
(Lejal et al., 2000). As determined by N-terminal sequencing, three (possibly four) 
additional cleavage sites for VP4, involved in the pVP2 maturation process, are 
present in the C-terminal domain of pVP2 (Da Costa et al., 2002).  
VP5 was first described in IPNV (Havarstein et al., 1990) and has been 
identified more recently in IBDV infected cells (Mundt et al., 1995). This non-structural 
protein proved to be non-essential for viral replication and infection but important 
for virus-induced pathogenicity (Mundt et al., 1997; Yao et al., 1998), although its 
exact function is still unknown. The protein is highly basic, cysteine-rich, and its 
sequence is conserved among all pathogenic strains of IBDV (>95% identity). 
Sequence-based topology predictions indicated that VP5 is a class II membrane 
protein, having an intracellular N-terminal tail, a transmembrane helix and an 
extracellular C-terminal region (Lombardo et al., 2000). Additionally, it was shown 
that VP5 accumulates within the host cell plasma membrane (Lombardo et al., 
2000). Expression of VP5 resulted in the alteration of cell morphology, the disruption 
of the plasma membrane, and a drastic reduction of cell viability (Lombardo et al., 
2000). Furthermore, the protein is capable of inducing a programmed cell death 
response in cell culture (Yao & Vakharia, 2001). VP5 is therefore suggested to play 
an important role in the release of the IBDV progeny. 
 
IBDV REPLICATION 
A characteristic of the pathogenic IBDV strains, especially vvIBDV strains, is their 
inability to grow in cell culture. Usually, these strains can be adapted to replicate 
and produce cytopathic effect (CPE) in primary cell cultures of chicken origin by 
extensive passaging either in chicken embryos or in cell culture using primary 
chicken embryo cells, primary chicken embryo fibroblast cells (CEF), or cell lines of 
avian or mammalian origin such as quail-derived cells (QT35, QM5 or QM7) and 
Vero cells (Lukert & Davis, 1974; Kibenge et al., 1988b). Adaptation of wild-type 
IBDV, however, always seems to correlate with attenuation (Yamaguchi et al., 
1996b; Yehuda et al., 1999).  
The first step in virus infection is the attachment of the virus to a specific 
receptor on the surface of susceptible host cells. According to the results of a flow 
CHAPTER 1  GENERAL INTRODUCTION 
 24
cytometric virus binding assay by Ogawa et al. (1998) the IBDV host range is mainly 
controlled by the presence of a virus receptor composed of an N-glycosylated 
protein associated with the B-lymphocytes represented mostly by IgM-bearing cells. 
Although some progress has been made in the identification of membrane proteins 
possibly involved in the entry of IBDV into chicken embryo fibroblasts or into chicken 
lymphocytes (Nieper & Muller, 1996; Setiyono et al., 2001), the actual nature of the 
receptor is still unknown.  
Recently, it was shown that wild-type vvIBDV, with its selective tropism for 
chicken B-lymphocytes, is able to replicate in non-B-lymphoid cells once it is 
artificially (transfection of cDNA) introduced in these cells (Boot et al., 2000a). The 
inability of vvIBDVs to infect non-B-lymphoid cells is therefore likely due to their 
inability to recognise a certain receptor and/or their inability to enter the cell. In 
contrast, cell culture adapted vvIBDV is able to enter and replicate in both B-
lymphoid and non-B-lymphoid cells. It has therefore been speculated that the 
typical B-lymphoid cell tropism of vvIBDV strains might be related to the recognition 
of an IBDV specific B-lymphoid cell receptor whereas cell culture adapted IBDV 
isolates recognise a general IBDV receptor present on a wide range of cells (Boot et 
al., 2000a). Previously, it was shown that the viral factor responsible for propagation 
in non-B-lymphoid cells is located on VP2 (Lim et al., 1999; Mundt, 1999; Yamaguchi 
et al., 1996a; van Loon et al., 2002). In addition, there are several studies in which 
amino acid changes of vvIBDV isolates, resulting from adaptation to non-B-lymphoid 
cell cultures, have been mapped (Lim et al., 1999; Mundt, 1999; Yamaguchi et al., 
1996a; van Loon et al., 2002). Important amino acids for propagation in non-B-
lymphoid cells were found within the hypervariable region of VP2 (i.e. amino acids 
at position 253, 279, and 284) (Lim et al., 1999; Mundt, 1999; van Loon et al., 2002). 
The consecutive steps involved in the replication of IBDV or of other 
birnaviruses have not been traced individually. The virus replicates in the cytoplasm 
and a single cycle of replication takes 10-12 hr at 37 °C (Petek et al., 1973; Nick et 
al., 1976). In vitro ssRNA synthesis studies showed that the RNA polymerase 
synthesises viral ssRNA by an asymmetric, semiconservative, strand-displacement 
mechanism, whereby the nascent strand displaces one of the parental strands 
(Spies et al., 1987; Mertens et al., 1982). Two genome-length 24S mRNAs hybridising 
to the 2 segments were detected both in vivo (Somogyi & Dobos, 1980) and in vitro 
(Mertens et al., 1982). In both cases, birnaviruses were transcriptionally active 
without the need for uncoating or for degradation of the capsid (Spies et al., 1987). 
The 24S ssRNA as well as 14S dsRNA are synthesised in vitro (Spies et al., 1987; 
Mertens et al., 1982; Somogyi & Dobos, 1980), where the 24S ssRNA component is 
believed to be the viral RNA that serves as the template for the synthesis  of 
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complementary strands to form dsRNA (Somogyi & Dobos, 1980). More recent 
experiments indicate that virion-associated VP1 catalyses a guanylylation reaction 
which serves to prime viral RNA synthesis; apparently only the plus strands of the two 
genome segments are synthesised in vitro which remain base-paired to their 
templates (Dobos, 1995) (Fig. 5). The initiation of viral RNA synthesis has been 
suggested to involve either 2 VP1 molecules, one serving as a primer and the other 
as the polymerase for chain elongation, or just a single VP1 molecule serving both 
functions (Dobos, 1995). 
 
VP1/VPg
(p)VP2
VP3
VP4
VP5
VPg-dsRNA
type II tubules
+
A
B
C
D
+
 
 
Figure 5. Schematic representation of a possible IBDV replication mechanism. (A) RNA 
polymerase activity of VP1 has no need for uncoating or degradation of the capsid; VP1 
primed, semiconservative strand-displacement transcription, by which the plus strands 
synthezised remain base-paired to the template. (B) Translation of viral mRNAs and 
proteolytic processing of the polyprotein. (C) Capsid protein assembly and virus 
maturation; formation of VP4-containing type II tubules. (D) VPg-ssRNA serving as template 
for the generation of VPg-dsRNA. 
 
Regulated expression of the viral genes may be essential for the multiplication of 
IBDV. IBDV specific polypeptides are identified in chicken bursal lymphoid cells as 
early as 90 min after infection and in the culture medium of such cells from 6 h after 
infection (Muller & Becht, 1982). The first step governing the IBDV capsid assembly is 
the autoproteolytic cleavage of the polyprotein, generating pVP2, VP4 and VP3. 
Moreover, recent data indicate that IBDV assembly is coupled with the polyprotein 
cleavage in a cleavage-restricted manner (Birghan et al., 2000). The VP4 protease 
would therefore be a key regulator in the assembly process. Furthermore, it is 
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expected that VP3, together with its role in providing structural integrity to the IBDV 
capsid, acts as an internal scaffold to control the particular type of capsid protein 
assembly (Martinez-Torrecuadrada et al., 2000a; Chevalier et al., 2002). Since VP2 
does not accumulate intracellularly, as do the other viral proteins, the pVP2-to-VP2 
conversion might be associated with the last steps of the viral cycle (Muller & Becht, 
1982). Recently, it was shown that three (most probably four) small peptides resulting 
from the pVP2 maturation process are associated with the virus particle (Da Costa 
et al., 2002). Two of these peptides proved to be essential for virus viability and are 
thus likely to play an important role in capsid assembly, genome encapsidation, 
and/or genome entry into the target cell. As is the case with other naked viruses, it is 
expected that the release of IBDV requires the alteration of the cell membrane. 
Both VP2 and VP5 have been implicated to play an important role in the release of 
the viral progeny by their capability to induce apoptosis in cell culture (Yao & 
Vakharia, 2001; Fernandez-Arias et al., 1997). 
 
RESEARCH TOOLS 
 
IBDV REVERSE GENETICS 
The development of a reverse genetics system for IBDV, which enables one to 
generate virus entirely from cloned cDNA, and hence allows the genetic 
manipulation of the virus, has progressed rapidly over the past decade. These 
techniques provide the tools for studying the biological role of the different coding 
and noncoding regions of the viral genome.  
The basis for the development of such a system for IBDV has been the 
construction of a full-length cDNA clone. This starts with the reverse transcription of 
the viral RNA into a single-stranded DNA copy, which is subsequently converted into 
a stable double-stranded form. The first IBDV reverse genetics system reported was 
based on the full-length cDNA cloning of the IBDV segments in a vector, producing 
full-length RNAs and the subsequent transfection thereof into eukaryotic cells, 
allowing the generation of completely new synthetic viruses (Mundt & Vakharia, 
1996).  
Changes or additions to the original system have included the 
development of improved methods for reverse transcription, polymerase chain 
reaction (PCR) and for cloning of full-length segments of both strands of IBDV (Akin 
et al., 1999; Boot et al., 2000b). More recently, simplifications of the IBDV reverse 
genetics systems have been proposed for the generation of synthetic particles by 
direct transfection of cDNA vector as opposed to transfection of RNA. In the present 
study, we made use of the reverse genetics system reported by Boot et al. (1999), 
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Figure 6. Schematic representation of the IBDV reverse genetics system reported by Boot et 
al., 1999. (A) Plasmids containing a full-length IBDV A-segment cDNA (pHB-36W) or B-
segment cDNA (pHB-34Z); boxes indicate open reading frames (ORFs), and several 
functional genetic elements such as a hepatitis delta ribozyme (HDR) and a T7 RNA 
polymerase promoter and terminator sequences are indicated. (B) In vivo Fowlpox  
T7 expression system. Eukaryotic cells (i.e. QM5 cells) are infected with a recombinant 
Fowlpox virus that expresses functional T7 RNA polymerase. The subsequent co-transfection 
of the plasmids pHB-36W and pHB-34Z allows the generation of both Fowlpox T7 virus and 
new synthetic IBDV. By filtration through a 100 nm filter the Fowlpox T7 virus can be 
completely removed from the rescued IBDV (rIBDV). 
 
where infectious IBDV was rescued from plasmids that contained full-length IBDV 
cDNAs behind a T7 promoter, by transfecting these plasmids into cells that had 
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been infected with a recombinant Fowlpox virus that expressed T7 RNA polymerase 
(Fig. 6). Another reverse genetics system which was reported only once relies on the 
transfection of vector plasmids containing the cDNAs under a cytomegalovirus 
(CMV) promoter (Lim et al., 1999).  
The genetic engineering of IBDV reassortants, recombinants and mutants 
has been (see figure 7), and will be, of considerable help to elucidate the role of 
segments, genes, regions or even single nucleotides and amino acids in the IBDV life 
cycle. 
 
THE YEAST TWO-HYBRID SYSTEM 
The yeast two-hybrid system provides a yeast-based genetic assay for detecting 
protein-protein interactions. The system has rapidly become an attractive method 
because it allows the selection of genes encoding potentially interacting proteins 
without the need for protein purification. Prior to the development of the yeast two-
hybrid system, both the identification of physical protein-protein interactions and 
their subsequent functional characterisation traditionally relied upon time and 
labour intensive biochemical approaches. The yeast two-hybrid system presents 
three major advantages over alternative assays for gene identification. First, since it 
is based on a powerful selection scheme performed with a convenient 
microorganism, it allows very high numbers of potential coding sequences to be 
assayed in a relatively simple experiment. Second, it relies on an assay performed in 
vivo and is thus not limited by the artificial conditions of in vitro assays. Finally, since it 
is based on a physical binding assay, a wide variety of protein-protein interactions 
can be detected and characterised following one single commonly used protocol. 
The original yeast two-hybrid GaL4 system, developed in 1989 by Fields and 
Song (Fields & Song, 1989), exploits the fact that the yeast transcriptional activator 
GaL4 has a separable DNA binding domain (GaL4BD) and activation domain  
 
 
Figure 7. Schematic representation of different applications of the reverse genetics 
systems. (A) VP5 gene knockout mutant of IBDV to study the function of VP5. (B) Site-
directed mutagenesis of different amino acid residues in (p)VP2 to examine their role in 
the adaptation of IBDV to cell culture. (C) Evidence for involvement of the 3’-terminal 
sequence in genome replication. (D) Chimeric viruses to study the molecular determinants 
of virulence, cell tropism and pathogenic phenotype of IBDV; (i) chimera’s of a classical 
IBDV and a vvIBDV, and (ii) of an attenuated vaccine virus and a variant or virulent virus. 
(E) Interserotypic chimeric viruses to study the different pathotypes of IBDV serotype I and 
II. (F) Site-directed mutagenesis of the pVP2 maturation cleavage sites to study the 
function of the four small pVP2 derived peptides. 
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(GaL4AD); neither can activate transcription on its own (Chien et al., 1991). 
Transcriptional activation is detected only when the binding domain is linked to its 
DNA recognition sequence and is also tethered, though not necessarily covalently, 
to the activation domain. The yeast two-hybrid system involves fusing the GaL4BD to 
a protein ‘X’ (bait) and the GaL4AD to a protein ‘Y’ (prey). If the bait and prey 
protein interact, then a functional GaL4 is restored and transcriptional activation 
can be detected. If binding sites for GaL4 are placed upstream of a reporter gene, 
transcriptional activation can be monitored easily. 
Over the last decade, a variety of versions of the two-hybrid method has 
been developed (Fashena et al., 2000; Legrain et al., 2001; Vidal & Legrain, 1999). 
The LexA-based version which we have used in this study, utilises the same basic 
idea as the GaL4 system except that the DNA binding protein is the Escherichia coli 
(E. coli) LexA protein while the activation domain is the 88-residue acidic E. coli 
peptide B42 (Gyuris et al., 1993). Two different vectors, expressing bait and prey 
fusions of these domains, are used to transform a yeast strain possessing a dual 
reporter system responsive to transcriptional activation through the LexA operator 
(see figure 8). Furthermore, the LexA-based system has been designed with a 
galactose-inducible promoter that has utility in studies of heterologous fusion 
proteins that are toxic or lethal in yeast. Yeast cells carrying recombinant plasmids 
are grown and maintained on glucose medium, which represses the expression of 
fusion proteins. Plating the yeast strain on galactose containing medium induces the 
expression of the fusion proteins for experimental purposes. Inducible expression 
means there is less opportunity for the foreign fusion protein to have a toxic effect 
on the yeast host and thus be eliminated from the pool of potentially interacting 
proteins. The LexA-based system in this two-hybrid format is therefore often referred 
to as an ‘interaction trap’ (Golemis & Khazak, 1997; Mendelsohn & Brent, 1994). 
The yeast two-hybrid system also has some potential drawbacks. For 
example, the system is limited to proteins that can be transported to the nucleus, 
which may prevent its use with certain extracellular and membrane proteins. 
Proteins must be able to fold and exist stably in yeast cells and to retain activity as 
fusion proteins. The use of protein fusions also means that the site of interaction may 
be occluded by one of the transcription factor domains. Interactions dependent on 
a posttranslational modification that does not occur in yeast cells will not be 
detected. Many proteins, including those normally not involved in transcription, may 
activate transcription when only fused to a DNA-binding domain (Ma & Ptashne, 
1987); this activation prevents a library screen from being performed. However, it is 
often possible to delete a small region of a protein that activates transcription and 
hence to remove the activation function while retaining other properties of the 
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Figure 8. Schematic representation of the LexA-based yeast two-hybrid system. Yeast cells 
are co-transformed with a bait and prey vector, coding for the LexA DNA-binding domain 
(DB) fused to a bait protein and the B42 activation domain (AD) fused to a prey protein 
(i.e. a library member), respectively. The bait is expressed under the control of the 
constitutive ADH1 promoter, whereas the expression of the prey is directed by the 
conditional GAL1 promoter, which is induced in galactose-containing medium but 
repressed in glucose-containing medium. The yeast strain contains two LexA operator-
responsive reporters, one a chromosomally integrated copy of the LEU2 gene (required for 
growth on medium lacking leucine), the second a plasmid bearing a LacZ gene (causing 
yeast to turn blue on medium containing X-gal). If the prey is induced and the encoded 
protein does not interact specifically with the bait protein the two reporters are not 
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activated. If the prey encoded protein interacts with the bait it will result in the activation 
of the two reporters. 
 
protein. The most common problem associated with a library search is the 
identification of false positives: fusion proteins that activate transcription when 
expressed alone, or show a high level of non-specific interactions. A very useful 
table of commonly identified two-hybrid false positives has been compiled 
(http://www.fccc.edu:80/research/labs/golemis/InteractionTrapInWork; a web 
page which gives details of false positives identified in two-hybrid screens). The 
elimination of false positives, however, requires extensive control experiments: clones 
must be tested alone and in combination with a number of unrelated bait fusion 
proteins. Finally, some proteins may be able to interact in yeast cells whereas they 
do not in their natural environment, simply because they are never expressed at the 
same time or in the same tissue or subcellular compartment. Thus it is important to 
confirm a potential interaction by a different strategy or method. A good first step to 
show biological significance is to verify the interaction by a biochemical technique, 
preferably co-immunoprecipitation from a cell in which both proteins are expressed. 
Ideally, the next step would involve a functional assay to show that both proteins 
are involved in the same biological process. 
 
PROTEIN-PROTEIN INTERACTION MAPS: A LEAD TOWARDS CELLULAR FUNCTIONS 
 
Viruses are obligatory intracellular parasites. For their multiplication they are 
essentially dependent on components and machineries provided by the host cell. 
Interactions between viral and host cell proteins occur at all stages of the infection 
process. Viruses recognize their target cell through interaction with specific 
receptors and/or other components on the cell membrane resulting in virion 
internalization. Gene expression of most DNA viruses is mediated by cellular 
polymerases and regulated largely by cellular transcription factors. Most RNA viruses 
replicate and transcribe their genomes by RNA-dependent RNA synthesis, a process 
foreign to eukaryotic cells. Therefore, many of the factors that are normal 
components of cellular RNA translation are subverted to play an integral or 
regulatory role in the replication and transcription of viral RNA. These replication 
complexes often include transient or long-lived interactions with host proteins for 
structural purposes or to recruit regulatory and catalytic functions. It is now well 
established that coupling of the different, sequential steps of virus replication is 
central to the overall infectious cycle of many RNA viruses. Identification of cellular 
interaction partners of viral proteins is therefore likely to provide a more complete 
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understanding of the dynamics of RNA replication, virus-mediated cellular 
modulation and host-range restriction. 
 
AIM OF RESEARCH AND SCOPE OF THESIS 
 
As we argued above, a detailed understanding of the IBDV infection process will 
require a full description of all interactions that the viral proteins have with 
themselves, with each other, and with host cell components. At the start of this 
project very little was known about this. What was known was a partly incorrect 
composition of the viral particle and a first cryoelectron microscopy structure of the 
virion (Bottcher et al., 1997), on the basis of which some interaction could be 
predicted. No host components interacting with viral proteins had been reported 
yet. The aim of this thesis therefore was to initiate making the inventory of 
interactions essential to the IBDV life cycle. To this end, we employed the then 
recently developed yeast two-hybrid system.  
First, we focussed on the homo- and heteromeric interactions of the known 
viral proteins. Proteins usually do not function as individual molecules. Very often 
they assemble into larger complexes, either by homo-oligomerization or by 
interaction with other proteins. Virus assembly is an obvious (and extreme) example 
of this as it is driven by the unique interactions between the viral structural 
components. Our evaluation revealed that several complexes of the viral proteins 
could form in yeast cells, some homologous and one heterologous (Chapter 2). The 
heterologous interaction, between VP1 and VP3, was also detected in vivo in IBDV-
infected cells. Then, we identified the domains responsible for the interaction 
between VP1 and VP3. By using the yeast two-hybrid system as well as by 
mutagenesis of an infectious cDNA clone of IBDV we mapped the domain in VP3 
interacting with VP1 to the extreme carboxy-terminal domain of the polypeptide. 
This interaction appeared to be crucial for the production of infectious progeny. 
These investigations also revealed that VP3 additionally binds to viral dsRNA, both of 
segment A and B (Chapter 3). 
 The results from a yeast two-hybrid search for candidate cellular proteins of 
the bursa of Fabricius interacting with VP1, pVP2, VP3 and VP5 are presented in 
Chapter 4. Putative biological implications for some of the interactions found are 
discussed. The yeast two-hybrid screening using VP1 as bait allowed the isolation of 
eight candidate cDNA clones with full-sequence identity to the carboxy-terminal 
domain of eukaryotic initiation factor 4AII (eIF4AII), a key component in the initiation 
of eukaryotic translation. In Chapter 5 we have followed up on this potential 
interaction. The specific interaction of VP1 with this particular eIF4AII carboxy-
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terminal domain was confirmed by co-immunoprecipitation. Interestingly, no 
interaction was observed between VP1 and full-length eIF4AII. 
 The study presented in Chapter 6 describes a further investigation of the 
potentially self-interacting viral proteins of IBDV. We initially reevaluated the 
interactions between the viral proteins VP1, pVP2, VP3, VP4 and VP5, using the 
coding sequences of pVP2, VP3 and VP4 based on the recently corrected 
polyprotein processing sites. The approach of using yeast two-hybrid interaction 
screens with protein segments, combined with radio-immunoprecipitation assays, to 
map individual contact sites on the viral proteins, yielded valuable information, in 
particular on the importance of the amino-terminal region in the homologous 
interaction of VP3.  
Finally, a comprehensive overview of the results described in chapters 2-6 is 
given in Chapter 7. 
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ABSTRACT 
 
Little is known about the intermolecular interactions between the viral proteins of 
infectious bursal disease virus (IBDV). By using the yeast two-hybrid system, which 
allows the detection of protein-protein interactions in vivo, all possible interactions 
were tested by fusing the viral proteins to the LexA DNA-binding domain and the 
B42 transactivation domain. A heterologous interaction between VP1 and VP3, and 
homologous interactions of  pVP2, VP3, VP5, and possibly of VP1, were found by co-
expression of the fusion proteins in Saccharomyces cerevisiae. The presence of the 
VP1-VP3 complex in IBDV-infected cells was confirmed by co-immunoprecipitation 
studies. Kinetic analyses showed that the complex of VP1 and VP3 is formed in the 
cytoplasm and eventually is released into the cell-culture medium, indicating that 
VP1-VP3 complexes are present in mature virions. In IBDV-infected cells, VP1 was 
present in two forms of 90 kDa and 95 kDa. Whereas VP3 initially interacted with 
both the 90 kDa and 95 kDa proteins, later it interacted exclusively with the 95 kDa 
protein both in infected cells and in the culture supernatant. These results suggest 
that the VP1-VP3 complex is involved in replication and packaging of the IBDV 
genome. 
 
INTRODUCTION 
 
Infectious bursal disease virus (IBDV), a member of the family Birnaviridae (Dobos et 
al., 1979), is the causative agent of a highly contagious immunosuppressive disease 
in young chickens. Two distinct serotypes, I and II, have been identified (McFerran, 
1980; Jackwood & Saif, 1987). All known pathogenic IBDV strains belong to serotype 
I, whereas serotype II viruses, capable of infecting chickens and turkeys, lack clinical 
manifestations of the disease (Ismail et al., 1988; Kibenge et al., 1991). IBDV multiplies 
rapidly in developing B lymphocytes in the bursa of Fabricius, leading to 
immunosuppression. This increases susceptibility to infections with opportunistic 
pathogens and reduces the growth rate of surviving animals (for reviews, see Becht 
& Müller, 1991; Kibenge et al., 1988).  
IBDV is an unenveloped, icosahedral virus about 60 nm in diameter (Hirai & 
Shimakura, 1974). Its  genome is composed of two double-stranded RNA (dsRNA) 
segments designated A and B (Dobos et al., 1979; Müller et al., 1979). The larger 
segment, A (3.3 kb), encodes a 110 kDa  polyprotein (pVP2-VP4-VP3) in a large 
open reading frame (ORF) (Hudson et al., 1986; Spies et al., 1989) which is cleaved 
autocatalytically to give pVP2 (48 kDa), VP3 (32 kDa), and VP4 (28 kDa). The viral 
protease, VP4, is responsible for this self-processing of the polyprotein, but the exact 
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locations of the cleavage sites are unknown (Azad et al., 1987; Jagadish et al., 
1988). How further processing of the precursor pVP2 takes place to yield the 
structural protein VP2 (40 kDa) has not been defined, but cellular proteases are not 
required for this maturation (Kibenge et al., 1997). Since VP2 does not accumulate 
intracellularly, as the other viral proteins do, post-translational modification of pVP2 
into VP2 probably occurs during or after virus assembly (Müller & Becht, 1982). VP4 
has often been described as a minor virion component because it was detected in 
purified virions prepared by a variety of methods (Kibenge et al., 1988). However, 
Granzow et al. (1997) showed that VP4 is not a constituent of mature virions but that 
its presence in virion preparations was due to contaminating VP4-containing type II 
tubules. The major structural proteins of the virion are VP2 and VP3, both constituents 
of the proteinaceous capsid of IBDV. VP2 carries major neutralizing epitopes (Azad 
et al., 1987; Becht et al., 1988), suggesting that it is at least partly exposed on the 
outer surface of the capsid. VP3, the major antigenic component (Fahey et al., 
1985), contains a very basic carboxy-terminal region which might interact with the 
packaged RNA and is therefore expected to be on the inner surface of the capsid 
(Hudson et al., 1986). In addition to the large ORF, segment A also contains a 
second ORF, preceding and partially overlapping the polyprotein gene, which 
encodes VP5 (17 kDa). This nonstructural protein has only been detected in IBDV-
infected cells (Mundt et al., 1995). VP5 proved to be non-essential for IBDV 
replication (Mundt et al., 1997) but plays a role in virus pathogenesis (Yao et al., 
1998), although its exact function is still unknown. The smaller RNA segment, B (2.9 
kb), contains one ORF encoding VP1 (90 kDa), the putative RNA-dependent RNA 
polymerase (RdRp) (Morgan et al., 1988; Spies et al., 1987). This protein is present as 
a free polypeptide and as a genome-linked protein, called VPg, within virions 
(Müller & Nitschke, 1987). 
Viral proteins generally function by interactions with viral and/or host cell 
proteins. Information about these interactions is thus essential for understanding the 
infection process. The yeast two-hybrid system is a technique that can be used to 
identify protein-protein interactions in vivo (Fields & Song, 1989). The system is based 
on the juxtaposition, driven by protein-protein interaction, of a yeast DNA-binding 
domain with a transcriptional activation domain, which results in transcription of a 
reporter gene (Bartel et al., 1993; Chien et al., 1991). Our aim is to use the yeast two-
hybrid system to determine specific protein-protein interactions in vivo between the 
IBDV proteins themselves and between IBDV proteins and cellular proteins. 
Generating interaction maps in this way may be a valuable first tool for the analysis 
of protein interactions present within a virion or during infection. Here, we report the 
evaluation of the interactions between the viral proteins VP1, pVP2, VP3, VP4, and 
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VP5. We found that several complexes can form in yeast cells, some homologous 
and one heterologous. The heterologous interaction (VP1-VP3) was also detected in 
vivo in IBDV-infected cells. These results suggest that the different interactions 
observed may be relevant to the functions of the proteins in the virus replication 
cycle. 
 
MATERIALS AND METHODS 
 
VIRUS, CELL LINE, PLASMIDS AND ANTISERA  
The IBDV isolate CEF94 is a derivate of PV1 (Petek et al., 1973). After receiving the 
PV1 isolate in our laboratory in 1973, we have further adapted this isolate by 
repeated passage (> 25 times) on either primary chicken embryo fibroblast (CEF) 
cells or bursa cells. 
QT35 cells (Moscovici et al., 1977) were cultured in QT35 medium (Fort-
Dodge) supplemented with 5 % foetal calf serum. Plasmids pHB36W (A-segment) 
and pHB34Z (B-segment), which contain full-length genomic cDNA of IBDV strain 
CEF94, were prepared by using full length RT-PCR fragments generated from purified 
dsRNA (H.J. Boot, unpublished results). 
A rabbit polyclonal antibody against VP1 was obtained after immunizing 
rabbits with a gel-purified E. coli expression product consisting of amino acids 580-
881 of VP1 of CEF94 (E. Claassen, unpublished results). A monoclonal antibody 
against VP3 (Mab C3) was kindly provided by H. Müller (University of Leipzig, 
Germany). 
 
CONSTRUCTION OF TWO-HYBRID EXPRESSION PLASMIDS 
cDNA coding sequences of VP1, pVP2, VP3, VP4, and VP5 of IBDV strain CEF94 were 
amplified by PCR by using the Expand high-fidelity PCR system (Boehringer 
Mannheim). The set of primers used was designed to introduce an EcoRI site at the 
upstream (5’) end and a stop codon plus a SalI, XhoI or StuI site at the downstream 
(3’) end of each coding sequence (Table 1). Plasmid pHB36W was used as the DNA 
template for amplification of the pVP2, VP3, VP4, and VP5 genes and plasmid 
pHB34Z was used for amplification of the VP1 gene. The PCR products were 
precipitated, digested with EcoRI/SalI (pVP2, VP3, and VP5), EcoRI/XhoI (VP1) or 
EcoRI/StuI (VP4), gel-purified by the QIAEX-II method (QIAGEN), and ligated with T4 
ligase (New England BioLabs) into the yeast expression vectors pLexABD and pB42AD 
(Clontech). These vectors had previously been digested either with EcoRI/XhoI, or 
with XhoI followed by a treatment with the Klenow fragment of DNA polymerase I 
and subsequent digestion with EcoRI. The ligation mixture was transformed into 
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Escherichia coli DH5-α cells (Life Technologies), which were subsequently grown 
under ampicillin selection. Plasmid DNA prepared from several independent 
transformants was screened for the presence of the insert, and plasmids from 
positive clones were sequenced at the fusion junction by cycle sequencing with an 
ABI 310 sequencer (Perkin Elmer) to ensure correct reading frames. 
 
 
Primer 
 
Protein 
 
LexABD 
plasmid 
 
B42AD 
plasmid 
 
 
Name 
 
 
Sequence 
 
 
VP1 
 
pVP2 
 
VP3 
 
VP4 
 
VP5 
 
pLexABD-VP1 
 
pLexABD-pVP2 
 
pLexABD-VP3 
 
pLexABD-VP4 
 
pLexABD-VP5 
 
pB42AD-VP1 
 
pB42AD-pVP2 
 
pB42AD-VP3 
 
pB42AD-VP4 
 
pB42AD-VP5 
  
 MT09 
 MT10 
 MT01 
 MT02 
 MT05 
 MT06 
 MT03 
 MT04 
 MT07 
 MT08 
  
 ccgGAATTCATGAGTGACATTTTCAACAGTCCA  
 cgtCTCGAGTCATGGCTGTTGGCGGCTCTCC 
 ccgGAATTCATGACAAACCTGCAAGATCAAACCC 
 gatcGTCGACTCACCTTATGGCCCGGATCATGTCTTTG 
 ccgGAATTCCGTTTCCCTCACAATCCACGCGAC 
 gatcGTCGACTCACTCAAGGTCCTCATCAGAGAC 
 ccgGAATTCAGGATAGCTGTGCCGGTGGTCTCC 
 gtAGGCCTTCATTTGATGAACGTTGCCCAGTTGGG 
 ccgGAATTCATGGTCAGTAGAGATCAGACAAACG 
 gatcGTCGACTCACTCAGGCTTCCTTGGAAGGTC 
 
Table 1. Plasmids and primers used in construction of LexABD and B42AD fusion proteins. 
Gene fusions were made by PCR amplification of cDNA flanked by engineered 
restriction sites and ligation into corresponding restriction sites of vectors pLexABD and 
pB42AD. The primer sequences are listed 5’ to 3’. Capital letters in italics denote 
homology with IBDV sequences. The restriction site in each primer is underlined. 
Additional nucleotides 5’ of the restriction site are in lower case letters. Bold letters 
indicate an in-frame stop codon.  
 
 
TWO-HYBRID ANALYSIS 
All two-hybrid media, buffers, and protocols were used as described by Clontech in 
the manual for the Matchmaker LexA two-hybrid system and in the Clontech yeast 
protocols handbook. The yeast strain S. cerevisiae EGY48 (Clontech) was first 
transformed by using the lithium acetate method with the URA3+ plasmid p8op-lacZ 
(Clontech), which has a LacZ reporter gene preceded by an upstream LexA 
binding domain. Transformed cells were amplified and subsequently transformed 
with pLexABD (HIS3
+) and pB42AD (TRP1
+) constructs carrying VP1, pVP2, VP3, VP4 and 
VP5, in every possible pairwise combination. Control plasmids were pLexABD-Bicoid 
(pRHFM1, OriGene), pLexABD-Lamin C (Clontech), pLexABD-53 (Clontech), pB42AD-
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SV40 T (Clontech), and pB42AD-empty vector. This resulted in 43 pairwise 
transformations (see Tables 2 and 3) which were plated onto SD/Glu/-His/-Ura/-Trp 
medium. About 10 His+ Ura+ Trp+ colonies from each transformation were 
subsequently plated onto SD/Gal/Raf/-His/-Ura/-Trp/-Leu medium to assess the 
transcriptional activation of the LEU2 reporter gene and onto SD/Gal/Raf/X-gal/-
His/-Ura/-Trp medium to assess the transcriptional activation of the LacZ reporter 
gene. 
 
pVP2 VP4 VP3
1 452 722 1012
1 145
MT 01
VP5
3’
3’
5’
5’
A-segment
VP1
1 881
3’5’
B-segment
MT 06MT 07
MT 09
MT 03 MT 05
MT 04MT 02
MT 08
MT 10
 
 
Figure 1. Construction of two-hybrid fusion proteins. Schematic representation of 
genome segments A and B of IBDV strain CEF94. The numbers under the lines below 
represent amino acid positions of expressed regions. The positions and names of the 
oligonucleotide primers used in PCR amplification of various regions are indicated. 
The boundaries between the viral proteins pVP2, VP4 and VP3 are deduced from the 
putative cleavage sites reported by Hudson et al. (1986). 
 
The ability of the LexA fusions used in this study to bind operator DNA was confirmed 
by a repression assay. For this, yeast strain S. cerevisiae EGY48 was transformed with 
the URA3+ plasmid pJK101 (OriGene) and, in parallel, with pJK101 together with one 
of the pLexABD constructs carrying VP1, pVP2, VP3, VP4, or VP5. Transformed yeast 
cells were plated onto SD/Glu/-Ura or SD/Glu/-His/-Ura medium. Plasmid pJK101 
contains a LacZ reporter gene, expression of which is driven by the yeast GAL1 
promoter. However, two LexA operators have been placed between the GAL1 
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promoter and the lacZ gene. When a LexABD fusion protein binds to these operators 
there will be a decrease in the level of GAL1-driven lacZ expression. A liquid assay to 
quantitate ß-galactosidase activities was performed by growing  transformants to 
mid-exponential phase in the appropriate selection medium, SD/Gal/Raf/-Ura or 
SD/Gal/Raf/-His/-Ura, and using O-nitrophenyl-ß-D-galactoside as the chromogenic 
substrate. Each enzyme activity assay was performed with at least five independent 
colonies and ß-Galactosidase specific activities were calculated as described by 
Clontech. 
 
RADIOLABELING OF INFECTED CELLS, IMMUNOPRECIPITATION AND GEL 
ELECTROPHORESIS 
Confluent monolayers of QT35 cells (25 cm2) were infected with IBDV strain CEF94 at 
a m.o.i. of 10 or mock-infected. At 2.5 h postinfection (p.i.), cells were starved of 
methionine for 1.5 h in methionine-free EMEM medium (Gibco/BRL). At 4 h p.i., cells 
were either pulsed for 4 h or, in case of the pulse-chase radiolabeling, for 1 h, with 20 
µCi/ml [35S]methionine (Amersham) in methionine-free EMEM medium. The latter 
were subsequently chased for different times in QT35 medium. After the 4 h-pulse or 
the pulse-chase period, the cell-culture medium was discarded (in case of the 4 h-
pulse experiment) or collected (in case of the pulse-chase experiment) and brought 
to a concentration of 1x PBS-TDS lysis buffer with a 5x PBS-TDS lysis buffer stock 
solution (5 % Triton X-100, 2.5 % sodium deoxycholate, 0.5 % SDS, 0.7 M NaCl, 14 mM 
KCl, 50 mM Na2HPO4, 7.5 mM KH2PO4). The cell monolayers were washed three times 
with ice-cold phosphate-buffered-saline (PBS) and solubilized in 1x PBS-TDS lysis 
buffer for 10 min at room temperature. Both the medium and cell lysates were then 
frozen and thawed twice, and clarified by centrifugation for 20 min at 13,000 rpm in 
a microfuge. All lysates were precleared with Protein A Sepharose (Amersham) 
before being immunoprecipitated with anti-VP1 or anti-VP3 antibodies. Protein A 
Sepharose-bound immune complexes were washed three times in 1x PBS-TDS lysis 
buffer and eluted in 20 µl sodium dodecyl sulfate (SDS) sample buffer (60 mM Tris-HCl 
[pH 6.8], 2.5% SDS, 5% β-mercaptoethanol, 10% glycerol, 0.1% bromophenol blue). 
Proteins were resolved on 12% separating gels by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and visualized by phosphor imaging (STORM-840, 
Molecular Dynamics) and ImageQuaNT software (Molecular Dynamics).  
 
CHAPTER 2  INTERACTIONS BETWEEN IBDV PROTEINS 
 
54
RESULTS 
 
INTERACTIONS BETWEEN IBDV PROTEINS IN A YEAST TWO-HYBRID SYSTEM 
In search of protein interactions between the viral proteins of IBDV, we used the 
LexA-dependent two-hybrid interaction assay (Clontech). cDNA segments 
encoding the viral proteins of IBDV strain CEF94 were generated by PCR and 
subcloned into the yeast expression vectors pLexABD and pB42AD (Fig. 1).  
To detect an interaction between the LexABD and B42AD fusion proteins, it is 
crucial that neither fusion protein has an intrinsic or nonspecific ability to activate 
transcription of the reporter genes. Therefore, all LexABD plasmids were 
cotransformed with pB42AD lacking an insert to test for intrinsic activation, while all 
the B42AD plasmids were cotransformed with pLexABD-Bicoid or pLexABD-Lamin C to 
test for specificity of interaction with each of the B42AD fusion proteins. pLexABD-Bicoid 
and pLexABD-Lamin C are commonly used as control plasmids encoding LexA fused 
to the Drosophila protein Bicoid (OriGene) and to the human lamin C, respectively, 
and have been reported not to interact with most other proteins (Bartel et al., 1993; 
Ye & Worman, 1995; Hughes et al., 1996). The results of the assays for reporter-
expression of LEU2 (selectable) and  LacZ (screenable) under the control of LexA 
binding sites are shown in Tables 2 and 3. None of the fusion proteins activated 
expression of the LEU2 and LacZ reporter genes intrinsically or non-specifically. 
Therefore, all interactions between the LexABD and B42AD fusion proteins of IBDV may 
be regarded as specific. Plasmids containing p53 fused to LexABD (Clontech) and 
SV40 large T antigen (SV40 T) fused to B42AD (Clontech) were cotransformed into 
EGY48 and used as a positive control.  
All possible pairwise combinations of plasmids containing the LexABD and 
B42AD fusion proteins were cotransformed into the S. cerevisiae EGY48 strain. We 
observed strong homologous interactions of the viral proteins pVP2, VP3 and VP5 
(Tables 2 and 3). The strength of these interactions was judged by intensity of the 
blue phenotype, which has been suggested to reflect semi-quantitatively the 
stability of the interaction between the candidate proteins (Estojak et al., 1995; Li & 
Fields, 1993; Yang et al., 1992).  
A possible homologous interaction was found for VP1. The yeast strain with 
LexABD-VP1 and B42AD-VP1 showed limited growth on Leucine-selective medium but, 
however, remained negative for ß-galactosidase expression. Measurements of ß-
galactosidase activity were done after one day, when colonies of the positive 
control (LexABD-p53 with B42AD-SV40 T) were deep blue, because at that time we 
could distinguish variations in intensity of the blue color of positive colonies. Beyond 
three days, the true positive colonies all had the same color intensity. Nevertheless,  
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Table 2. Interactions between the viral proteins of IBDV strain CEF94 in the yeast two-
hybrid system, assayed for leucine autotrophy. Growth was recorded after 2 days 
when the strain with LexABD-p53 and B42AD-SV40 T antigen (positive control) showed 
clear growth. +, Clear growth (strong interaction); +/-, limited growth (weak 
interaction); -, no growth (no interaction); ND, not determined. All results shown are 
representative of at least seven independent transformants. 
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Table 3. Interactions between the viral proteins of IBDV strain CEF94 in the yeast two-
hybrid system, assayed for β-galactosidase activity. The relative strength of the 
interaction was judged by intensity of the blue phenotype after 1 day when the 
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strain with LexABD-p53 and B42AD-SV40 T antigen (positive control) had deep-blue 
colonies. ++, Deep-blue colonies (strong interaction); +, light-blue colonies 
(interaction); -, white colonies (no interaction); ND, not determined. All results shown 
are representative of at least seven independent transformants.  
 
after three days of incubation, we observed some ß-galactosidase activity for the 
homologous interaction of VP1 (data not shown). However, we did not consider this 
blue phenotype to represent a true positive interaction because at that time point 
we also observed weak interactions between some of the B42AD fusions with LexABD- 
Bicoid or LexABD-Lamin C as well, although not between B42AD-VP1 and LexABD-
Bicoidor LexABD-Lamin C  (data not shown). Moreover, it is known that there is an 
increased risk of false positive results after a prolonged incubation due to the 
sensitivity of the lacZ reporter system. Taken together, the yeast two-hybrid data 
indicate that VP1 might interact with itself although this would be a very weak 
interaction according to our observation that only one of the two reporters was 
sensitive enough to detect this interaction. 
One heterologous interaction was found, between VP1 and VP3. This 
interaction was found for both reciprocal combinations, although the combination 
of LexABD-VP1 with B42AD-VP3 proved to have a stronger LacZ reporter activity than 
the combination LexABD-VP3 with B42AD-VP1 (Table 3). 
The lack of any significant interaction of the LexABD-VP4 fusion may be a 
consequence of the protein not entering the yeast nucleus and binding to 
operators, since it led to almost no decrease in ß-galactosidase activity in a 
repression assay (data not shown). This repression assay exploits the fact that LexA 
when bound to its operator blocks activation of a constitutively expressed LacZ 
reporter gene (Brent & Ptashne, 1984). 
In summary, the yeast two-hybrid assay demonstrated homologous 
interactions of pVP2, VP3, VP5, and possibly VP1, and a heterologous interaction 
between VP1 and VP3. 
 
VP1 INTERACTS WITH VP3 IN IBDV-INFECTED CELLS 
Since a complex between VP1 and VP3 may have an important function in the virus 
replication cycle (see discussion), we employed a co-immunoprecipitation assay to 
obtain corroborating evidence for this interaction.  
Both IBDV-infected and mock-infected cells were metabolically labeled at 
4 h postinfection, with [35S]methionine, for 4 h. The proteins in the cleared cell lysates 
were subjected to immunoprecipitation with a rabbit polyclonal antibody against 
VP1 or a monoclonal antibody against VP3 and analysed by SDS-PAGE. In addition 
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to the protein against which the antibodies were directed, each antibody co-
immunoprecipitated the other protein, indicating that an interaction had taken 
place between them (Fig. 2). The observation that only a small amount of VP1 was 
co-precipitated by the antibody against VP3 (lane 2) may be a consequence of 
the use of a limiting amount of anti-VP3 antibodies that was unable to precipitate all 
of the VP3. VP3 is probably synthesized in much larger quantities than VP1, since 
analysis of the protein composition of IBDV has shown that VP3 constitutes 40%, 
whereas VP1 constitutes only 3% of the protein in the infectious virus (Dobos et al., 
1979; Kibenge et al., 1988). Therefore, precipitation of a fraction of VP3 will 
precipitate only that proportion of VP1 that is interacting with it, whereas 
precipitation of all the VP3 will precipitate all of the interacting VP1. 
 
 
 
 
 
 
 
 
 
Figure 2. Interaction of VP1 and VP3 
in IBDV-infected cells. IBDV-infected 
QT35 cells were pulsed at 4 h p.i. 
with [35S]methionine for 4 h. At 8 h 
p.i., cells were lysed and subjected 
to immunoprecipitation with 
polyclonal anti-VP1 serum (αVP1) or 
with a monoclonal antibody 
against VP3 (αVP3) followed by 
SDS-PAGE (lanes 1 and 2). Mock-
infected cells were used as controls 
for each immunoprecipitation 
(lanes 3 and 4). Positions of the viral 
proteins and molecular size markers 
(in kDa) are indicated. 
 
 
 
A noteworthy observation was the appearance of two proteins at the position of 
VP1 (90 kDa and 95 kDa), although the existence of these two polypeptides has 
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previously been reported for different IBDV strains (Müller & Becht, 1982; Jackwood 
et al., 1984). The same protein bands were obtained when the immunoprecipitate 
was treated with RNAse prior to SDS-PAGE (data not shown), indicating that the 
difference in size between the two proteins was not due to the presence of a VP1-
RNA complex. 
The other bands obtained in the precipitates with lower apparent molecular 
sizes were VP3 specific, as they were precipitated by anti-VP3 and also co-
precipitated by anti-VP1 antibodies, whereas they were absent in the mock-
infected control. Moreover, the VP3 specificity of these bands, as well as the VP1 
specificity of the 90 and 95 kDa band, was confirmed by Western blot analysis (data 
not shown). 
To test for nonspecific co-immunoprecipitation of VP1 and VP3, we 
synthesized and radiolabeled VP1 and VP3 seperately in vitro in a rabbit reticulocyte 
lysate and tested both antibodies for cross-reactivity. We found that the anti-VP1 
and anti-VP3 antibodies each precipitated only their cognate protein (data not 
shown). In addition, we analysed whether VP1 and VP3 could also interact in vitro 
by co-expression in a rabbit reticulocyte lysate. However, the results showed that 
neither VP1 nor VP3 co-precipitated in vitro (data not shown). 
In summary, the heterologous interaction between VP1 and VP3 that was 
detected in the two-hybrid system could be confirmed by co-immunoprecipitation 
using IBDV-infected cells. 
 
KINETICS OF ASSOCIATION BETWEEN THE VIRAL PROTEINS VP1 AND VP3 IN VIVO 
A pulse-chase experiment was performed with IBDV-infected cells to assess the rate 
of complex formation between VP1 and VP3. Both IBDV-infected and mock-
infected cells were metabolically labeled at 4 h postinfection for 1 h, and chased 
for different times. Subsequently, the proteins in the cleared cell lysates as well as in 
the cell-culture media were immunoprecipitated with antibodies specific for either 
VP1 or VP3 and analysed by SDS-PAGE. Complexes consisting of VP1 and VP3 were 
detected in cell lysates directly after the pulse (Fig. 3A, lanes 1 and 5). VP1 detected 
immediately after the pulse, again appeared to be present in two forms, 90 kDa 
and 95 kDa, in nearly equal amounts (Fig. 3A, lanes 1 and 5). However, during the 
chase, the amount of the 90 kDa protein in the cell lysate decreased more rapidly 
than the amount of the 95 kDa protein (lanes 1 to 4). Furthermore, at 5, 9 and 19 h of 
the chase, VP3 interacted only with the 95 kDa form of VP1 and not with the 90 kDa 
form (lanes 6-8). The same phenomenon was detected in the cell-culture media. 
Here, the complexes consisting of VP1 (95 kDa) and VP3 were detected from 5 h of 
chase onwards, that is 10 h p.i. (Fig. 3B). This timing is consistent with the release of 
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Figure 3. Kinetics of association between the viral proteins VP1 and VP3 in vivo. 
IBDV-infected QT35 cells were pulse-labeled at 4 h p.i. for 1 h with 
[35S]methionine and chased in medium containing an excess of unlabelled 
methionine. At the times indicated, the cell-culture medium was collected and 
cells were lysed. Subsequently, the cleared cell lysates (A) and cell-culture 
media (B) were subjected to immunoprecipitation with polyclonal anti-VP1 
serum (αVP1) or with a monoclonal antibody against VP3 (αVP3) followed by 
SDS-PAGE (lanes 1-8). Mock-infected cells were used as controls for each 
immunoprecipitation (lanes 9-16). Positions of the viral proteins and molecular 
size markers (in kDa) are indicated. 
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progeny virus particles into the culture medium (Petek et al., 1973). 
In the smaller molecular size region, at least two smaller forms of VP3 were 
again detected (Fig. 3A and B).  
Finally, after 5, 9 and 19 h of the chase, two additional bands were 
detected in the high molecular size region (Fig. 3A and B). These two bands proved 
to be VP1 specific, as confirmed by Western blot analysis (data not shown). 
 
 
DISCUSSION 
 
The LexA-dependent yeast two-hybrid system was used to examine all potential 
interactions existing between the viral proteins VP1, pVP2, VP3, VP4, and VP5 of 
IBDV. The resulting set of positive pairings are a heterologous interaction between 
VP1 and VP3 and homologous interactions of pVP2, VP3, VP5, and possibly of VP1 
(Fig. 4).  
The heterologous interaction between VP1 and VP3 was found in different 
strengths in the reciprocal combinations of the LexABD or B42AD plasmids. Such 
“polarity” of two-hybrid interactions is frequently observed (Cuconati et al., 1998; 
Xiang et al., 1995). An interaction can be impaired when a fusion protein is folded 
improperly or inherently unstable, when its expression is poor, or when the fused 
LexABD- or B42AD-domain partly occludes the site of interaction.  
In order to verify whether VP1 and VP3 can interact physically, their 
association was analysed further by co-immunoprecipitation studies. We found that 
VP1 and VP3 interacted in vivo in IBDV-infected cells but not in vitro in a rabbit  
reticulocyte lysate. In the in vitro experiment, the protein(s) may not be folded in 
their native conformation, which would hinder the interaction. Likewise, Black et al. 
(1998) detected interactions in a co-immunoprecipitation assay among the proteins 
G2R, A18R, and H5R of vaccinia virus expressed during infection, whereas they failed 
to detect these interactions when these proteins were synthesized in vitro in a rabbit 
reticulocyte lysate. The interaction between VP1 and VP3 is specific, since the 
antibodies used showed no cross-reactivity in a co-immunoprecipitation assay of 
VP1 and VP3 synthesized seperately in vitro. It should also be mentioned that all 
immunoprecipitations were performed in the presence of a small amount of SDS to 
disrupt virions. Since this detergent did not disrupt the VP1-VP3 complex, this 
interaction proved to be relatively strong, which is consistent with the data from the 
yeast two-hybrid assay.  
The interaction between VP1 and VP3 is intriguing, as the known or putative 
biochemical and biological properties of these proteins do not suggest the 
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likelihood of such an interaction. The complexes consisting of VP1 and VP3 are 
formed immediately or shortly after translation in the cytoplasm of IBDV-infected 
cells, and are eventually released into the cell-culture medium from 10 h 
postinfection onwards. Therefore, it is likely that VP1-VP3 complexes are also present 
in mature virions, since this timing is consistent with the release of extracellular 
progeny virus particles into the culture medium (Petek et al., 1973). 
In our co-immunoprecipitation studies, we detected two proteins in the 
molecular mass region of VP1, of 90 kDa and 95 kDa. Müller & Becht (1982) and 
Jackwood et al. (1984) have previously reported the existence of these two 
polypeptides in different IBDV strains. They indicated that these proteins may have a 
precursor-product relationship. Since the VP1 specificity of these proteins has been 
confirmed by Western blot analysis (data not shown), we now have the first 
evidence that these are indeed two forms of VP1. We found that VP3 interacts with 
both forms of VP1 immediately or shortly after translation (Fig. 2, lane 2, and Fig. 3A, 
lane 5), but that later during infection VP3 interacts only with the 95 kDa form of VP1 
(Fig. 3A and B, lanes 6 to 8). Further experimentation is required to determine the 
exact nature of these two forms of VP1 and whether there is a precursor-product 
relationship between them. The difference in size between these two forms is 
probably not a consequence of a VP1-RNA complex, since there was no change in 
size of either the 90 kDa or 95 kDa protein after RNAse treatment (data not shown). 
However, it has been shown for infectious pancreatic necrosis virus that short VP1-
linked oligonucleotides can survive RNAse treatment, probably due to steric 
hindrance by the unusually large VP1 (Magyar et al., 1998).  
It was noteworthy that, after RNAse treatment, the two additional VP1-
specific bands detected in the high molecular size region after 5, 9 and 19 h of the 
chase (Fig. 3A and B), had disappeared, meaning that these bands represented 
VP1-RNA complexes. 
It should also be mentioned that in addition to the 32 kDa form of VP3 we 
also detected at least two smaller forms of VP3 (Figs 2 and 3). Such forms are 
frequently seen in IBDV infected cells but are usually ignored or confused with VP4. 
In infectious pancreatic necrosis virus, one such form has been described as VP3a 
(Dobos, 1995a). 
Recently, the interaction between VP1 and VP3 has also been described by 
Lombardo et al. (1999) who observed the interaction by co-localisation and co-
immunoprecipitation studies of vaccinia virus expressed VP1 and VP3. Their and our 
results raise several interesting possibilities regarding the function of the interaction 
between VP1 and VP3. The interaction may be involved in the regulation of viral 
RNA synthesis or may be a part of the replication apparatus, as has been proposed 
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for the interaction between the RdRp and the virus coat protein of tobacco vein 
mottling virus (Hong et al., 1995). An interaction between the RdRp and the virus 
coat protein has also been observed for alfalfa mosaic virus (AIMV) (Quadt et al., 
1991). In this case, minus-strand synthesis by the AIMV RdRp is inhibited by AIMV coat 
protein (Quadt et al., 1991). In rotavirus, an interaction between the inner capsid 
protein,VP6, and the inner core polypeptide, VP3, is necessary for recovery of RNA 
polymerase activity (Sandino et al., 1994). Alternatively, the interaction between 
VP1 and VP3 may be involved in virus assembly or encapsidation of the virus. It is 
known for hepatitis B viruses that an interaction between the viral polymerase and 
capsid protein is required for encapsidation of their pregenomic RNA (Ziermann & 
Ganem, 1996). These and other possibilities await further experimental study to 
elucidate the exact function of the interaction between VP1 and VP3. 
 
VP1/(VPg) VP3
Heterologous  
interaction
VP2
VP1/(VPg) VP1/(VPg)
VP2
VP5
VP3 VP3
VP5
Homologous 
interactions
Detected as a 
very weak 
interaction  
 
Figure 4. Protein linkage map of the viral proteins of IBDV 
suggested by data obtained by the yeast two-hybrid system. 
 
Of the homologous two-hybrid interactions found, we did not interpret the VP1-VP1 
interaction as a true positive interaction, since this interaction resulted in very weak 
reporter activity. The signal for this homologous  interaction was so weak that LacZ 
expression was undectable (Table 3). The weakness of this interaction may be 
related to an intrinsically weak interaction between VP1 polypeptide chains. 
However, as mentioned above, weak signals in the two-hybrid assay are not 
necessarily indicative of the strength of specific protein-protein interaction; poor or 
unstable expression, improper folding, or steric hindrance of the fused LexABD- or 
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B42AD-domains at the site of interaction, may impair the interaction. Using the two-
hybrid system, Xiang et al. (1998) reported a very weak interaction between the 
proteins 3AB and 3CDpro of poliovirus, which was observed as a strong interaction 
when tested by far-Western blotting. It is conceivable that a homologous interaction 
of VP1 can occur. Xiang et al (1998) reported an interaction between VPg and the 
polymerase 3Dpol of poliovirus. The poliovirus protein VPg is covalently linked to the 5' 
ends of both genomic and antigenomic viral RNA and 3Dpol is the RNA-dependent 
RNA polymerase. These authors suggested that a direct interaction between these 
molecules is involved in the mechanism of initiation of viral RNA synthesis. VP1 of 
IBDV exists also as a genome-linked protein (VPg) (Müller & Nitschke, 1987). 
Therefore, an interaction between VPg and VP1 of IBDV may have a similar 
function. Moreover, it has been suggested that the initiation of viral RNA synthesis of 
birnaviruses may involve two VP1 molecules, one serving as a primer and the other 
for polymerase chain elongation (Dobos, 1995b). 
We expected to find an interaction between VP2 and VP3, since these two 
proteins comprise the proteinaceous capsid of IBDV. Although we used pVP2 
instead of mature VP2, this should not influence the results, since Kibenge et al. 
(1999) showed that processing of pVP2 to VP2 is not necessary for capsid assembly. 
However, no heterologous interaction between pVP2 and VP3 was detected, only 
strong homologous interactions of pVP2 and VP3. Of course, false-negative results 
from the yeast two-hybrid assay are not without precedent, as failure to identify 
other known protein-protein interactions in the two-hybrid system has been reported 
(Cuconati et al., 1998; Fields & Sternglanz, 1994; Van Aelst et al., 1993). On the basis 
of electron micrographs, the subunits of the IBDV capsid are predominantly 
clustered as trimers (Bottcher et al., 1997). On the outer surface, the trimer units 
protrude from a continuous shell of density, and on the inner surface these trimers 
appear as Y-shaped units. Bottcher et al. (1997) suggested that it is likely that the 
outer trimers correspond to the protein VP2, carrying the dominant neutralizing 
epitopes, and the inner trimers correspond to protein VP3, which has a basic 
carboxy-terminal tail expected to interact with the packaged RNA. According to 
this study, it is not surprising to find strong homologous interactions for pVP2 and VP3. 
Therefore, it is also possible that (p)VP2 interacts only with VP3 when they are both 
present as a trimer subunit. If so, this cannot be detected in the yeast two-hybrid 
system. It is worth noting that, in the co-immunoprecipiation studies with anti-VP3 
serum, we detected no interaction between VP2 and VP3, consistent with the data 
obtained with the yeast two-hybrid system. However, as mentioned above, all the 
immunoprecipitations were performed in the presence of a small amount of SDS, so 
the presumed VP2-VP3 interaction could have been disrupted. 
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A homologous interaction was also detected for VP5. Since the exact function of 
this protein is still unknown, it is difficult to speculate about the functional 
significance of this interaction. A VP5 deficient virus can replicate in the bursa of 
inoculated chickens but will not induce bursal lesions (Yao et al., 1998). Whether VP5 
must assemble into dimers or multimers to produce its effects is unkown. 
One potential drawback of a two-hybrid system arises when the fusion 
protein fails to localize to the nucleus and bind operators. This was possibly the case 
for the LexABD-VP4 fusion protein, since this fusion protein showed no significant 
interaction with other viral proteins. Moreover, we performed a repression assay in 
which VP4 caused hardly any repression of transcription of the LacZ reporter gene 
(data not shown). This means that nuclear localization or operator binding of this 
fusion protein is impaired. However, since the B42AD-VP4 fusion protein, which 
possesses a nuclear localization signal and does not have to bind operators, also 
showed no interaction with other viral proteins, VP4 is probably not able to form 
heterologous complexes with the distinct viral proteins. Whether VP4 is able to 
interact with itself therefore remains uncertain. A homologous interaction of VP4 is 
not inconceivable, since VP4 aggregates to type II tubules (Granzow et al., 1997).  
All the interactions found between the viral proteins of IBDV were detected 
in the classical attenuated strain CEF94. To check whether there are significant 
differences between this attenuated strain and a very virulent strain, we also 
determined the two-hybrid interactions between the viral proteins of the very 
virulent isolate D6948, with the exception of VP1. The interactions observed were the 
same as found for the classical attenuated strain, indicating that there are probably 
no great differences between these strains in this respect (data not shown).  
Taken together, the interactions observed between the viral proteins of IBDV 
described in the present study underscore the highly coordinated nature of the 
events in which these proteins must participate during genome expression, 
replication and assortment. However, extensive studies are still required to confirm 
the role of these proteins and the functional relevance of the interactions 
described. 
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ABSTRACT  
 
Infectious bursal disease virus (IBDV) is a double-stranded RNA (dsRNA) virus of the 
Birnaviridae family. Its two genome segments are encapsidated together with 
multiple copies of the viral RNA-dependent RNA polymerase, VP1, in a single-shelled 
capsid that is composed of VP2 and VP3. In this study we identified the domains 
responsible for the interaction between VP3 and VP1. Using the yeast two-hybrid 
system we found that VP1 binds to VP3 through an internal domain, while VP3 
interacts with VP1 solely by its carboxy-terminal 10 amino acids. These results were 
confirmed by using a reverse genetics system that allowed us to analyze the 
interaction of carboxy-terminally truncated VP3 molecules with VP1 in infected cells. 
Co-immunoprecipitations with VP1- and VP3-specific antibodies revealed that the 
interaction is extremely sensitive to truncation of VP3. The mere deletion of the C-
terminal residue reduced co-precipitation almost completely and also fully 
abolished production of infectious virions. Surprisingly, these experiments additionally 
revealed that VP3 also binds to RNA. RNase treatments and RT-PCR analyses of the 
immunoprecipitates demonstrated that VP3 interacts with dsRNA of both viral 
genome segments. This interaction is not mediated by the carboxy-terminal domain 
of VP3 since C-terminal truncations of 1, 5 or 10 residues did not prevent formation of 
the VP3-dsRNA complexes. VP3 seems to be the key organizer of birnavirus structure 
as it maintains critical interactions with all components of the viral particle: itself, 
VP2, VP1 and the two genomic dsRNAs. 
 
INTRODUCTION 
 
Infectious bursal disease virus (IBDV) is the causative agent of a highly contagious 
disease of young chickens. IBDV multiplies rapidly in developing B lymphocytes in 
the bursa of Fabricius, leading to immunosuppression and increased susceptibility to 
other diseases. Of the two IBDV serotypes, only serotype 1 is pathogenic to chickens 
(Jackwood et al., 1982). IBDV belongs to the family Birnaviridae (Dobos et al., 1979). 
Members of this family are characterized by a double-stranded RNA (dsRNA) 
genome consisting of 2 segments (A and B) that are packaged within a single 
shelled icosahedral capsid of 60 nm. 
The smaller genome segment B of IBDV (approximately 2.9 kb) encodes a 
single protein, viral protein 1 (VP1; 91 kDa). This protein is the putative RNA-
dependent RNA polymerase (RdRp) (Bruenn, 1991). It has the intriguing feature of 
occurring in virions in two forms, both covalently bound to the 5’ ends of the 
genomic dsRNA segments (viral protein genome-linked; VPg) (Dobos, 1993), and as 
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a free polypeptide. The larger dsRNA segment A (approximately 3.3 kb) contains 
two partly overlapping open reading frames (ORFs). The first ORF encodes a non-
structural protein, VP5 (17 kDa).  This protein proved to be non-essential for viral 
replication and infection (Granzow et al., 1997; Mundt et al., 1997; Yao et al., 1998). 
The second ORF encodes a 110 kDa polyprotein, which is autocatalytically cleaved 
to give pVP2 (48 kDa), VP4 (28 kDa) and VP3 (32 kDa). The viral protease VP4, 
through a catalytic site belonging to the Lon-protease family, is responsible for this 
self-processing of the polyprotein (Birghan et al., 2000; Lejal et al., 2000; Sanchez & 
Rodriguez, 1999). During virus maturation, the precursor pVP2 is further processed 
into mature VP2 (40 kDa) probably as a result of a site-specific cleavage of pVP2 by 
VP4 protease activity (Kibenge et al., 1997; Lejal et al., 2000). 
VP2 and VP3 are the major viral structural proteins. They form the 
proteinaceous capsid, the structure of which was shown by cryoelectron 
microscopy and image reconstruction to exhibit a T=13 lattice (Bottcher et al., 1997; 
Caston et al., 2001). The capsid shell is composed of homotrimeric subunits of VP2 
and VP3; 260 VP2 trimers constitute the outer surface while the 200 Y-shaped VP3 
trimers line the inner surface. Consistently, VP2 carries the major neutralizing epitopes 
(Azad et al., 1987; Becht et al., 1988) while VP3, by virtue of its basic carboxy-
terminal domain, has been suggested to interact with the packaged dsRNA 
(Bottcher et al., 1997; Hudson et al., 1986). 
While these ultrastructural studies already provided important insight into the 
general architecture of the virus, essentially nothing is yet known about the specific 
interactions between the different viral components and how these give rise to the 
formation of viral particles. We and others recently reported that VP3 is able to 
associate with VP1 (Lombardo et al., 1999; Tacken et al., 2000). We showed that 
VP1-VP3 complexes are formed in the cytoplasm of IBDV-infected cells and 
eventually released into the cell culture medium, suggesting that the viral 
polymerase is incorporated into virions through interactions with the inner capsid 
protein (Tacken et al., 2000). Likewise, Lombardo et al. (1999) showed that VP1 is 
efficiently incorporated into IBDV virus-like particles (VLPs) produced in mammalian 
cells co-expressing the IBDV polyprotein and VP1.  
In the present study we have followed up on these supposedly essential 
interactions. By using the yeast two-hybrid system as well as by mutagenesis of an 
infectious cDNA clone of the virus we mapped the domain in VP3 interacting with 
VP1 to the extreme carboxy-terminal tail of the polypeptide. This interaction 
appeared not to be required for negative-strand RNA synthesis but to be crucial for 
the production of infectious progeny virus as deletion of just 1 carboxy-terminal 
residue already abolished virus replication. These investigations also revealed that 
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VP3 additionally binds to viral dsRNA, both of the A segment and of the B segment, 
and that it does so through a domain distinct from that binding to VP1.  
 
MATERIALS AND METHODS 
 
CELLS, VIRUSES, PLASMIDS AND ANTISERA 
QM5 cells (Antin & Ordahl, 1991) were cultured in QT35 medium (Gibco-BRL) 
supplemented with 5 % fetal calf serum (FCS) and 2% antibiotic solution ABII (1,000 U 
of penicillin [Yamanouchi], 1 mg of streptomycin [Radiumfarma], 20 µg of 
amphotericin B [Fungizone], 500 µg of polymixin B, and 10 mg of kanamycin/ml) in a 
CO2 (5%) incubator at 37°C. The classical IBDV isolate CEF94 is a derivate of PV1 
which has been adapted for growth in cell cultures (Boot et al., 1999; Petek et al., 
1973). Recombinant fowlpox virus expressing the T7 polymerase gene (FPV-T7) 
(Britton et al., 1996) was received from the laboratory of M. Skinner (Compton 
Laboratory, Berks, United Kingdom). The preparation of the plasmids pHB36W (A-
segment) and pHB34Z (B-segment) which contain full-length genomic cDNA of IBDV 
strain CEF94, has been described (Boot et al., 1999). Polyclonal rabbit antisera 
against VP1 and VP3 were produced by injecting rabbits with purified recombinant 
VP1 or VP3 (Boot et al., 2000a; Tacken et al., 2000). Monoclonal antibody directed 
against VP3 (MAb C3) was kindly provided by H. Müller (University of Leipzig, 
Germany). 
 
CONSTRUCTION OF TWO-HYBRID EXPRESSION PLASMIDS 
Copy DNA encoding the full-length sequences of VP1 and VP3 of IBDV strain CEF94, 
or defined parts thereof (see figure 1), were amplified by PCR by using the Expand 
high fidelity PCR system (Boehringer Mannheim). Plasmid pHB36W was used as the 
DNA template for preparing the VP3 constructs and plasmid pHB34Z for the VP1 
constructs. The sets of primers used were designed to introduce an EcoRI site at the 
upstream (5’) end and a stop codon plus either a SalI site (VP3 constructs) or a XhoI 
site (VP1 constructs) at the downstream (3’) end of each coding sequence (Table 
1). PCR products were precipitated, digested with EcoRI/SalI (VP3 PCR fragments) or 
EcoRI/XhoI (VP1 PCR fragments), gel purified by the QIAEX-II method (QIAGEN), and 
ligated with T4 DNA ligase (New England BioLabs) into the yeast expression vectors 
pLexABD and pB42AD (Clontech). These vectors had previously been digested with 
EcoRI/XhoI. The ligation mix was transformed into Escherichia coli DH5-α cells (Life 
Technologies) which were subsequently grown under ampicillin selection. Plasmid 
DNA prepared from several independent transformants was screened for the 
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presence of the insert, and plasmids from positive clones were sequenced at the 
fusion junction by cycle sequencing using an ABI 310 sequencer (Perkin Elmer) to 
ensure correct reading frames. 
 
TWO-HYBRID ANALYSIS 
All two-hybrid media, buffers, and protocols were prepared and used as described 
by Clontech in the manual for the Matchmaker LexA Two-Hybrid System and in the 
Clontech Yeast Protocols Handbook. The yeast strain S. cerevisiae EGY48 (Clontech) 
was transformed by using the lithium acetate method with the URA3+ plasmid p8op-
lacZ (Clontech), which has a LacZ reporter gene preceded by an upstream LexA 
binding domain. Transformed cells were amplified and subsequently co-transformed 
with pLexABD (HIS3
+) and pB42AD (TRP1
+) constructs carrying the VP1 cDNA (or 
fragments thereof) and the VP3 cDNA (or segments thereof). Control plasmids were 
pLexABD-Bicoid (pRHFM1, OriGene) and pB42AD-empty vector. Transformants were 
plated onto SD/Glu/-His/-Ura/-Trp medium. His+ Ura+ Trp+ colonies from each 
transformation were subsequently plated onto SD/Gal/Raf/-His/-Ura/-Trp/-Leu 
medium to assess the transcriptional activation of the LEU2 reporter gene and onto 
SD/Gal/Raf/5-bromo-4-chloro-3-indolyl ß-D-galactopyranoside (X-gal)/-His/-Ura/-Trp 
medium to assess the transcriptional activation of the LacZ reporter gene. 
Transformants containing plasmids pLexABD-53 (Clontech) and pB42AD-SV40 T 
(Clontech), in which 53 codes for the murine p53 protein known to physically 
associate strongly with SV40 large T antigen (Chien et al., 1991; Li & Fields, 1993), 
served as a positive control to assess assay conditions.  
 
MODIFICATION OF THE FULL-LENGTH cDNA CLONE OF IBDV SEGMENT A  
Plasmid pHB36W was used for oligonucleotide-directed mutagenesis to introduce 
stop codons in the 3’ terminal region of the coding strand of VP3 by PCR. Primers 
p139, p140, p141, and p142 (Table 1) containing nucleotide substitution(s) to create 
these stop codons were used in combination with primer p138 (Table 1). 
The resulting PCR fragments were digested with BglII and KpnI, agarose gel 
purified (Qiaex gel extraction kit), and ligated (Rapid ligation kit, Boehringer-
Mannheim) into the full-length segment A clone (pHB36W), which had been 
digested with the same restriction enzymes. The ligation mixture was subsequently 
used to transform Escherichia coli DH5-α cells (Life Technologies). To confirm the 
correct nucleotide sequence of the pHB36W derivates, designated pHB36W-
VP3∆1(tag), pHB36W-VP3∆1(tga), pHB36W-VP3∆5(tga), and pHB36W-VP3∆10(tga), 
respectively, we determined the nucleotide sequence of the exchanged part 
(BglII/KpnI fragment). Two independently obtained plasmids of each pHB36W 
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derivate were used for in vitro transcription/translation and for transfection of QM5 
cells. 
 
IN VITRO TRANSCRIPTION AND TRANSLATION 
In vitro T7 polymerase-driven expression was carried out by using the TNT Quick 
coupled transcription/translation system (Promega) as described by the 
manufacturer, except that reactions were performed in a final volume of 2.5 µl. 
Plasmid pHB36W or its derivatives (0.4 µg) were used as template. The resulting viral 
proteins were resolved in 12% separating gels by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and visualized by autoradiography. 
 
TRANSFECTION OF QM5 CELLS 
QM5 cells were grown to 80% confluency in 60-mm dishes and infected with FPV-T7 
(multiplicity of infection [MOI] = 3). After 1 h, the cells were washed once with 5 ml 
QT35 medium and covered with 5 ml of Optimem 1 (Gibco-BRL). In the meantime, 
2.0 µg of DNA was mixed with 25 µl Lipofectamine (Gibco-BRL) in 0.5 ml Optimem 1 
and kept at room temperature for at least 30 min. The QM5 cells were subsequently 
covered with 4 ml of fresh Optimem 1, and the DNA-Lipofectamine mixture was 
added. The transfection was performed overnight (18 h) in a 37°C incubator (5.0% 
CO2). The transfected monolayer was rinsed once with QT35 medium and fresh QT35 
medium supplemented with 5% FCS and 2% ABII was added. The plates were further 
incubated for another 24 h. 
 
RADIOLABELING OF TRANSFECTED CELLS, IMMUNOPRECIPITATION AND GEL 
ELECTROPHORESIS 
At 48 h post-transfection, cells were starved for 1 h in methionine-free Eagle’s 
minimal essential medium (EMEM) (Gibco-BRL). Cells were then labeled for 3 h with  
 
 
Table 1. Nucleotide sequences and positions of the primers used for VP1 and VP3 
deletion mutagenesis, for the generation of mutant segment-A cDNA constructs, and 
for RT-PCR analysis 
a  The primer sequences are listed 5’ to 3’. Restriction sites are in italics. Additional 
nucleotides 5’ of a restriction site are in lowercase. Boldface letters indicate an in-
frame stop codon. Mutated nucleotides are underlined.  
b  A+ and B+, A and B segment plus strands, respectively; A– and B–, A and B 
segment minus strands, respectively. 
c  (+) RNA, plus strand RNA; (–) RNA, minus strand RNA. 
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Primer Nucleotide sequencea Positionb       Purposec 
 
p009 ccgGAATTCATGAGTGACATTTTCAACAGTCCAC B+ (nt 112) VP1 and VP1∆C derivates 
p110 cgtCTCGAGTCATGGCTGTTGGCGGCTCTCC B− (nt 2754) VP1 and VP1∆N derivates 
p075 ccgGAATTCCTCTTGATCCCTAAAGTTTGGGTG B+ (nt 202) VP1∆N30 
p076 ccgGAATTCGTTTTGCAGCCACGGTCTCTGC B+ (nt 292) VP1∆N60 
p078 ccgGAATTCCCCAATGCGTACCCGCCAGAC B+ (nt 472) VP1∆N120 
p080 ccgGAATTCGAGGTCGCCACTGGAAGAAACC B+ (nt 652) VP1∆N180 
p082 ccgGAATTCGGCGACTTTGAGGTTGAAGATTAC B+ (nt 832) VP1∆N240 
p084 ccgGAATTCAAGAAGCTACTCAGCATGTTAAGTG B+ (nt 1012) VP1∆N300 
p086 ccgGAATTCAATAACGTGTTGAACATTGAAGGGTG B+ (nt 1192) VP1∆N360 
p088 ccgGAATTCGAGGCAAACTGCACTCGCCAAC B+ (nt 1372) VP1∆N420 
p089 ccgGAATTCCAAACATGGGCCACCTTTGCCATG  B+ (nt 1462) VP1∆N450 
p104 cgtCTCGAGTCATCTGCTCGTTCCTGCTCCGAG B− (nt 2664) VP1∆C30 
p103 cgtCTCGAGTCACTGTGGGTTCTTGACTTCTGGG B− (nt 2574) VP1∆C60 
p101 cgtCTCGAGTCACTTGGACTTGTGGAGTTTCTCGG B− (nt 2394) VP1∆C120 
p099 cgtCTCGAGTCAGGGCTTGGGGGGTACTGGCTTG B− (nt 2214) VP1∆C180 
p097 cgtCTCGAGTCAGCAGGCTTTGTTCAGGAGTGGG B− (nt 2034) VP1∆C240 
p095 cgtCTCGAGTCAGAGATCTTTGCTGTATGTAGCTGAC B− (nt 1854) VP1∆C300 
p093 cgtCTCGAGTCACTCAATTGATTTGAACTCCTCGCTG B− (nt 1674) VP1∆C360 
p091 cgtCTCGAGTCAGGCAATGTTCATGGCAAAGGTGG B− (nt 1494) VP1∆C420 
p090 cgtCTCGAGTCAGGCTTGCATGTGTTGGCGAGTG B− (nt 1404) VP1∆C450 
p057 tcGAATTCGCTTCAGAGTTCAAAGAGACCCCC A+ (nt 2396) VP3 and VP3∆C derivates 
p006 gatcGTCGACTCACTCAAGGTCCTCATCAGAGAC A− (nt 3166) VP3 and VP3∆N derivates 
p061 aagtGTCGACTCAGCTTGGCCCTCGGTGCCCATTG A− (nt 2782) VP3∆C129 
p060 ccgGAATTCGGCCAGCTAAAGTACTGGCAGAAC A+ (nt 2786) VP3∆N129 
p063 aagtGTCGACTCAATAGACTTTGGCAACTTCGTCTATG A− (nt 2977) VP3∆C64 and VP3∆N64,C64 
p062 ccgGAATTCAACGCACCACAAGCAGGCAGCAAG A+ (nt 2588) VP3∆N64 
p064 gatcGTCGACTCACCAGCGGCCCAGCCGACCAG A− (nt 3136) VP3∆C10 
p065 gatcGTCGACTCATGTTGGAGCATTGGGTTTTGGCTTG A− (nt 3106) VP3∆C20 
p066 gatcGTCGACTCATGGTAGAGCCCGCCTGGGATTGCG          A− (nt 3076) VP3∆C30 
p067 gatcGTCGACTCACAGCTCCATCGCAGTCAAGAGCAGATC A− (nt 3046) VP3∆C40 
p068 gatcGTCGACTCACATCTGTTCTTGGTTTGGGCCACGTC A− (nt 3016) VP3∆C50 
p069 gatcGTCGACTCAGTTGATTTCATAGACTTTGGCAACTTCG A− (nt 2986) VP3∆C60 
p106 gatcGTCGACTCAAAGGTCCTCATCAGAGACGGTCC A− (nt 3163) VP3∆C1 
p107 gatcGTCGACTCAGTCCTCATCAGAGACGGTCCTG A− (nt 3160) VP3∆C2 
p108 gatcGTCGACTCAATCAGAGACGGTCCTGATCCAGC A− (nt 3154) VP3∆C4 
p109 gatcGTCGACTCAGACGGTCCTGATCCAGCGGCC A− (nt 3148) VP3∆C6 
p110 gatcGTCGACTCACCTGATCCAGCGGCCCAGCC A− (nt 3142) VP3∆C8  
p111 tcGAATTCGAAGAACAAATCCTAAGGGCAGCTAC A+ (nt 2882) VP3∆N162 
p112 tcGAATTCGAAATCAACCATGGACGTGGCCC A+ (nt 2978) VP3∆N194 
p113 tcGAATTCCCAAAGCCCAAGCCAAAACCCAATG A+ (nt 3074) VP3∆N226 
p114 tcGAATTCATCAGGACCGTCTCTGATGAGGAC A+ (nt 3137) VP3∆N248 
p138 CTCAAAGAAGATGGAGACC A+ (nt 2704) pHB36W derivates 
p139 CAGGTACCTCACTAAAGGTC A− (nt 3177) pHB36W-VP3∆1(tag) 
p140 CAGGTACCTCATCAAAGGTCC A− (nt 3177) pHB36W-VP3∆1(tga) 
p141 CAGGTACCTCACTCAAGGTCCTCTCAAGAGAC A− (nt 3177) pHB36W-VP3∆5(tga) 
p142 CAGGTACCTCACTCAAGGTCCTCATCAGAGACGGTCCTTCACCAGC      A− (nt 3177) pHB36W-VP3∆10(tga) 
pA(+) CCCTGACCCTGTGTCCCCCACAGTC A− (nt 295) RT, (+)RNA segment A 
pAC1 GATCGGTCTGACCCCGGGGGAG A+ (nt 3) PCR, segment A specific 
pANC1 TAGGTCGAGGTCTCTGACCTGAGAG A− (nt 264) PCR, segment A specific 
pA(−) GTGCATGCAGAGAAGAGCCGGTTGGC A+ (nt 2852) RT, (−)RNA segment A 
pANC2 ACCCGCGAACGGATCCAATTTGGG A− (nt 3256) PCR, segment A specific 
pAC2 ATCTACGGGGCTCCAGGACAGGC A+ (nt 2912) PCR, segment A specific 
pB(+) GGGCGATGTGTTGGGTAGTACTTTGGG B− (nt 458) RT, (+)RNA segment B 
pBC1 ATACGATGGGTCTGACCCTCTGGG B+ (nt 3) PCR, segment B specific 
pBNC1 GGAAGTACTCCTGATCTCCAATAGGG B− (nt 433) PCR, segment B specific 
pB(−) GGGTTCCCACTCGACGAGTTCCTAGC B+ (nt 2077) RT, (−)RNA segment B 
pBNC2 CCCCCGCAGGCGAAGGCCGGG B− (nt 2822) PCR, segment B specific 
pBC2 TGAGCTGTCAGAGTTCGGTGAGGC B+ (nt 2112) PCR, segment B specific 
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20 µCi of [35S]methionine (Amersham)/ml in methionine-free EMEM. At the end of the 
labeling, the cell cultures were lysed on ice in 1x phosphate-buffered saline (PBS)-
TDS lysis buffer, using a 5x PBS-Triton-sodium deoxycholate-SDS (TDS) lysis buffer stock 
solution (5 % Triton X-100, 2.5 % sodium deoxycholate, 0.5 % SDS, 0.7 M NaCl, 14 mM 
KCl, 50 mM Na2HPO4, 7.5 mM KH2PO4). Cell debris was removed by centrifugation at 
4°C for 20 min at 13,000 × g. All lysates were pretreated with Protein A Sepharose 
(Amersham) prior to being immunoprecipitated with polyclonal anti-VP1 serum or 
monoclonal anti-VP3 (MAb C3) serum. Protein A Sepharose-bound immune 
complexes were washed three times in 1x PBS-TDS lysis buffer and eluted in 30 µl 
sodium dodecyl sulfate (SDS) sample buffer (60 mM Tris-HCl [pH 6.8], 2.5% SDS, 5% β-
mercaptoethanol, 10% glycerol, 0.1% bromophenol blue). Proteins were resolved in 
12% separating gels by SDS-PAGE and visualized by autoradiography. 
 
RNase TREATMENT OF IMMUNOPRECIPITATES 
Before SDS-PAGE the Protein A Sepharose-bound immune complexes were 
resuspended in 10 µl of 10 mM Tris-HCl (pH 7.5) and treated as follows. For RNaseONE 
treatment, the immunoprecipitates were incubated for 45 min at 37°C with 1,000 
U/ml RNaseONE (Promega) in 10 mM Tris-HCl (pH 7.5), 5 mM EDTA, and 200 mM 
sodium acetate. RNaseONE, a RNase able to cleave a phosophodiester bond 
between any two ribonucleotides, catalyzes the degradation of ssRNA to cyclic 
nucleotide monophosphate intermediates (Promega). For RNaseA treatment, the 
immunoprecipitates were incubated for 45 min at 37°C with RNaseA at a 
concentration of 100 µg/ml in 10 mM MgCl2. RNaseA is often considered as an 
ssRNA-specific enzyme, though at a low salt concentration (i.e. 10 mM MgCl2 ) it 
degrades both ssRNA and dsRNA (Libonati & Sorrentino, 2001). At the end of the 
RNase treatments the sepharose beads were collected and washed three times 
with 1x PBS-TDS lysis buffer, after which the immune complexes were eluted in 30 µl 
SDS-sample buffer and subjected to SDS-PAGE. 
 
RT-PCR ANALYSIS OF IMMUNOPRECIPITATES  
For the negative- and positive-strand specific reverse transcription (RT-)PCR of 
segment A and B, 1 µl of the respective immunoprecipitates was used. To prime 
cDNA synthesis on the genomic positive and negative strand of segment A we used 
oligonucleotide pA(+) and pA(−), that hybridized to nt 271-295 and 2852-2877 of the 
plus and minus strand,  respectively (Table 1). To prime cDNA synthesis on the 
genomic positive and negative strand of segment B we used oligonucleotide pB(+) 
and pB(−), that hybridized to nt 432-458 and 2077-2102 of the plus and minus strand, 
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respectively (Table 1). For reverse transcription, samples containing 1 µl of the 
immunoprecipitate and 2 pmol primer in a total volume of 10 µl were incubated at 
98°C for 2 min and immediately chilled on ice. Subsequently, 10 µl of an RT-mix 
containing 2 x Superscript II first strand synthesis buffer (Gibco-BRL), 20 mM DTT, 1 mM 
of each dNTP and 200 U of Superscript II (Gibco-BRL) were added. For the negative 
control reaction, the addition of Superscript II enzyme was omitted. The RT reaction 
was carried out at 50°C for 60 min, after which the incubation was continued at 
70°C for 15 min to inactivate the RT. The reaction products were amplified by PCR 
using primer pairs pAC1/pANC1 for the plus strand of segment A (yielding a PCR 
product of 262 bp corresponding to nt 3-264), pAC2/ pANC2 for the minus strand of 
segment A (yielding a 345 bp PCR product corresponding to nt 2912-3256), 
pBC1/pBNC1 (yielding a 431 bp PCR product corresponding to nt 3-433) for the plus 
strand of segment B and pBC2/pBNC2 for the minus strand of segment B (yielding a 
711 bp product corresponding to 2112-2822) (Table 1). The PCR consisted of 25 
cycles, each comprising 15 sec of denaturation at 94°C, 30 sec of annealing at 
68°C, and 45 sec of elongation at 72°C. The 25 cycles were followed by a 90 sec 
incubation at 72°C.  
 
DETECTION OF INFECTIOUS RESCUED IBDV 
To rescue infectious virus, transfected cells and culture fluid were freeze-thawed 
three times and the supernatant was filtered through a 200 nm pore size filter 
(Acrodisc; Gelman Sciences) to remove the FPV-T7 and cellular debris. The cleared 
supernatant was either stored at –20°C or used directly for further analysis. Infectious 
rescued IBDV (rIBDV) was detected by inoculating a subconfluent monolayer of 
QM5 cells with part of the cleared supernatant. After incubation for 48 h at 37°C the 
cells were washed with PBS, dried, and stored at –20°C  until an immunoperoxidase 
monolayer assay (IPMA) was performed using a polyclonal antiserum against VP3 
(Wensvoort et al., 1986).  
 
RESULTS 
 
A CARBOXY-TERMINAL BINDING SITE IN VP3 IS RESPONSIBLE FOR VP1-VP3 
INTERACTION 
The yeast two-hybrid system (Fields & Song, 1989; Fields & Sternglanz, 1994; Warbrick, 
1997) is an increasingly popular tool for the detection of protein-protein interactions. 
Here we used the system to map the domains responsible for the VP1-VP3 
interaction. Various truncated versions of VP1 and VP3 were inserted into the plexABD 
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(‘bait’) and pB42AD (‘prey’) yeast expression plasmids. An interaction between the 
bait and prey fusion proteins allows yeast cells containing both plasmids to grow on 
medium lacking leucine and to produce β-galactosidase (β-gal), giving rise to blue 
colonies on X-Gal-containing medium. The strength of the protein-protein 
interaction can be judged by the intensity of the blue phenotype, allowing a semi-
quantitative evaluation of the interaction between the candidate proteins (Estojak 
et al., 1995; Li & Fields, 1993; Yang et al., 1992). As positive controls, a combination of 
plasmids pLexABD-VP1 and pB42AD-VP3, as well as the reciprocal combination 
pLexABD-VP3 and pB42AD-VP1, each one containing a complete gene, were tested 
and these produced the expected phenotypes. Individually, or in combination with 
the respective control plasmids pLexABD-bicoid and pB42AD-empty, these constructs 
were negative in both assays, confirming the specificity of the test system.  
To map the interacting domain of VP3, five different deletion mutants were 
initially generated: VP3∆C129 and VP3∆N129, in which the carboxy-terminal and 
amino-terminal halves of VP3 were deleted; VP3∆C64 and VP3∆N64, lacking 64 
amino acids at either end; and VP3∆N64,C64, missing 64 amino acids from both 
termini of the protein (Fig. 1B-I). Similarly, a large series of amino- and carboxy-
terminal deletion mutants were generated for VP1 (Fig. 1A). The coding region of 
each of the deletion mutants was expressed by both pLexABD and pB42AD expression 
vectors, and the products were tested for their capability to interact with wild-type 
VP1 or VP3. To rule out the possibility of non-specific transactivation of the reporter 
genes, all constructs were additionally assayed for reporter gene activation when 
expressed either alone or together with the respective control plasmids pLexABD-
bicoid and pB42AD-empty. Since all constructs proved to be negative in these tests 
(data not shown), all interactions between the LexABD and B42AD fusion proteins were 
regarded as specific. The results of the assays for the VP1-VP3 interaction are 
presented in figure 1. Of the VP1 deletion mutants both carboxy- and amino-
terminally truncated fusion proteins scored positive in the test assessing production 
of β-gal and growth on medium lacking Leu, except for the mutants with an amino- 
or carboxy-terminal truncation of 240 amino acids or larger (Fig. 1A). These results 
suggest that the internal core domain of VP1 is essential for VP3 interaction. For the 
domain mapping of VP3 the results showed that a deletion of 64 amino acids or 
more at the carboxy terminus completely abolished binding to VP1, whereas the 
deletions at the amino terminus had no effect on this interaction (Fig. 1B-I). This 
indicated that the carboxyl terminus of VP3 is critical for the VP1-VP3 interaction.  
To determine the interacting domain in VP3 more precisely, we constructed 
and tested six progressive carboxy-terminal deletion mutants, lacking 10, 20, 30, 40, 
50, and 60 amino acids. None of these mutants showed reporter gene activation, 
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Figure 1. Mapping of the VP1-VP3 binding domain(s) by using deletion mutagenesis 
and the yeast two-hybrid system. Schematic representations of the deletion 
mutations in VP1 and VP3 are presented. VP1 and VP3 deletion mutants were 
cloned into pLexABD and pB42AD yeast expression vectors and tested for their ability 
to interact with full-length VP3 or full-length VP1, respectively. Interactions were 
assayed for leucine autotrophy (LEU) and for β-galactosidase activity (LacZ). 
LEU:++, clear growth (strong interaction); +, growth (interaction); –, no growth (no 
interaction). LacZ: +++, deep-blue colonies (very strong interaction); ++, blue 
colonies (strong interaction); +, light-blue colonies (interaction); –, white colonies 
(no interaction). All results shown are representative of at least seven independent 
transformants. 
CHAPTER 3  IBDV VP3 INTERACTS WITH BOTH VP1 AND VIRAL dsRNA 
 
82
suggesting that the binding domain of VP3 is located within the very last 10 amino 
acids of the carboxyl terminus (Fig. 1B-II). We therefore constructed and tested five 
additional carboxy-terminal deletion mutants lacking 1, 2, 4, 6, and 8 amino acids. 
Each of these deletion mutants had VP1 binding activity, albeit activity weaker than 
that of wild-type VP3 (Fig. 1B-III). To confirm these findings, we also tested a series of 
VP3 proteins with amino-terminal deletions by removing up to 248 of the 258 amino 
acids of the protein. All these truncated proteins, even the mutant VP3∆N248, 
consisting of just the 10-residue carboxy-terminal domain of VP3, conferred growth 
on Leu- medium and gave blue colonies on X-gal-containing medium (Fig. 1B-IV).  
Collectively, these yeast two-hybrid experiments consistently identified the 
10-amino-acid carboxy-terminal peptide of VP3 as the VP1 interaction domain. To 
independently confirm this conclusion and to study the function of the VP1-VP3 
interaction, we made use of our reverse genetics system (Boot et al., 2000b) to 
generate viral VP3 carboxy-terminal deletion mutants. 
 
IN VIVO INTERACTION BETWEEN VP1 AND CARBOXY-TERMINALLY TRUNCATED VP3 
To test for a functional role of VP1-VP3 interaction during IBDV replication, mutant 
IBDV cDNA clones of the full-length segment A were constructed by introducing 
stop codons in the 3’ terminus of the coding strand to generate carboxy-terminally 
truncated VP3 mutants. cDNA clones pHB36W-VP3∆10(tga), pHB36W-VP3∆5(tga), 
pHB36W-VP3∆1(tga), and pHB36W-VP3∆1(tag), containing a stop at the codon 
positions 10, 5, or 1 preceding the natural stop codon of the VP3 gene, were 
prepared (Fig. 2). In all mutants the original codon was replaced by a TGA stop 
codon except in clone pHB36W-VP3∆1(tag) where a TAG stop codon, which 
required only a single point mutation (GAG to TAG), was used, 
To analyze the expression and processing of the viral proteins of the 
mutated A segments, in vitro transcriptions and translations were performed by using 
a rabbit reticulocyte system. The radiolabeled translation products were 
subsequently analyzed by  SDS-PAGE and autoradiography (Fig. 3). In all cases the 
viral polyprotein was processed normally into pVP2, VP3,  and VP4. As predicted, the 
apparent molecular mass of VP3 decreased with increasing deletions: the removal 
of 5 or 10 carboxy-terminal amino acids gave rise to an apparent reduction in 
molecular mass of some 1 to 2 kDa. 
To study more directly the role of the VP3 carboxy-terminal domain in 
interaction with VP1, we co-expressed the proteins in cells using the co-transfection 
system described previously (Boot et al., 2000b). The wild-type and mutated full-
length segment A cDNA clones, pHB36W, pHB36W-VP3∆1(tag), pHB36W-VP3∆1(tga), 
pHB36W-VP3∆5(tga), and pHB36W-VP3∆10(tga), were each transfected into QM5 
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cells together with either the wild-type full-length segment B cDNA clone (pHB34Z) or 
a mutant full-length segment B cDNA clone, named pMB13 (Fig. 4A). The last clone 
was used as a negative control for virus replication. In this clone, the stem-loop 
structure in the 3’ terminus of the coding strand predicted by Boot et al. (1999), was 
changed into a more stable stem-loop structure by the replacement of three 
adjacent cytosine residues (nt 2802-2804) by three guanines, which resulted in a 
construct failing to yield virus in combination with wild-type segment A cDNA (Boot 
et al., 2001). 
 
3’-UTR
HDRVP5
pVP2 VP4 VP3
5’-UTR
T7 promotor
T7 terminator
GGCCGCTGGATCAGGACCGTCTCTGATGAGGACCTTGAGTGA
∆1
stop
TGA
TAG
stop
TG A
stop
TG A
∆5∆10
pHB36W
pHB36W-VP3∆10(tga) pHB36W-VP3∆5(tga) pHB36W-VP3∆1(tga)
pHB36W-VP3∆1(tag)
 
Figure 2. Schematic representation of mutagenesis of the segment A cDNA clone. Plasmid 
pHB36W, containing the full-length cDNA sequence of segment A, preceded by a T7 
promoter sequence and followed by the autocatalytic hepatitis delta virus ribozyme (HDR) 
and a T7 terminator, is shown at the top of the figure. The nucleotide sequence of the 3’ 
terminus of the ORF for the polyprotein is depicted below. The TGA stopcodon of VP3 is 
underlined. Mutated nucleotides are boxed and introduced stopcodons are indicated 
below in bold letters. The generated plasmids are named pHB36W-VP3∆10(tga), pHB36W-
VP3∆5(tga), pHB36W-VP3∆1(tga) and pHB36W-VP3∆10(tag), according to the position and 
kind of stopcodon in the 3’ terminus of the coding sequence of VP3. 
 
Forty-eight hours post-transfection, cells were metabolically labeled for 3 hours with 
[35S]methionine and subsequently subjected to immunoprecipitation with either anti-
VP1 or anti-VP3 serum. The immunoprecipitates obtained were analyzed by SDS-
PAGE and the labeled proteins visualized by autoradiography. As shown in the 
upper panel of Fig. 4B, when using the anti-VP3 serum, comparable amounts of the 
full-length and the truncated VP3 proteins were detected in the transfected QM5 
cells. VP1 was clearly co-precipitated with full-length VP3 but only in minor amounts 
with the carboxy-terminally truncated VP3∆1 (lanes 1-3). The immunoprecipitations 
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Figure 3. Autoradiogram of an SDS-
PAGE analysis of a coupled in vitro 
transcription/translation reaction. 
Plasmids containing the full-length A-
segment, pHB36W (lane 1), pHB36W-
VP3∆1(tag) (lane 2), pHB36W-
VP3∆1(tga) (lane 3), pHB36W-
VP3∆5(tga) (lane 4), pHB36W-
VP3∆10(tga) (lane 5) were used as 
DNA template to produce the viral 
proteins. The positions of the viral 
proteins and the sizes of the marker 
proteins (lane M) are indicated. 
 
 
 
 
 
 
of VP3∆5 and VP3∆10 (lanes 4-5) completely failed to co-precipitate detectable 
amounts of VP1. This is in contrast with the anti-VP1 immunoprecipitations where VP1 
and VP3 were both present in all immunoprecipitates (lanes 1-5). The same results 
were found with the pMB13 co-transfected QM5 cells (lanes 6-10) indicating that 
productive viral replication is not required for VP1-VP3 binding. For IBDV strain CEF94  
we recently showed free VP1 protein to occur in two forms with molecular masses of 
90 and 95 kDa (Tacken et al., 2000). In IBDV-infected cells both these forms 
appeared to interact with VP3 initially after their translation, though the interaction 
 
 
Figure 4. Radio-immunoprecipitation analysis of VP1-VP3 interaction in transfected QM5 
cells. (A) QM5 cells were (co-)transfected with the indicated plasmids containing either the 
wild-type or a mutated cDNA of the A-segment and/or B-segment. At 48 h post 
transfection cells were metabolically labeled for 3 h with [35S]methionine. Subsequently, 
cells were lysed and immunoprecipitated with anti-VP3 serum (αVP3) or with anti-VP1 
serum (αVP1) followed by SDS-PAGE, either directly (B) or after an RNaseONE (C) or 
RNaseA treatment (D). Positions of the viral proteins and sizes of marker proteins (in kDa) 
are indicated. 
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2 pHB36W-VP3∆1(tag)    ,,
3 pHB36W-VP3∆1(tga)     ,,
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5 pHB36W-VP3∆10(tga)         ,,
6 pHB36W pMB13
7 pHB36W-VP3∆1(tag)    ,,
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10 pHB36W-VP3∆10(tga)        ,,
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with the 90 kDa form gradually became undetectable thereafter (Tacken et al., 
2000). These observations explain the presence of the two discrete bands of free 
VP1 in the 90-95 kDa size range seen in the anti-VP1 immunoprecipitates (Fig. 4B-D), 
while only the 95 kDa band appears in the anti-VP3 immunoprecipitates: apparently 
only the 95 kDa form of VP1 was interacting with VP3 and therefore co-precipitated 
when using the anti-VP3 serum. 
Furthermore, with the exception of the controls of transfected A-segment or 
B-segment alone (lanes 11-13), all immunoprecipitations revealed the presence of 
several bands in the high molecular mass region of > 97 kDa (lanes 1-10). Our 
previous studies have shown that these bands are VP1 specific and represent VP1-
RNA complexes, as ascertained by Western blot analysis using VP1-specific sera and 
RNase treatment (Tacken et al., 2000). It was obvious that these VP1-RNA complexes 
were present in both the VP1-specific and the VP3-specific immunoprecipitations. 
Since, in the latter case, neither VP3∆5 nor VP3∆10 were able to co-precipitate VP1, 
we speculated that the presence of these VP1-RNA complexes in the VP3-specific 
immunoprecipitates might be a consequence of a direct VP3-RNA interaction, 
rather than of a VP1-VP3 interaction. This assumption would also explain the 
unexpected co-precipitation of VP3∆5 and VP3∆10 proteins using the VP1 
antibodies. The observation that the amount of co-precipitated VP3 correlated with 
the amount of precipitated VP1-RNA complex rather than with the amount of 
precipitated VP1 (lanes 1-5 and 6-10) also supports this interpretation. We therefore 
analyzed the sensitivity of the immune complexes to RNase. 
 
VP3 INTERACTS BOTH WITH VP1 AND WITH IBDV SPECIFIC dsRNA 
To study the VP1-VP3 interaction per se, i.e. without the interference of RNA-
mediated co-immunoprecipitation, we performed an RNase treatment on all the 
VP1-specific and VP3-specific immunoprecipitates. To distinguish between ssRNA 
and dsRNA we performed an RNaseONE as well as an RNaseA treatment, thereby 
degrading specifically ssRNA or both ssRNA and dsRNA, respectively. The RNaseONE 
treatment failed to degrade the VP1-RNA complexes (Fig. 4C). The electrophoretic 
patterns of both the VP1- and VP3-specific co-immunoprecipitates were 
indistinguishable from those presented in Fig. 4B, indicating that the integrity of the 
VP1-RNA complexes is not dependent on ssRNA. In contrast, in the RNaseA treated 
samples, no high molecular mass (>97 kDa) complexes were present (Fig. 4D; lanes 
1-13). Hence, the VP1-RNA complexes were maintained by dsRNA. Furthermore, in 
the VP3-specific immunoprecipitations, VP1 was co-precipitated with full-length VP3 
and, to a lesser extent, with VP3∆1, but not with VP3∆5 and VP3∆10. The reciprocal 
immunoprecipitations fully confirmed these results. The VP1 antiserum co-
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precipitated full-length VP3 and, again in much lower amounts, VP3∆1 (clearly seen 
after a prolonged exposure of the autoradiograph; data not shown). Obviously, 
VP3∆5 and VP3∆10  were no longer co-precipitated in the absence of dsRNA. 
Apparently, VP3 is able to associate with the VP1-dsRNA complexes through direct 
VP3-dsRNA interaction.  
It was therefore of interest to determine whether the dsRNA in these 
complexes represented IBDV genome segment A- and/or B- specific sequences. To 
this end we performed an RT-PCR analysis. The untreated, RNaseONE and RNaseA 
treated VP3-specific immunoprecipitates were analyzed for the presence of positive 
and negative stranded genomic RNA. As expected, RT-PCR products specific for 
the 5’ end of both strands of both segments were obtained from the untreated and 
RNaseONE treated samples but not from the RNaseA treated samples (Table 2; data 
of the RNaseONE treated samples not shown). The finding that no product was 
obtained when reverse transcriptase was omitted from the reaction before PCR, 
indicates that the PCR products were derived from RNA, not from contaminating 
DNA. In cells transfected with either pHB36W or pHB34Z alone, no RT-PCR products 
were obtained, confirming the absence of IBDV specific VP1-dsRNA complexes in 
these immunoprecipitates. Plasmids pHB36W and pMB13, a combination known to 
be incapable of generating infectious progeny virus when transfected into cells, 
appeared to be RNA-replication competent as shown by the RT-PCR products 
obtained (Table 2). Hence, the RNaseONE-resistant but RNaseA-sensitive high 
molecular mass material in the radio-immunoprecipitation analysis of this 
combination (Fig. 4B-D, lanes 6-10) was of IBDV-specific dsRNA origin. Infection 
induced in cells by using pMB13 and pHB36W is probably affected at the level of 
particle assembly or the particles produced are somehow not infectious.  
As the RT-PCR analysis was performed with primers designed to amplify 5’ 
end sequences from plus as well as minus strand RNA, the results indicate that full-
length dsRNA was present in the immunoprecipitates. Consequently, the higher 
molecular mass material of ≥ 220 kDa that had barely entered the gel in the 
immunoprecipitation assays, most likely represents the full-length dsRNA-VPg 
complexes. The smear below it suggests the presence of incomplete dsRNA 
molecules such as VPg linked to partial dsRNA molecules, consisting of one full-
length strand and one partial, complementary strand; this material runs faster than 
the full-length dsRNA-VPg complexes and appears as a smear due to its 
heterogeneity (Cho et al., 1993; Kordyban et al., 1997). When full-length dsRNA-VPg 
complexes from another birnavirus, infectious pancreatic necrosis virus (IPNV), were 
treated with RNase by Magyar et al. (1998), VPg molecules were obtained carrying 
oligonucleotides that had survived the enzymatic treatment, supposedly due to 
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         Transfected plasmids    Strand-specific RT-PCRa 
      
   Untreated   RNaseA treated 
A segment    B segment A+ A− B+ B− A+ A− B+ B− 
pHB36W   pHB34Z +  +  +  +  −  −  −  − 
pHB36W -VP3∆1(tag)     pHB34Z +  +  +  +  −  −  −  − 
pHB36W -VP3∆1(tga)  pHB34Z  +  +  +  +  −  −  −  − 
pHB36W -VP3∆5(tga)     pHB34Z  +  +  +  +  −  −  −  − 
pHB36W -VP3∆10(tga)   pHB34Z +  +  +  +  −  −  −  − 
pHB36W   − −  −  −  −  −  −  −  − 
       −  pHB34Z   −  −  −  −  −  −  −  − 
pHB36W   pM B13  +  +  +  +  −  −  −  − 
 
Table 2. RT-PCR analysis of the anti-VP3 immunoprecipitation reactions of Fig.4B and 
4D.  
a Specific positive sense and negative sense primers of segments A and B (A(+), 
A(−), B(+) and B(−), respectively) were used for RT. Following RT, the reaction 
products were amplified by PCR using specific primer pairs based on 5’ terminal 
sequences of both the positive and negative strands of segments A and B (for 
details, see Materials and Methods). The plus and minus signs indicate the presence 
or absence of a specific PCR product. Controls, in which reverse transcriptase was 
omitted from the reaction, were negative. 
 
 
steric hindrance by the unusually large VPg. The two discrete bands seen migrating 
at ≈ 110-150 kDa might therefore represent two forms of VPg linked to short 
oligonucleotides that were inacessible for RNase. Interestingly, these short VPg-
linked oligonucleotides were not resistant to RNaseA treatment. 
Altogether, these observations supported the results of the yeast two-hybrid 
screen with the truncated VP3 deletion mutants. In addition, they revealed that the 
(co-)precipitated VP1-RNA complexes contained genomic dsRNA and that VP3 is 
able to associate with these complexes by interacting directly with the dsRNA.  
 
VP1-VP3 INTERACTION IS ESSENTIAL FOR THE GENERATION OF INFECTIOUS PROGENY 
To analyze the VP3 truncated viral mutants, VP3∆1(tag), VP3∆1(tga), VP3∆5(tga) 
and VP3∆10(tga), for their ability to produce infectious virus we examined the 
transfection supernatants of these mutants for the presence of recombinant IBDV. 
Aliquots of the supernatants were inoculated onto fresh monolayers of QM5 cells 
which were subsequently incubated for 48 h and fixed. An IBDV-specific antibody 
assay was used to analyze whether infection had occurred. In none of the assays 
IBDV proteins could be detected in the QM5 monolayer except for the wild-type 
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situation where unmodified segments A and B had originally been transfected (data 
not shown). These results indicate that all mutant viruses were unable to generate 
infectious progeny.  
 
DISCUSSION 
 
Little is yet known about the nature and significance of the interactions between the 
viral components during the IBDV life cycle. Here we focussed on the viral capsid 
protein VP3. We demonstrated that its interaction with VP1 is critically mediated by 
its carboxy terminal domain. The removal of just the terminal residue already 
affected its association with VP1 and inhibited the production of infectious progeny 
completely. The VP3 protein also appeared to interact with both segments of the 
viral dsRNA. Our results thus point to an essential role for VP3 in virus morphogenesis, 
it being involved not only in the formation of the capsid shell but also in the 
incorporation of the genome and the viral RNA polymerase. 
The VP3-domain interacting with VP1 was unambiguously mapped to the 
carboxy-terminal tail by two independent approaches. In yeast two-hybrid analyses 
the ability to associate with VP1 was lost when 10 or more terminal residues of VP3 
were removed while, conversely, the corresponding decapeptide by itself was able 
to establish interaction. These assays additionally demonstrated the VP1 protein to 
interact with VP3 through its more internal domain, but further mapping thereof was 
not pursued. Site-directed mutagenesis of our infectious cDNA clone revealed that 
in IBDV infection the interaction between the two proteins is even more sensitive to 
changes in the VP3 carboxy-terminal tail. The mere deletion of the ultimate residue 
dramatically affected the strength of their association, as judged by the almost 
complete loss of their interaction in the co-immunoprecipitation assay and the 
complete loss of infectious virus production.  
These studies unexpectedly led us to the detection of the VP3-dsRNA 
interactions. The key observation here was that higher molecular mass material, 
which we mentioned earlier to contain VPg-linked RNA (Tacken et al., 2000), was 
immunoprecipitated with anti-VP3 serum from lysates of cells undergoing infection 
with VP3∆5 and VP3∆10 mutant virus (Fig. 4B). Because this material was unlikely to 
have been precipitated through interaction of the mutant VP3 molecules with VPg 
(free VP1 was clearly not co-precipitated from these lysates) a direct VP3-RNA 
interaction seemed most plausible. RNase treatments subsequently confirmed this 
interpretation demonstrating in addition that the interaction was double-strand 
specific: RNaseA but not the single-strand specific RNaseONE degraded the 
immune complexes. Furthermore, RT-PCR analysis substantiated that the RNA was 
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indeed of IBDV origin and that it contained both positive and negative strands of 
each of the two genome segments. As the RT-primers were designed to amplify the 
5’ end sequence from the plus or the minus RNA strand, the results indicate that full-
length dsRNA had been produced. Less dsRNA-linked VP1 was detected in cells 
expressing the C-terminally truncated proteins VP3∆5 and VP3∆10 than when wild-
type VP3 or VP3∆1 were expressed, suggesting that the VP3 truncations are either 
affecting the capacity of VP3 to associate with dsRNA or impairing dsRNA synthesis 
by affecting the capacity of VP1 to function as a replicase, transcriptase or primase. 
Wild-type VP3 was found predominantly in association with the dsRNA-linked form of 
VP1, relatively little being associated with free VP1. This may indicate that not all free 
VP1 is bound to VP3 during infection. Alternatively, the observation might have been 
brought about by the experimental conditions used: differences in efficiencies with 
which the different complexes (VP3/VP1 vs. VP3/VPg-dsRNA) had been 
immunoprecipitated or the amount of anti-VP3 antibodies having been limiting. VP3 
is probably synthesized in excess of VP1 (VP3 constitutes 40% of the virion protein, 
VP1 only 3%; Dobos et al., 1979). Limiting VP3 antibodies would be expected to 
favour the precipitation of dsRNA-VP1/VP3 complexes over free VP1/VP3 complexes 
as the former probably carry relatively more VP3. Finally it is of note that the same 
autoradiographic patterns were obtained in different RIP-assays, both with 
transfected and with infected cells, using different labeling periods and different 
labeling times (data not shown), indicating that the results obtained in the present 
co-immunoprecipitation analysis were not skewed by unlabeled VP1 and VP3 
formed prior to metabolic labeling.  
Our results finally provide experimental evidence for the long anticipated 
role of VP3 in binding to viral nucleic acids. Already in 1986 Hudson et al. (1986) 
proposed such a role on the basis of the polypeptide’s primary sequence. These 
investigators noticed that the predicted carboxy-terminal domain, with 12 positively 
charged residues (and 8 prolines) among its last 40 residues, is highly basic in nature. 
Interestingly, the very terminal stretch of this domain is on the contrary very acidic, 
with 4 negatively charged amino acids being present within the last 5 residues. This 
suggests that VP3 might possess two functional domains within its carboxy- terminus: 
the extreme terminal part that binds to VP1 and the positively charged domain 
immediately upstream thereof that binds the viral dsRNA. Future mutation analyses 
will be required to experimentally confirm the role of this latter domain. 
Knowledge about the morphogenesis of birnaviruses is still very limited. Most of what 
we know came from studies in which IBDV cDNAs were expressed in cells using 
vaccinia- or baculovirus systems (Caston et al., 2001; Fernandez-Arias et al., 1998; 
Lombardo et al., 1999; Martinez-Torrecuadrada et al., 2000; Vakharia, 1997). These 
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studies revealed that virus-like particles indistinguishable from authentic virions can 
be assembled just from the segment A derived polyprotein precursor (Fernandez-
Arias et al., 1998; Lombardo et al., 1999). It appeared that correct particle assembly 
is not dependent on the presence of viral RNA or VP1, nor of the small protein VP5 
also specified by segment A, but that it merely requires the proteins pVP2 and VP3, 
the latter acting as an internal scaffold (Martinez-Torrecuadrada et al., 2000). VP1 
was co-incorporated into such particles, and to an extent similar to that in virions, 
when its cDNA was co-expressed with segment A cDNA (Lombardo et al., 1999). 
These investigations in addition pointed to an important role of the carboxy-terminal 
tail of pVP2 in the assembly of the T=13 capsid, this terminal region being crucially 
involved in the control of the interactions between VP2 trimers and between VP2 
trimers and VP3 trimers (Caston et al., 2001).  
The results demonstrate that the VP3 protein is a key organizer in birnavirus 
morphogenesis. By its interactions with all the structural components in the virion it 
appears to create the interior architecture that is required for the proper execution 
of the replication and transcription activities that are the hallmark of double-
stranded RNA viruses. It is now clear that VP3 entertains interactions with itself, with 
VP2, with free VP1 molecules, most likely also with genome-bound VP1, and with the 
dsRNA segments A and B. Different domains in the protein are responsible for these 
different interactions. The carboxy-terminal domains binding to the dsRNAs and to 
VP1 are, for instance, distinct from the region involved in the homotypic interactions 
giving rise to the VP3 trimers that have been observed in viral particles by the 
ultrastructural analyses (Bottcher et al., 1997; Caston et al., 2001; M. G. J. Tacken et 
al., unpublished data). We have not yet explored the domain(s) in the homotrimeric 
VP3 complex interacting with the homotrimeric VP2 complexes that constitute the 
outer surface of the viral capsid. 
Of particular interest are the interactions of VP3 with VP1 and VPg. These 
interactions are obviously of critical importance as the various activities embodied 
in the polymerase protein are essential for the virus life cycle. Though we did not 
provide direct evidence for it, we assume that VP3 does interact with VPg and that 
the interacting domain in VP1 and VPg is the same. Free VP1 molecules present in 
virions have been shown to carry covalently bound, short stretches of viral RNA, 
presumably 5’-terminal sequences (Kibenge & Dhama, 1997). Their association with 
VP3 suggests that VP1 does not bind through the domain that contains the serine 
residue by which these oligonucleotides are attached, and by which also VPg is 
linked to genomic RNA. It is therefore more likely that VP1 and VPg both bind 
through another, but identical domain. It will be interesting to find out if and how the 
virus regulates the number of free and genome-bound VP1 molecules assembled in 
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each viral particle. Higher resolution structural analyses may shed light on this 
question and establish whether free VP1 and VPg assume distinct and specific 
positions within the internal virion cavity. Precise spatial arrangements are likely to be 
required within the virion for the expeditious functioning of this replication and 
transcription machine. 
 Double-stranded RNA viruses of higher eukaryotes invariably contain 
multiple genome segments. It is still an unresolved issue how these segments are 
correctly assorted during particle assembly. Among these viruses the birnaviruses are 
exceptional because of their genome-linked polymerase protein VPg, the other 
viruses all having a cap structure associated with the 5’end of the positive RNA 
strand of each segment. A role of the VPg moiety in the selection of the genome 
segments is therefore conceivable. Alternatively, this selection might be achieved 
by VP3, through its capacity of binding dsRNA. This capacity might of course also 
serve to assist the proper positioning of the two dsRNA segments within the virion. We 
have not investigated whether dsRNA binding activity of VP3 is sequence-specific 
and, if so, whether the sequences recognized are segment-specific or occur in the 
common terminal genomic regions. If this dsRNA binding activity would indeed 
operate at the level of segment selection during particle assembly we should 
assume that VP3 binds to specific double-stranded regions within the viral mRNAs, as 
all dsRNA viruses are assumed to synthesize their negative RNA strand only after the 
packaging of their mRNAs. The specific encapsidation of IBDV mRNAs might thus 
resemble the mechanism by which the hepatitis B virus assembles its pregenomic 
RNA. Here the viral polymerase binds to a specific stem-loop structure present in viral 
mRNAs which subsequently leads to the polymerase-dependent encapsidation of 
the viral nucleic acid (Bartenschlager & Schaller, 1992; Ziermann & Ganem, 1996). 
Much work will be required to resolve these issues, not only for IBDV but as well for 
the other dsRNA viruses. It is expected that the continued molecular virological 
studies in combination with the advancing ultrastructural analyses will allow us to 
answer the many outstanding questions concerning the biology of these viruses. 
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ABSTRACT 
 
The yeast LexA interaction trap was used to screen a cDNA library from bursae of 3-
weeks-old chickens in order to identify proteins that interact with the viral proteins 
VP1, VP3, or VP5 of the classical infectious bursal disease virus (IBDV) strain CEF94 or, 
with pVP2 of the very virulent IBDV strain D6948. In each case a large number of 
cDNA clones was obtained, which were partially sequenced. Searches in 
databases with these cDNAs identified some known proteins. We report here the 
identification of several candidate interactors for the viral proteins VP1, pVP2, VP3, 
and VP5 of IBDV. Putative biological implications for some of the interactions found 
are discussed. Whether these cellular proteins are true interactors remains to be 
established.  
 
INTRODUCTION 
 
Infectious bursal disease virus (IBDV) is the causative agent of infectious bursal 
disease, a highly contagious immunosuppressive disease in young chickens. IBDV, a 
member of the genus Avibirnavirus in the family Birnaviridae (Dobos et al., 1979), 
replicates specifically in developing B lymphocytes in the bursa of Fabricius. During 
replication, viral proteins induce apoptosis, resulting in a rapid depletion of B 
lymphocytes (Vasconcelos & Lam, 1995; Jungmann et al., 2001). Infection of 3- to 6-
week-old chickens with IBDV causes an acute disease characterized by high 
morbidity and mortality. Surviving chickens as well as younger chickens that are 
infected with IBDV generally show no clinical signs, but may be immunosuppressed 
during their remaining lifetimes. The pathogenic serotype I IBDV isolates are 
subdivided into classical, antigenic-variant, and very virulent isolates. Very virulent 
IBDV (vvIBDV) strains are unable to infect non-B-lymphoid cells.  
IBDV is a non-enveloped, icosahedral virus with a diameter of 60 nm (Hirai & 
Shimakura, 1974). Its genome is composed of two double-stranded (ds) RNA 
segments designated A and B (Dobos et al., 1979; Müller et al., 1979). Segment A 
encodes a polyprotein (pVP2-VP4-VP3) that is processed into the major structural 
proteins VP2 and VP3 (Hudson et al., 1986) by VP4, a virus-encoded protease that 
shares some characteristics with bacterial Lon proteases (Sanchez & Rodriguez, 
1999; Birghan et al., 2000; Lejal et al., 2000). The non-structural VP4 protein is mainly 
associated with type II tubules of 24 nm in diameter (Granzow et al., 1997). VP2 and 
VP3 form the outer and inner layers, respectively, of the icosahedral virions (Bottcher 
et al., 1997). Processing of the precursor pVP2 into mature VP2 occurs during or after 
virus assembly (Müller & Becht, 1982), presumably by VP4 protease activity (Kibenge 
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et al., 1997; Lejal et al., 2000). A second open reading frame in segment A encodes 
a small, non-structural protein VP5 (Mundt et al., 1995). This protein proved to be 
non-essential for IBDV replication (Mundt et al., 1997). Although the exact function 
of VP5 is still unknown, Yao et al. (1998) showed that it plays a role in virus 
pathogenesis. Segment B encodes the putative RNA-dependent RNA polymerase, 
VP1. This protein is present within virions both as a free polypeptide and as a 
genome-linked protein, called VPg, attached to the 5’ end of the positive strands of 
the two genomic segments (Müller & Nitschke, 1987). Whether the 5’ termini of the 
noncoding strands also have this covalently linked VPg is not known. Also unclear is 
the nature of the 5’ termini of birnaviral mRNAs. Whereas Spies & Müller (1990) 
reported that these mRNAs may contain a cap structure, Dobos found that VP1 
lacks the enzymatic activities for generating such a cap structure (Dobos, 1993). 
Although in vitro synthesized mRNA containing a cap structure has been used for 
the rescue of infectious IBDV after transfection into eukaryotic cells (Mundt & 
Vakharia, 1996) this does not prove that viral mRNA is indeed capped and not VPg-
linked. Moreover, it has been shown for other viruses that the VPg can be replaced 
by a cap structure to rescue infectious virus from cloned cDNA (Boyer & Haenni, 
1994). 
In general, viral replication is the result of a complex interplay between 
functions encoded by the viral and host genomes. While purification of replication 
complexes has allowed some insight as to the participation of host proteins in this 
process (Hayes & Buck, 1993; Quadt et al., 1993), genetic approaches are required 
for the identification and analysis of these host proteins. The yeast two-hybrid system 
is a powerful tool to screen DNA libraries for proteins that interact with a specific 
protein of interest (Fields & Song, 1989). The system is based on the functional 
reconstitution of a transcriptional activator. The target protein (bait) is fused to a 
DNA-binding domain (BD) while library encoded proteins (prey) are fused to the 
activation domain (AD) (Bartel et al., 1993; Chien et al., 1991). Interaction between 
bait and prey hybrids reconstitutes the transcriptional activation function and 
stimulates reporter gene expression. This procedure has permitted the 
characterization of protein associations in vivo where biochemical experiments, 
such as copurification, failed to show interaction (Huet et al., 1994; Brondyk et al., 
1995; Rossi et al., 1996), likely due to kinetic parameter constraints (Brent, 1996).  
Recently, we have used the yeast two-hybrid system to analyse the 
intermolecular interactions between the viral proteins of IBDV themselves (Tacken et 
al., 2000). In the present study, we aimed to identify cellular partners for the viral 
proteins and have applied the inducible LexA-dependent yeast two-hybrid system 
to screen a cDNA library from bursae of 3-weeks-old chickens using VP1, VP3, and 
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VP5 of IBDV strain CEF94, as well as pVP2 of vvIBDV strain D6948, as a bait. Very 
virulent IBDV was taken as the source of pVP2 rather than the cell culture adapted 
IBDV strain CEF94 as this is the protein responsible for the particular B-lymphoid cell 
tropism (Lim et al., 1990; Mundt, 1999; Boot et al., 2000). The LexA-based interaction 
trap offers inducible expression of the library fusion proteins, which allows less 
opportunity for the foreign fusion proteins to have a toxic effect on the yeast host 
and thus to be eliminated from the pool of potentially interacting proteins. We 
found that several host cell proteins are able to form complexes with the viral 
proteins of IBDV in yeast cells.  
 
MATERIALS AND METHODS 
 
BACTERIAL AND YEAST STRAINS 
Escherichia coli strain DH5-α (Life Technologies) was used for subcloning. 
Saccharomyces cerevisae strain EGY48 (MATα, his3, trp1, ura3, LexAop(x6)-LEU2) was 
used for the interaction trap. Yeast strain EGY[p8oplacZ] is the host strain EGY48 
transformed with the autonomously replicating reporter plasmid p8op-LacZ 
(Clontech). 
 
PLASMIDS AND CDNA LIBRARY 
The plasmids pLexABD-VP1, pLexABD -VP3 and pLexABD -VP5 containing cDNA-coding 
sequences of VP1, VP3, and VP5, respectively, of IBDV strain CEF94, have been 
described previously (Tacken et al., 2000). Plasmids pLexABD-pVP2 and pLexABD-VP4 
were constructed as follows. Plasmid pHB-22R, containing the consensus cDNA of 
the A-segment of the vvIBDV strain D6948 (Boot et al., 2000) was used as a template 
to generate the cDNA encoding pVP2 by PCR using the Expand high fidelity PCR 
system (Boehringer Mannheim). Similarly, plasmid pHB-36W, containing the 
consensus cDNA of the A-segment of the IBDV strain CEF94 (Boot et al., 1999) was 
used as the template to generate the cDNA encoding VP4. The sets of primers used 
for pVP2 (upstream: 5’-CCGGAATTCATGACAAACCTGCA AGATCAAACCC-3’; 
downstream: 5’-GATCGTCGACTCACCTTATGGCCCGGATCA TGTCTTTG-3’) and for 
VP4 (upstream: AGGAATTCGCCGACAAGGGGTACGAGGT AGTC-3’; downstream: 
5’-TAACTCGAGTCAGGCCATGGCCAGGTCGTACTGGC-3’) were designed to 
introduce an EcoRI site at the upstream (5’) end and a stop codon plus a SalI or 
XhoI site, respectively, at the downstream (3’) end of the coding sequence. The PCR 
products were precipitated, digested with EcoRI/SalI or EcoRI/XhoI, gel purified by 
the QIAEX-II method (QIAGEN), and ligated with T4 ligase (New England BioLabs) 
into the yeast expression vector pLexABD (Clontech). This vector had previously been 
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digested with EcoRI/XhoI. The ligation mix was transformed into Escherichia coli DH5-
α cells, which were subsequently grown under ampicillin selection. Plasmid DNA 
prepared from several independent transformants was screened for the presence of 
the insert, and plasmids from positive clones (containing pLexABD-pVP2 or pLexABD-
VP4) were sequenced at the fusion junction by cycle sequencing using an ABI 310 
sequencer (PE Applied Biosystems) to ensure correct reading frames.  
Control plasmids pLexABD-53 (human p53 gene in pLexABD) and pB42AD-SV40 T 
(SV40 large T antigen in pB42AD) were from Clontech. 
For the generation of a pB42AD cDNA plasmid library total RNA was isolated 
from bursae of 3-weeks-old chickens in a one-step protocol with acidic guanidinium 
thiocyanate, phenol, and chloroform (Chomczynski & Sacchi, 1987) and used for 
poly(A)+ RNA purification with Mini-Oligo(dT) Cellulose Spin Columns (5 Prime → 3 
Prime, Inc.) according to the manufacturer’s instructions. Five micrograms of 
poly(A)+ RNA was used for cDNA synthesis by a custom cDNA library service 
(OriGene Technologies, Inc.). Details of construction: cDNA was made using an 
XhoI-oligo d(T) primer. An EcoRI adapter was ligated onto the 5’ end of the cDNA. 
Subsequently, the cDNA was cut with XhoI (internal sites were protected) and size-
fractionated before cloning into EcoRI-XhoI sites of pB42AD. Transformation into 
bacterial cells yielded 4.8 x 106 independent clones. Some 85% of the clones 
contained an insert, with an average insert size of about 1 kb and an insert size 
range of 0.4-2.5 kb, which was determined by purifying plasmid DNA from 48 
random clones. 
 
TWO-HYBRID LIBRARY SCREENING 
All two-hybrid media, buffers, and protocols were as described in the Clontech 
Manual for the Matchmaker LexA Two-Hybrid System and in the Clontech Yeast 
Protocols Handbook. The yeast strain S. cerevisiae EGY48[p8op-lacZ] (Clontech), 
containing two reporter genes, LEU2 and LacZ, under the control of two 
independent promotors, was first transformed by using the lithium acetate method 
with the pLexABD (HIS3
+) constructs carrying VP1, pVP2, VP3, VP4, and VP5, 
respectively. The resulting strains were selected and grown in SD/Glu/-His/-Ura 
medium. Stable expression of the LexA hybrid proteins was verified by Western blot 
analysis according the manufacturer’s instruction (Clontech). The ability of the LexA 
fusions to bind operator DNA, as well as the inability of these LexA fusions for 
autonomous reporter gene activation, was confirmed by a repression and an 
activation assay, respectively, as described previously (Tacken et al., 2000). The 
obtained yeast strains EGY48[p8op-LacZ] harboring  plexABD-VP1, plexABD-pVP2, 
plexABD-VP3, plexABD-VP4, or plexABD-VP5 were transformed according to the lithium 
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acetate protocol  with plasmid DNA from the pB42AD-bursae-cDNA library. Double 
transformants were grown on SD/Glu/-His/-Ura/-Trp medium to select for the 
presence of both types of hybrid plasmids and the LacZ reporter plasmid. Only 
when >106 independent clones were obtained the primary library cotransformants 
were harvested, pooled, and plated on SD/Gal/Raf/-His/-Ura/-Trp/-Leu medium to 
screen for transcriptional activation of the LEU2 reporter gene. Yeast strain 
EG48[p8op-LacZ] transformed with an empty vector construct, pB42AD-empty, was 
used as negative control, whereas yeast strain EG48[p8op-LacZ] transformed with 
pLexABD-53 and pB42AD-SV 40 T was used as positive control. After 4 days of 
incubation at 30 °C, Leu+ colonies were patched onto SD/Glu/X-gal/-His/-Ura/-Trp 
medium as well as SD/Gal/Raf/X-gal/-His/-Ura/-Trp medium to screen for 
transcriptional activation of the LacZ reporter gene. Colonies and the library 
plasmids they contained were tentatively considered positive if they were blue on 
the Gal/Raf containing plates but not blue or only faintly blue on the Glu containing 
plates. Colonies of the LacZ+ clones were restreaked, at least once, onto SD/Glu/-
His/-Ura/-Trp plates to isolate single colonies and were retested for both Leucine 
autotrophy and β-galactosidase activity. Positive candidate clones were analyzed 
by sequencing. For this purpose, yeast cells of a single colony were resuspended in 
40 µl H2O and broken up by a heat-treatment of 5 minutes at 100 °C followed by a 
vortex-treatment for 1 minute in the presence of glass beads. Cell debris was 
removed by centrifugation and 4 µl aliquots of the supernatants were used as 
template for PCR amplification of the bursa derived cDNA inserts in pB42AD using the 
pB42AD specific primers 5’ CCAGCC TCTTGCTGAGTGGAGATG 3’ (upstream) and 5’ 
GTAGACAAGCCGACAACCTTGATTGG 3’ (downstream). PCR products were 
purified using a PCR purification kit (Qiagen) and analyzed by sequencing. 
 
DNA SEQUENCING AND SEQUENCE ANALYSIS 
Partial sequence analysis of cDNAs was performed by cycle sequencing (BigDye 
terminator kit, PE Applied Biosystems) with an ABI 310 sequencer (PE Applied 
Biosystems). Sequence similarity searches of the databases were conducted by 
using the default settings of the BLAST program (Altschul et al., 1990) on the National 
Center for Biotechnology Information World Wide Web server.  
 
RESULTS 
 
In search of cellular proteins interacting with IBDV proteins, we performed a LexA-
dependent two-hybrid screen. Bursae of 3-weeks-old chickens were chosen as a 
source for poly(A)+ RNA, from which a directionally cloned cDNA library in the pB42AD 
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vector was generated.  cDNA segments encoding VP1, VP3, VP4, and VP5 of IBDV 
strain CEF94, and pVP2 of vvIBDV strain D6948 were generated by PCR and 
subcloned into the yeast expression vector pLexABD. The generated pLexABD fusion 
plasmids were introduced into yeast cells carrying two reporter genes, LEU2 
integrated in the genome, and LacZ located on the p8op-LacZ reporter plasmid. 
Protein expression of the LexA fusion plasmids was verified by Western analysis (data 
not shown). Activation and repression assays (Golemis et al., 1996) confirmed that 
the fusion protein by itself did not activate the reporter genes and that it was 
localized in the nucleus (data not shown). The yeast strains obtained, harboring 
plexABD-VP1, pLexABD-pVP2, plexABD-VP3, plexABD-VP4 or pLexABD-VP5, were 
transformed with the pB42AD-bursae-cDNA library and plated on glucose SD medium 
lacking his, ura, and trp. All transformations yielded >106 independent clones except 
for the yeast strain harboring pLexABD-VP4 (Table 1). 
 
 
Yeast strain EGY48[p8op-LacZ] 
harboring the following 
plasmids 
 
 
Number of independent cDNA clones 
 
1st screening 
 
rescreening  
 
   pLexABD              pB42AD 
   -fusion:                -fusion: 
 
 
Primary 
transformantsa)  (cfu)  
Leu+ b) 
 
LacZ+ c) 
 
Leu+ 
 
LacZ+ 
 
       VP1            bursae-cDNA 
 
2.0 x 106 
 
3825 
 
329 
 
329 
 
192 
 
       pVP2          bursae-cDNA 
 
2.1 x 106 
 
130 
 
54 
 
54 
 
48 
 
       VP3            bursae-cDNA 
 
3.0 x 106 
 
226 
 
45 
 
45 
 
44 
 
       VP4            bursae-cDNA 
 
5.0 x 103 
 
nd 
 
nd 
 
nd 
 
nd 
 
       VP5            bursae-cDNA 
 
1.7 x 106 
 
326 
 
194 
 
165 
 
77 
 
Table 1. Compilation of Yeast two-hybrid screening results.  Yeast strain EGY48[p8oplacZ] was 
sequentially transformed, first with a pLexABD plasmid encoding one of the IBDV proteins VP1, 
pVP2, VP3, VP4, or VP5, and then with the pB42AD-bursae-cDNA library. In a first screening, 
yeast clones were initially tested for leucine autotrophy (Leu+) and subsequently Leu+ clones 
were assayed for β-galactosidase activity (LacZ+). In a rescreening all isolated Leu+/LacZ+ 
clones were assayed for a second time for expression of both reporter genes analogous to 
the first screening. cfu; colony-forming units. nd; not determined. 
a) Total approximate number of transformants obtained on SD/glu/-His/-Ura/-Trp plates.  
b) Yeast clones were scored as Leu+ if they grew on SD/Gal/Raf/-His/-Ura/-Trp plates but 
not  on SD/Glu/-His/-Ura/-Trp plates.  
c) Yeast clones were scored as LacZ+ if they turned blue on SD/Gal/Raf/X-gal/-His/-Ura/-
Trp but not or only faintly blue on SD/Gal/Raf/X-gal/-His/-Ura/-Trp plates. 
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Since a saturating screen of the library requires at least 106 independent 
transformants, the library screen with VP4 was not further analyzed. For the 
screenings with VP1, pVP2, VP3, and VP5, all primary transformants were pooled and 
subsequently plated for Leu+ selection on galactose/raffinose SD medium lacking 
his, ura, trp, and leu. Yeast transformed with an empty vector construct, pB42AD-
empty, was used as a negative control, whereas yeast transformed with pLexABD-53 
and pB42AD-SV 40 T was used as a positive control. All Leu+ colonies were 
subsequently replica-plated to glucose-, as well as galactose/raffinose- SD medium  
 
Number of clones 
with same 
sequence 
information 
 
Proteins of database matching the cDNA sequence of the 
respective cDNA clones 
 
42 Cytochrome C oxidase 
21 Unknown 
16 Paladin [accession no: NM_013753] 
8 Eukaryotic translation initiation factor 4A, isoform 2 (eIF4AII) 
7 NAD(+)-isocitrate dehydrogenase  
5 Unknown  
4 Unknown 
4 RAN binding protein 1 (RanBP1) 
4 Putative cyclin G1 interacting protein [accession no: NP_006340] 
3 Unknown 
3 Ribosomal protein 
2 Unknown 
2 Unknown 
2 Unknown 
2 Unknown 
2 Unknown 
1 Enhancer of rudimentary homolog [accession no: NP_004441] 
1 Zinc finger transcription factor [accession no: AAC05500] 
 (27 x)a) Unknown 
 (36 x)b) ND  
Total number of 
positive cDNA 
clones: 129 
 
 
 
Table 2. Putative cellular interactors of VP1. The yeast LexA interaction trap was used to 
screen a cDNA library from bursae of 3-weeks-old chickens in order to identify proteins that 
interact with VP1 of IBDV strain CEF94. Positive cDNA clones were selected on the basis of 
their ability to activate transcription of both LEU2 and LacZ reporter genes under the 
control of LexA binding sites. Sequence comparisons of the respective cDNAs were 
performed using the default settings of the BLAST program the National Center for 
Biotechnology Information World Wide Web server. Proteins that are notoriously found as 
non-specific interactor in a two-hybrid assay are in italics. Unknown; no similarities were 
found. ND; not done (cDNA has to be sequenced). 
a) Number of clones, each with a different sequence information. 
b) Number of clones that were not sequenced. 
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Number of 
clones with same 
sequence 
information 
 
Proteins of database matching the cDNA sequence of the respective 
cDNA clones 
6 Unknown 
5 Unknown 
3 Unknown 
3 Unknown 
2 Calmodulin 
2 Ubiquitin 
2 Ribosomal protein 
2 Unknown 
1 Sin3-associated polypeptide 18 (Sap18) [accession no: NP_033145] 
1 Ornithine decarboxylase antizyme (ODC-AZ) 
1 Hypothetical protein KIAA0168 [accession no: P50749] 
 (11 x)a) Unknown 
 ( 9 x)b)  ND                
Total number of 
positive cDNA 
clones: 48 
 
 
Table 3. Putative cellular interactors of pVP2. The yeast LexA interaction trap was used to 
screen a cDNA library from bursae of 3-weeks-old chickens in order to identify proteins that 
interact with pVP2 of vvIBDV strain D6948. For further details see legend of Table 2. 
a) Number of clones, each with a different sequence information.  
b) Number of clones that were not sequenced. 
 
 
Number of clones 
with same 
sequence 
information 
 
Proteins of database matching the cDNA sequence of the 
respective cDNA clones 
6 RAN binding protein 1 (RanBP1) 
5 Ferritin, heavy chain 
4 Unknown 
4 Thymocyte protein cThy28kD [accession no: AAA75591] 
2 Unknown  
2 Unknown 
2 Unknown 
1 Embryonic ectoderm development protein [accession no: 
AAC53302] 
1 Pyruvate kinase 
1 Cytochrome C oxidase 
1 Ribosomal protein 
 (  5 x)a) Unknown 
 (10 x)b) ND         
Total number of 
positive cDNA 
clones: 44 
 
 
 
Table 4. Putative cellular interactors of VP3. The yeast LexA interaction trap was used to 
screen a cDNA library from bursae of 3-weeks-old chickens in order to identify proteins that 
interact with VP3 of IBDV strain CEF94. For further details see legend of Table 2. 
a) Number of clones, each with a different sequence information.  
b) Number of clones that were not sequenced. 
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Number of clones 
with same 
sequence 
information 
 
Proteins of database matching the cDNA sequence of the 
respective cDNA clones 
8 Unknown  
7 Elongation factor 1-alpha 
4 Guanine nucleotide binding protein (G protein) [accession no: 
NP_006089] 
4 Ovoinhibitor [accession no: AAA48994] 
3 Phosphoglycerate kinase (PGK) 
3 Unknown 
2 Unknown 
1 Gamma-immunoglobulin heavy chain [accession no: CAA30161] 
1 Elonase [accession no: BAA07132] 
1 Ornithine decarboxylase antizyme (ODC-AZ) 
1 Death associated protein 5 (DAP5) [accession no: CAA61857] 
1 DNA polymerase epsilon subunit B 
1 Beta-tubulin 
1 Clusterin 
1 Inorganic pyrophosphatase 
1 Phosphoglucanate dehydrogenase  
1 Hypothetical protein P15-2 [accession no: NP_061168] 
1 Peptidylprolyl isomerase E (cyclophilin E) [accession no: NP_006103] 
1 HSPC322 [accession no: AAF29010] 
1 RAN binding protein 16 (RanBP16) 
1 RNA-binding protein siahBP [accession no: AAD44358] 
 (19 x)a) Unknown 
 (13 x)b)  ND         
Total number of 
positive cDNA 
clones: 77 
 
 
 
Table 5. Putative cellular interactors of VP5. The yeast LexA interaction trap was used to 
screen a cDNA library from bursae of 3-weeks-old chickens in order to identify proteins that 
interact with VP5 of IBDV strain CEF94. For further details see legend of Table 2. 
a) Number of clones, each with a different sequence information.  
b) Number of clones that were not sequenced.  
 
 
containing X-gal and lacking his, ura, and trp, to assess the transcriptional activation 
of the LacZ reporter. About 10-50% of the screened Leu+ colonies turned blue on 
the galactose/raffinose plates and not or only faintly blue on the glucose plates 
(Table 1). All positive colonies were restreaked at least once on glucose SD medium 
lacking his, ura, and trp, to allow segregation of some multiple pB42AD-bursae-cDNA 
library plasmids within single colonies while maintaining selective pressure for the 
plasmids. Consequently, these restreaked colonies were rescreened for expression 
of LacZ and LEU2 reporter genes. The rescreenings led to the isolation of a number 
of distinct clones as putative interactors for VP1, pVP2, VP3, and VP5 as compiled in 
Table 1. Partial sequences of the cDNA inserts of these clones were determined, and 
aligned to protein sequences in data banks. The results of these analyses are 
documented in Table 2 – 5. As is clear from these tables, for each viral protein a 
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number of different sequences were obtained with different frequencies. While 
many of these sequences had significant homology to known proteins, for several 
no such match was found. We also obtained several protein scores that are 
notoriously found as non-specific interactors in two-hybrid screens. Finally, for some 
clones the sequence analysis failed for unknown reasons. Putative biological 
implications for several interactions found are discussed below.  
 
DISCUSSION 
 
Little is known about the intermolecular interactions of the viral proteins of IBDV and 
host cell proteins. In general, viral proteins often function by contacting other 
proteins, particularly proteins that regulate the different cellular processes such as 
transcription, translation, replication, signal transduction, cell cycling, and 
programmed cell death. In this way the virus interferes with these processes to adjust 
the conditions for its optimal replication. Finding interacting partners of viral proteins 
can thus reveal much about the function of these proteins. Here we used the 
inducible LexA-dependent two-hybrid system in yeast to search for cellular partners 
of the viral proteins VP1, VP3, and VP5 of IBDV strain CEF94, and pVP2 of vvIBDV 
strain D6948. The screening of a cDNA library from bursae of 3-weeks-old chickens 
allowed the isolation of a number of putative cellular interactors. Because of the 
large amounts of information flowing from these interaction experiments, it is difficult 
to make a qualitative interpretation. Which of the individual interactions found are 
meaningful? Many of the proteins identified in interactor hunts are non-specific 
interactors: they appear to interact with a number of different unrelated LexA 
fusions (Chien et al., 1994). Interestingly, the commonly isolated non-specific 
interactors, which include ribosomal proteins, cytochrome oxidase, proteasome 
subunits, mitochondrial proteins, ferritin, NADH dehydrogenase, zinc finger proteins, 
elongation factors, and other proteins (http://www.fccc.edu/research/labs/golemis 
/main_false.html), are not isolated in every interactor hunt, and in fact do not 
appear to interact with every bait. For example, frequently a non-specific interactor 
will interact with just 30% of different bait proteins (Finley & Brent, 1997). Conversely, 
these commonly found non-specific interactors are occasionally found to be true 
specific interactors. Furthermore, we tend to give less weight to interactions 
between proteins that are so ubiquitous in the life of the cell (e.g., members of the 
ubiquitin system or heat shock proteins) that the interactions might be meaningful 
but relatively uninformative.  
From our two-hybrid screen with VP1 we obtained 8 independent yeast 
clones harboring cDNAs encoding the eIF4AII C-terminal domain. Eukaryotic 
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initiation factor 4A, an essential component of the translation initiation system, 
normally binds to the initiation complex in a cap-mediated way (Gingras et al., 
1999). A direct interaction between VP1 and eIF4A might therefore be feasible since 
the viral mRNAs of IBDV are likely to lack a cap-structure, carrying a covalently 
linked VP1 (VPg) at their 5’ end instead. Furthermore, we found a total of 21 
independent cDNA clones each coding for the same unknown protein, and a total 
of 16 cDNA clones encoding paladin, as putative cellular partners for VP1. Paladin, 
obtained in a subtractive screen of mouse gastrulation (Pearce et al., unpublished 
data, 1996), however, is also a novel protein with unknown function. It is therefore 
difficult to speculate about a possible function of these two putative interactors. An 
approach to search for more information would be to assume that these new 
proteins function in a network of protein interactors and to use them as bait in an 
additional two-hybrid screening to identify other members of the network. 
Repeating this process would further increase the chances of isolating a previously 
characterized protein, or one the sequence of which might provide clues to its 
function. Another putative interactor found for VP1 was RanBP1. It is worth noting 
that RanBP1 was found as putative interactor for both VP1 and VP3. RanBP1, a 
RanGTP-binding protein, is located in the cytoplasm and has been implicated in the 
release of nuclear export complexes from the cytoplasmic side of the nuclear pore 
complex (Görlich & Kutay, 1999; Kehlenbach et al., 2001). Since VP1 and VP3 also 
interact with each other we could speculate that these proteins are involved in a 
network of proteins functioning in nucleocytoplasmic transport. However, 
considering that the known interactor for RanBP1, Ran, requires only a strech of five 
acidic amino acids for its interaction with RanBP1 (Kehlenbach et al., 2001), our 
observed putative interactions of VP1 and VP3 with RanBP1 might simply be non-
specific. Other putative interactors found for VP1 were either unknown proteins, 
notorious non-specific interactors, or interactors unlikely to be meaningful. 
For the interaction hunt with pVP2 we used the gene from a vvIBDV strain 
rather than from the cell culture adapted IBDV strain CEF94 as bait, since VP2 of the 
vvIBDV strain is responsible for the particular B-lymphoid cell tropism (Lim et al., 1990; 
Mundt, 1999; Boot et al., 2000). Recently, it was found that wild-type vvIBDV is able 
to replicate in non-B-lymphoid cells once it is artificially (transfection of cDNA) 
introduced into these cells (Boot et al., 2000). Therefore, the inability of vvIBDV strains 
to infect non-lymphoid cells is likely due to the inability to recognize a certain 
receptor and/or the inability to enter the cell. It was speculated that the typical B-
lymphoid cell tropism of vvIBDV strains might be related to the recognition of an 
IBDV specific B-lymphoid cell receptor whereas classical IBDV strains recognize a 
general IBDV receptor present on a wide range of cells (Boot et al., 2000). Thus, by 
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using the vvIBDV pVP2 protein as bait in our screening we thought we might have a 
chance to find a candidate B-lymphoid specific IBDV receptor, though this thought 
is also somewhat impetuous for various reasons. For instance, to accomplish a 
receptor-interaction it is usually necessary that the protein in question is in its natural 
conformation, so there might be only a receptor-interaction with mature VP2, and 
not with the premature form pVP2. Furthermore the pVP2 and, in addition, the VP3 
coding sequences that we have used as bait, were based on the putative 
polyprotein cleavage sites reported by Hudson et al. (1986). Recently, the exact 
proteolytic processing sites at the pVP2-VP4 and VP4-VP3 junctions of the 
polyprotein of IBDV were identified (Sanchez & Rodriguez, 1999). Hence, the pVP2 
and VP3 coding sequences we have used were therefore incorrect. Also, the virus 
specific receptor might be composed of glycosylated proteins (Ogawa et al., 1998). 
Interactions dependent on a posttranslational modification, such as glycosylation, 
do not occur in yeast cells and therefore will not be detected. Finally, there are 
some drawbacks of the yeast two-hybrid system: (i) the two-hybrid system is limited 
to proteins that can be localized to the nucleus, which may prevent its use with 
certain extracellular proteins (ii) the bait and prey protein must be able to fold and 
exist stably in yeast cells and retain activity as fusion protein (iii) the use of protein 
fusions means that the site of interaction may be occluded by one of the fusion 
domains. Taken all together, it thus might be unlikely to find a possible IBDV-specific 
receptor in a yeast two-hybrid hunt. Nevertheless, as nothing is known about the 
existence of possible cellular interactors for pVP2, we also aimed to search for such 
putative cellular partners. Our interaction hunt yielded 48 putative interactors (Table 
3). Most of these did not have any obvious homology to known proteins and their 
significance thus remains unclear. Of those that had a match in the database a 
Sap18 homologue and ornithine decarboxylase antizyme (ODC-AZ) are worth 
mentioning. Sap18 is a polypeptide that is associated with the mammalian 
transcriptional repressor Sin3 (Zhang et al., 1997). pVP2 might somehow contribute to 
the regulation of gene expression through the recruitment of the Sap18 homologue 
and/or the Sap18-Sin3 complex. ODC-AZ is the central element in a feedback loop 
that controls the cellular level of polyamines. Polyamines play key roles in processes 
ranging from the functioning of certain ion channels (Williams, 1997), nucleic acid 
packaging, DNA replication, apoptosis, transcription and translation. The expression 
of ODC-AZ genes in vertebrates requires a specific +1 translational frameshift. This 
frameshifting occurs in the decoding of the antizyme (AZ) gene, which consists of 
two partially overlapping open reading frames. The AZ protein binds to ornithine 
decarboxylase (ODC) (Murakami et al., 1992a; Li & Coffino, 1993, 1994), inhibits it 
(Heller et al., 1976) and targets it for degradation (Murakami et al., 1992b; Murakami 
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et al., 1999). ODC catalyzes the first and rate-controlling step in the synthesis of 
polyamines, conversion of ornithine to putrescine. Increasing polyamine levels 
induce frameshifting in AZ mRNA and so increase the level of AZ (Gesteland et al., 
1992; Rom & Kahana, 1994). Since AZ negatively regulates the synthesis and uptake 
of polyamines, the frameshifting is the sensor for the autoregulatory circuit. Our 
observation that a viral protein might bind to AZ is potentially interesting. Often virus 
particles contain polyamines packaged with the viral components suggesting that 
polyamines are in some way important for viral replication. Like the AZ gene the 
IBDV A segment has two overlapping open reading frames. It is therefore tempting 
to speculate that the cellular polyamine levels somehow regulate the differential 
expression of the VP5 and pVP2-VP4-VP3 open reading frames through 
programmed frame-shifting. Remarkable enough, ODC-AZ was found as a putative 
interactor both for pVP2 and for VP5. Nevertheless, we should bear in mind that 
ODC-AZ was only found once in both screenings whereas a library that has been 
screened to exhaustion usually represents each interactor cDNA more than once in 
the putative positives. Whether ODC-AZ is a true interactor is therefore at this point 
very speculative.  
By the two-hybrid screen with VP3, we isolated only a few cDNA clones with 
sequence homology to known proteins. Among them: RanBP1 (discussed above), 
Thymocyte protein cThy28kD, and embryonic ectoderm developmental protein 
(EED). cThy28kD is a nuclear phosphoprotein that is highly expressed in the bursa, 
thymus and spleen. It is thought to have a functional role in bursal lymphocyte 
apoptosis (M.M. Compton; personal communication). EED belongs to the 
Polycomb-Group (PcG) proteins, which form multimeric protein complexes involved 
in maintaining the transcriptional repressive state of genes over successive cell 
generations (van Lohuizen, 1998). At this point in time it is difficult to speculate about 
a putative relationship between VP3 and cThy28kD or EED. Besides, these putative 
interactors should first be confirmed with a bait protein of VP3 that is based on the 
recently identified (Sanchez & Rodriguez, 1999) VP4-VP3 proteolytic processing site 
of the IBDV polyprotein.  
The interaction hunt with VP5 yielded quite a number of different putative 
interactors. As discussed, most two-hybrid approaches inevitably produce false 
positives. Possibly VP5 is a “sticky” protein and therefore associates with multiple 
non-specific interactors. Therefore, it is difficult to speculate which of the putative 
interactors found for VP5 are potential candidates to pursue as biologically relevant. 
Despite this, possibly worth mentioning are guanine nucleotide binding protein (G 
protein), ovoinhibitor, and death associated protein 5 (DAP5) as putative 
interactors. G-protein [accession no: NP_006089], homologous to chicken B complex 
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protein, is a membrane-associated protein (Guillemot et al., 1989). Lombardo et al. 
(2000) hypothesised that accumulation of VP5, a class II membrane protein, in the 
plasma membrane leads to a progressive alteration of the plasma membrane that 
facilitates the release of the virus progeny. Although speculative, an interaction 
between VP5 and G-protein might be involved in the process of release. 
Ovoinhibitor is a multidomain Kazal-type proteinase inhibitor with each domain 
containing an actual or putative reactive site for a serine proteinase (Saxena & 
Tayyab, 1997). Whether there may be a biological relevant relation between IBDV 
VP4, which is delineated as a new type of viral serine protease (Lejal et al., 2000), 
and VP5 might be too speculative. Finally, although it was only found once in the 
screening, death associated protein 5 (DAP5) might also be worth mentioning. If 
DAP-5 proves to be a true interactor this interaction is interesting. DAP-5 is a putative 
modulator of programmed cell-death (Levy-Strumpf et al., 1997). Since the 
mechanism of IBDV-induced apoptosis is still unknown this putative interaction might 
therefore be a first clue to unravelling this mechanism.  
Finally, a two-hybrid screen for putative cellular interactors of VP4 failed. For 
some reason the transformation efficiency of the bursae-cDNA library into the yeast 
host strain harboring VP4 as bait was too low. At least 106 independent transformants 
are required before a meaningful screen can be done, while we obtained only 
5x103 transformants with the VP4 expressing yeast cells.  
Taken altogether, the yeast two-hybrid screenings described here allowed 
the isolation of several putative cellular interactors for the viral proteins VP1, pVP2, 
VP3 and VP5 of IBDV. Although the candidates found in a two-hybrid assay do not 
address the biological significance of the interactions, several interactions that we 
observed may have a real in vivo function. A first step to demonstrate biological 
relevance is to verify these interactions by a different, biochemical assay, preferably 
by a co-precipitation from a cell in which both proteins are expressed. Ideally, the 
next step would involve a functional assay for the interactor, to show, for example, 
that the protein is involved in the same biological process as the viral protein. We 
hope that our ongoing studies will indeed elucidate the biological significance of 
some of the putative interactors in the IBDV life cycle. 
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ABSTRACT 
 
Infectious bursal disease virus (IBDV), a member of the Birnaviridae family, is a non-
enveloped, double-stranded RNA (dsRNA) virus. Viral protein 1 (VP1), the putative 
RNA-dependent RNA polymerase, occurs in virions both as a free polypeptide and 
as a genome-linked protein, called VPg. To gain more insight in its function, we 
initiated a yeast two-hybrid screen of a cDNA library from the bursa of Fabricius of 3-
weeks-old chickens, using VP1 as bait. With this approach, we isolated eight cDNA 
clones with complete sequence homology to the carboxy-terminal domain of 
eukaryotic translation initiation factor 4AII (eIF4AII). These clones behaved as bona 
fide VP1 partners in yeast two-hybrid control crosses. The association was confirmed 
by co-immunoprecipitation analyses of the co-expressed VP1 protein and carboxy-
terminal domain of eIF4AII. eIF4A plays an essential role in the initiation of translation 
of both capped and uncapped mRNAs. Its association with IBDV VP1 or, rather, with 
viral mRNA-linked VPg points to an important function of this viral protein in IBDV 
mRNA translation. An interaction between VP1 and full-length eIF4AII was, however, 
not observed. In view of the known two-domain structure of the eIF4AII protein it is 
conceivable that the interaction of VP1 with the full-length molecule requires 
collaborating proteins that open up its structure and expose the VP1-binding site in 
the carboxy-terminal domain. The biological relevance of the potential VPg-eIF4AII 
interaction is discussed. 
 
INTRODUCTION 
 
Infectious bursal disease virus (IBDV) is the causative agent of a highly contagious 
disease of young chickens that causes significant losses to the poultry industry. In the 
infected animal, IBDV targets the developing B lymphocytes in the bursa of 
Fabricius, in which it multiplies rapidly, leading to immune suppression. This condition 
increases the animal’s susceptibility to opportunistic infections with other pathogens 
and reduces the growth rate of surviving animals (Kibenge et al., 1988). 
IBDV belongs to the genus Avibirnavirus of the family Birnaviridae (Dobos et 
al., 1979). The virus consists of a non-enveloped capsid, 60 nm in diameter, that 
contains two segments of double-stranded RNA (dsRNA) of 3.3 kb (segment A) and 
2.9 kb (segment B). Segment A contains two partially overlapping open reading 
frames (ORFs). The smaller ORF, located at the 5’ end, encodes VP5. This 17 kDa 
protein, detected only in IBDV-infected cells (Mundt et al., 1995), is not required for 
virus replication but plays a role in viral pathogenesis (Mundt et al., 1995; Mundt et 
al., 1997).  The large ORF encodes a 110 kDa polyprotein precursor that is 
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autocatalytically cleaved to produce pVP2 (48 kDa), VP3 (32 kDa), and VP4 (28 
kDa). VP4 is the protease responsible for the processing of the polyprotein. In mature 
virions, pVP2 is further processed into VP2 (40 kDa) (Da Costa et al., 2002). VP2 and 
VP3 are the structural proteins that constitute the viral capsid.  
Segment B contains one ORF which encodes VP1, the putative RNA-
dependent RNA polymerase (RdRp). This 90 kDa protein is responsible for 
transcription (plus-strand or mRNA synthesis) and replication (minus-strand synthesis) 
(Spies et al., 1987). Moreover, it interacts with VP3, an association likely to be 
essential for IBDV particle morphogenesis (Lombardo et al., 1999; Tacken et al., 2000; 
Tacken et al., 2002). VP1 is present within virions both as a free polypeptide and as a 
genome-linked protein, called VPg, attached to the 5’ end of the positive strands of 
both genomic segments (Muller & Nitschke, 1987). RNA polymerase activity can be 
demonstrated in purified virions without any pretreatment (Spies et al., 1987) 
indicating that, like with reovirus (Skehel & Joklik, 1969), transcription can be initiated 
without the need for uncoating. In vitro, transcription by the virion RdRp is primed by 
VP1 and proceeds via an asymmetric, semiconservative strand-displacement 
mechanism (Spies, et al., 1987). The initiation of viral mRNA synthesis may therefore 
involve either two VP1 molecules, one serving as a primer and the other as a 
polymerase for chain elongation, or just a single VP1 molecule performing both 
these functions (Dobos, 1995). The newly synthesized viral mRNAs contain a 
covalently linked VP1 at their 5’ end and, similar again to reovirus mRNAs, lack a 
poly(A) tail at their 3’ end. The IBDV VP1 protein is unusually large compared to 
other VPg’s (e.g. adeno- and picornavirus) and its function as primer as well as 
polymerase is without precedent.  
Viruses are obligatory intracellular parasites. For their multiplication they are 
essentially dependent on components and machineries provided by the host cell. 
Interactions between viral and host cell proteins occur at all stages of the infection 
process. Viruses recognize their target cell through interaction with specific 
receptors and/or other components on the cell membrane resulting in virion 
internalization. Gene expression of most DNA viruses is mediated by cellular 
polymerases and regulated largely by cellular transcription factors. Most RNA viruses 
replicate and transcribe their genomes by RNA-dependent RNA synthesis, a process 
foreign to eukaryotic cells. Therefore, many of the factors that are normal 
components of cellular RNA translation are subverted to play an integral or 
regulatory role in the replication and transcription of viral RNA. These replication 
complexes often include transient or long-lived interactions with host proteins for 
structural purposes or to recruit regulatory and catalytic functions. It is now well 
established that coupling of the different, sequential steps of virus replication is 
CHAPTER 5  IBDV VP1 INTERACTION WITH eIF4AII C-TERMINUS 
 
 124 
central to the overall infectious cycle of many RNA viruses. Identification of cellular 
interaction partners of viral proteins is therefore likely to provide a mre complete 
understanding of the dynamics of RNA replication, virus-mediated cellular 
modulation and host-range restriction. 
Recently, we analysed the intermolecular interactions between the IBDV 
proteins using the yeast two-hybrid system (Tacken et al., 2000; Tacken et al., 2003). 
In the present study, we aimed at identifying potential cellular partners for the viral 
RdRp and genome-linked protein, VP1. To this end we applied the inducible LexA-
dependent yeast two-hybrid system to screen a cDNA library from bursae of 3-
weeks-old chickens using VP1 as a bait. The LexA-based interaction trap offers 
inducible expression of the library fusion proteins, which allows less opportunity for 
the foreign fusion proteins to exhibit a toxic effect on the yeast host and thus to be 
eliminated from the pool of potentially interacting proteins. The screening allowed 
the isolation of eight candidate cDNA clones coding for the carboxy-terminal 
domain of RNA-helicase translation initiation factor eIF4AII, a key component in the 
initiation of eukaryotic translation. Co-immunoprecipitation analyses confirmed the 
interaction between VP1 and the carboxy-terminal domain of  eIF4AII in vivo. 
 
MATERIAL AND METHODS 
 
CELLS, VIRUSES, BACTERIAL AND YEAST STRAINS 
QM5 cells (Antin & Ordahl, 1991) were cultured in QT35 medium (Gibco-BRL) 
supplemented with 5% fetal calf serum (FCS) and 2% antibiotic solution ABII (1,000 U 
of penicillin [Yamanouchi], 1 mg of streptomycin [Radiumfarma], 20 µg of 
amphotericin B [Fungizone], 500 µg of polymixin B, and 10 mg of kanamycin/ml) in a 
CO2 (5%) incubator at 37°C. The classical IBDV isolate CEF94 is a derivate of PV1 
which has been adapted for growth in cell cultures (Boot et al., 1999). Recombinant 
fowlpox virus expressing the T7 polymerase gene (FPV-T7) (Britton et al., 1996) was 
received from the laboratory of M. Skinner (Compton Laboratory, Berks, United 
Kingdom). Escherichia coli strain DH5-α (Life Technologies) was used for general 
DNA manipulation, and KC8 (Clontech) for rescuing prey plasmids from yeast 
cotransformants. Yeast (Saccharomyces cerevisiae) strain EGY48 (MATα, his3, trp1, 
ura3, LexAop(x6)-LEU2) was used for the interaction trap. Yeast strain EGY[p8oplacZ] is 
the host strain EGY48 transformed with the autonomously replicating reporter 
plasmid p8op-LacZ (Clontech). 
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ANTIBODIES 
The rabbit anti-VP1 serum directed against amino acids 580-881 of VP1 of IBDV strain 
CEF94 has been described previously (Tacken et al., 2000). The polyclonal rabbit 
antiserum against eIF4A was a gift from of Dr. C. Kuhlemeier (University of Berne, 
Switserland) and monoclonal mouse anti-eIF4A antibody was a gift from Dr. H. 
Trachsel (University of Berne, Switserland). The c-myc monoclonal antibody was 
purchased from Clontech. 
 
PLASMIDS AND cDNA LIBRARY  
Plasmids pLexABD-VP1 and pB42AD-VP1, both containing the cDNA-coding sequence 
of VP1 of IBDV strain CEF94, have been described previously (Tacken et al., 2000). 
Plasmid pB42AD-c-eIF4AII(full-length) encoding the full-length cDNA sequence of 
chicken bursa-specific eIF4AII (Gen-Bank accession number AF515726) was used as 
the DNA template for preparing c-eIF4AII constructs and plasmids pTZ18R-4A and 
pTZ19-4AII (Scheper et al., 1992) encoding the full-length cDNA sequences of mouse 
eIF4AI and eIF4AII, respectively, for preparing m-eIF4AI and m-eIF4AII constructs. The 
full-length coding sequences of eIF4A were subcloned in-frame with the LexA DNA-
binding domain in pLexABD (Clontech), the B42-activation domain in pB42AD 
(Clontech), and the c-myc epitope tag in pGBKT7 (Clontech). The carboxy-terminal 
(C) domain coding sequences of eIF4A, c-eIF4AII(C-domain), m-eIF4AI(C-domain) 
and m-eIF4AII(C-domain), starting at Leu244 (Leu243 for m-eIF4AI), and the amino-
terminal (N) domain coding sequences of eIF4A, c-eIF4AII(N-domain), m-eIF4AI(N-
domain) and m-eIF4AII(N-domain), from Met1 to Thr243 (Thr242 for m-eIF4AI), as well 
as the carboxy-terminal 107aa (C-107aa) coding sequences of mouse eIF4A, m-
eIF4AI(C-107aa) and m-eIF4AII(C-107aa), starting at Ser301 (Ser300 for m-eIF4AI), 
were obtained by PCR using appropriate primers on pB42AD-c-eIF4AII(full-length), 
pTZ18R-4A and pTZ19-4AII, and then subcloned into pLexAAD, pB42AD and pGBKT7. 
The subcloning of the pB42AD-cDNA library fragments c-eIF4AII(C-107aa), c-eIF4AII(C-
109aa) and c-eIF4AII(C-122aa) in the EcoRI site of pLexABD and pGBKT7 gave 
plasmids pLexABD-c-eIF4AII(C-107aa), pLexABD-c-eIF4AII(C-109aa), pLexABD-c-
eIF4AII(C-122aa), and pGBKT7-c-eIF4AII(C-107aa) and pGBKT7-c-eIF4AII(C-122aa). 
Each construct was sequenced to verify correctness of the sequences and fusions. 
The preparation of the plasmid pHB34Z which contains the full-length genomic 
cDNA of segment B of IBDV strain CEF94, has been described previously (Boot et al., 
1999). Control plasmids pLexABD-53 (human p53 gene in pLexABD), pB42AD-SV40 T 
(SV40 large T antigen in pB42AD) and pLexABD–Lamin C (human Lamin C gene in 
pLexABD) were obtained from Clontech. Plasmids pLexABD-pVP2, pB42AD-pVP2, 
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pLexABD-VP3 and pB42AD-VP3 contain cDNA-coding sequences of pVP2 and VP3 of 
IBDV strain CEF94 (Tacken et al., 2003). 
For the generation of the pB42AD cDNA plasmid library, total RNA was 
isolated from bursae of 3-weeks-old chickens in a one-step protocol with acidic 
guanidinium thiocyanate, phenol, and chloroform (Chomczynski & Sacchi, 1987) 
and used for poly(A)+ RNA purification with Mini-Oligo(dT) Cellulose Spin Columns (5 
Prime → 3 Prime, Inc.) according to the instructions. Five micrograms of poly(A)+ RNA 
was used for cDNA synthesis by a custom cDNA library service (OriGene 
Technologies, Inc.). This library contained 4.8 x 106 independent clones.  
 
TWO-HYBRID LIBRARY SCREENING 
All yeast two-hybrid media, buffers, and protocols were as described in the 
Clontech Manual for the Matchmaker LexA two-hybrid system and in the Clontech 
Yeast Protocols Handbook. The yeast strain EGY48[p8op-lacZ] was first transformed 
by using the lithium acetate method with the pLexABD (HIS3
+) construct carrying VP1. 
Stable expression of the LexA hybrid protein was verified by Western blot analysis 
according to the manufacturer’s instruction. The ability of the LexA fusion to bind 
operator DNA, as well as the inability of the LexA fusion for autonomous reporter 
gene activation, was confirmed by a repression and an activation assay, 
respectively, as described previously (Tacken et al., 2000). The obtained yeast strain 
EGY48[p8op-LacZ] harbouring  plexABD-VP1 was transformed according to the 
lithium acetate protocol  with plasmid DNA from the pB42AD-bursae-cDNA library. 
Double transformants were grown on SD/Glu/-His/-Ura/-Trp medium to select for the 
presence of both types of hybrid plasmids and the LacZ reporter plasmid. The 
primary transformant cells (2x106 CFU) were pooled and plated on SD/Gal/Raf/-His/-
Ura/-Trp/-Leu medium to screen for transcriptional activation of the LEU2 reporter 
gene. Yeast strain EG48[p8op-LacZ] transformed with the empty vector construct, 
pB42AD-empty, was used as negative control, whereas yeast strain EG48[p8op-LacZ] 
transformed with pLexABD-53 and pB42AD-SV 40 T was used as positive control. After 4 
days of incubation at 30°C, Leu+ colonies were patched onto SD/Glu/X-gal/-His/-
Ura/-Trp medium as well as SD/Gal/Raf/X-gal/-His/-Ura/-Trp medium to screen for 
transcriptional activation of the LacZ reporter gene. Colonies were tentatively 
considered positive if they were blue on the Gal/Raf containing plates but not blue 
or only faintly blue on the Glu containing plates. Colonies of the LacZ+ clones were 
restreaked, at least once, onto SD/Glu/-His/-Ura/-Trp plates to allow possible 
segregation of multiple cDNA library plasmids within single colonies, and were 
retested for both Leucine autotrophy and β-galactosidase activity. Positive clones 
were analysed by sequencing. For this purpose, yeast cells of a single colony were 
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resuspended in 40 µl H2O and broken by a heat-treatment of 5 min at 100°C 
followed by a vortex-treatment for 1 min in the presence of glass beads. Cell debris 
was removed by centrifugation and 4 µl aliquots of the supernatants were used as 
template for PCR amplification of the bursa derived cDNA inserts in pB42AD using the 
pB42AD specific primers 5’ CCAGCCTCTTGCTGAGTGGAGATG 3’ (upstream) and 5’ 
GTAGACAAGCCGACAACCTTGATTGG 3’ (downstream). PCR products were 
purified using a PCR purification kit (Qiagen) and analysed by sequencing. 
Yeast clones harbouring plasmids encoding candidate interacting proteins 
were grown in SD/Glu/-Trp medium and library plasmids were isolated using Method 
1 (described by Clontech in the Yeast Protocols Handbook) and transformed into 
electrocompetent Escherichia coli KC8. Bacterial transformants were selected on 
M9 minimal medium (Clontech Yeast Protocols Handbook). Library plasmids were 
repurified from bacterial transformants and used to retransform EGY[p8op-lacZ] 
yeast cells together with control plasmids (pLexABD-Lamin C, pLexABD-pVP2 and 
pLexABD-VP3) or for subcloning the cDNA library insert in pLexABD and pGKT7. 
 
DNA SEQUENCING AND SEQUENCE ANALYSIS 
Sequence analysis of cDNAs was performed by cycle sequencing (BigDye 
terminator kit, PE Applied Biosystems) with an ABI 310 sequencer (PE Applied 
Biosystems). Sequence similarity searches of the databases were conducted by 
using the default settings of the BLAST program (Altschul et al., 1990) on the National 
Center for Biotechnology Information World Wide Web server 
(http://www.ncbi.nlm.nih.gov/BLAST/). 
 
TRANSFECTION OF QM5 CELLS 
QM5 cells were grown to 80% confluency in 60-mm dishes and infected with FPV-T7 
(multiplicity of infection [MOI] = 3). After 1 h, the cells were washed once with 5 ml 
QT35 medium and covered with 5 ml of Optimem 1 (Gibco-BRL). In the meantime, 
2.0 µg of DNA was mixed with 25 µl Lipofectamine (Gibco-BRL) in 0.5 ml Optimem 1 
and kept at room temperature for at least 30 min. The QM5 cells were subsequently 
covered with 4 ml of fresh Optimem 1, and the DNA-Lipofectamine mixture was 
added. The transfection was performed overnight (18 h) in a 37°C incubator (5.0% 
CO2). The transfected monolayer was rinsed once with QT35 medium and fresh QT35 
medium supplemented with 5% FCS and 2% ABII was added. The plates were 
incubated for another 24 h. 
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RADIOLABELING OF TRANSFECTED CELLS AND IMMUNOPRECIPITATION 
At 48 h post-transfection, cells were starved for 1 h in methionine-free EMEM medium 
(Gibco-BRL). Cells were then labeled for 3 h with 20 µCi/ml of [35S]methionine 
(Amersham) in methionine-free EMEM medium. At the end of the labeling, the cell 
cultures were lysed on ice in 1x PBS-TDS lysis buffer, using a 5x PBS-TDS lysis buffer 
stock solution (5% Triton X-100, 2.5% sodium deoxycholate, 0.5% sodium dodecyl 
sulfate (SDS), 0.7 M NaCl, 14 mM KCl, 50 mM Na2HPO4, 7.5 mM KH2PO4). Cell debris 
was removed by centrifugation at 4°C for 20 min at 13,000 × g. All lysates were 
pretreated with Protein A Sepharose (Amersham) before they were used for 
immunoprecipitation with polyclonal anti-VP1 serum or monoclonal anti-c-myc 
serum. Protein A Sepharose-bound immune complexes were washed three times in 
1x PBS-TDS lysis buffer and eluted in 30 µl SDS sample buffer (60 mM Tris-HCl [pH 6.8], 
2.5% SDS, 5% β-mercaptoethanol, 10% glycerol, 0.1% bromophenol blue). Proteins 
were resolved in 18% separating gels by SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) and visualized by autoradiography.  
 
IBDV INFECTION AND IMMUNOBLOTTING 
Monolayer cultures of 80% confluency of QM5 cells were infected with IBDV strain 
CEF94 (MOI = 5), or mock-infected. After 1 h of virus absorption, QT35-medium (1% 
serum) was added to the cells, and incubation was continued until the indicated 
times (time zero was the time when virus was added to the cells). Where 
appropriate, 15 min prior to harvesting, cells were washed 3 times with methionine-
free EMEM medium (Gibco-BRL) and subsequently labeled for 15 min with 20 µCi/ml 
of [35S]methionine (Amersham) in methionine-free EMEM medium (Gibco-BRL). Cell 
extracts were prepared on ice with 1x PBS-TDS lysis buffer. Labeled proteins were 
subjected to SDS-PAGE (12%) and visualized by autoradiography. Alternatively, 
unlabeled samples were transferred onto Immobilon-P (Millipore) and probed with 
rabbit antibodies specific for eIF4A (1:3,000). Thirty ng of purified rabbit eIF4AI 
(Scheper et al., 1992) was used as a positive control for the immunoblotting. 
Detection on X-ray film was achieved by using peroxidase-linked goat anti-rabbit 
immunoglobulins (Ig) (1:3,000; DAKO) and chemiluminescent reagents (Pierce).  
 
RESULTS 
 
VP1 INTERACTS WITH THE C-TERMINAL DOMAIN OF eIF4AII 
To investigate the possible interaction of VP1 with cellular proteins, the LexA-
dependent yeast two-hybrid interaction assay was used. To this end, the VP1 gene 
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was subcloned into the yeast expression vector pLexABD. The generated pLexABD–VP1 
fusion plasmid was introduced into yeast cells carrying two reporter genes, i.e. LEU2 
integrated in the genome, and LacZ located on the p8op-LacZ reporter plasmid. 
Expression of the VP1-fusion protein was verified by Western blot analysis (data not 
shown). Activation and repression assays (Golemis et al., 1996) confirmed that the 
fusion protein by itself did not activate the reporter genes and that it was localized 
to the nucleus (data not shown).  
A yeast two-hybrid cDNA library in pB42AD, constructed from poly(A)+ RNA 
from bursae of 3-weeks-old chickens, was screened with pLexABD–VP1 used as a 
bait. Plasmids from positive clones were isolated and the inserts were sequenced in 
both directions. The identity of the respective genes was determined by BLAST 
analysis. Of the eleven putative VP1 binding proteins that were found more than 
twice, three were listed by the “Interaction Trap Table of False Positives” 
(http://www.fccc.edu/research/labs/golemis/main_false.html) as notoriously non-
specific interactors, and five were classified as proteins of unknown function, i.e. 
having no known functional or structural homologues. Other interacting proteins 
were RAN binding protein 1 (RanBP1) and the putative cyclin G1 interacting protein 
[accession no: NP_006340]. However, the clone that was frequently recovered 
(eight isolates) and, in addition, exhibited a more robust β-galactosidase activity, 
corresponded to part of the translational eukaryotic initiation factor 4AII (eIF4AII) 
and would thus be the chicken representative of this initiation factor. For this reason 
we focused our attention on the study of the interaction between VP1 and eIF4AII. 
An additional consideration was the recent demonstration of another interaction of 
a viral RdRp, the NS5B protein of hepatitis C virus, with (human) eIF4AII (Kyono et al., 
2002). 
The eight recovered eIF4AII-homologous cDNAs ranged in size from 983 to 
1028 nt. They all mapped to the 3’ end of the eIF4AII gene sequence, five clones 
encoding 107 aa, one clone encoding 109 aa and two clones encoding 122 aa of 
the eIF4AII carboxy-terminus (Fig. 1; indicated by asterisks). All cDNAs had the same 
662 nt-3’ UTR in which two potential polyadenylation signals occur. The eight cDNAs 
were derived from at least two different mRNA populations since a comparison of 
their sequences showed the occurrence of two nucleotide differences in the 
coding region neither of which, however, affected the predicted amino acid 
sequence of eIF4AII. As the actual N-terminus of the chicken eIF4AII was unknown 
we isolated and sequenced the full-length cDNA clone of this protein from our 
bursae library. A 1845 nt cDNA sequence was obtained for the chicken eIF4AII gene 
(c-eIF4AII; Gen-Bank accession number AF515726). Its coding sequence of 1221 nt 
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predicts a 407 aa protein. The 3’terminal part of the gene corresponding to the aa 
sequence that was common to all eight VP1-interacting eIF4AII-cDNAs showed 
 
c-eIF4AII 1 MSGGSADYSRDHGGPEGMEPDGVIESNWNEIVDNFDDMNLKESLLRGIYA
m-eIF4AII 1 --------N-E-------D-------------------------------
m-eIF4AI 1 --ASQDSR---N•--D----E------------S------S---------
c-eIF4AII 51 YGFEKPSAIQQRAIIPCIKGYDVIAQAQSGTGKTATFAISILQQLEIDLK
m-eIF4AII 51 -----------------------------------------------EF-
m-eIF4AI 50 --------------L-----------------------------I-----
c-eIF4AII 101 ETQALVLAPTRELAQQIQKVILALGDYMGATCHACIGGTNVRNEMQKLQA
m-eIF4AII 101 --------------------------------------------------
m-eIF4AI 100 A-------------------VM--------S-----------A-V----M
c-eIF4AII 151 EAPHIVVGTPGRVFDMLNRRYLSPKWIKMFVLDEADEMLSRGFKDQIYEI
m-eIF4AII 151 --------------------------------------------------
m-eIF4AI 150 -----I-------------------Y----------------------D-
c-eIF4AII 201 FQKLSTNIQVVLLSATMPMDVLEVTKKFMREPIRILVKKEELTLEGIKQF
m-eIF4AII 201 ------S-----------T-----------D-------------------
m-eIF4AI 200 -----S-T----------S-----------D-------------------
c-eIF4AII 251 YINVEREEWKLDTLCDLYETLTITQAVIFLNTRRKVDWLTEKMHARDFTV
m-eIF4AII 251 --------------------------------------------------
m-eIF4AI 250 --------------------------------------------------
c-eIF4AII 301 SALHGDMDQKERDVIMREFRSGSSRVLITTDLLARGIDVQQVSLVINYDL
m-eIF4AII 301 --------------------------------------------------
m-eIF4AI 300 --M-----------------------------------------------
c-eIF4AII 351 PTNRENYIHRIGRGGRFGRKGVAINFVTEEDKRILRDIETFYNTTVEEMP
m-eIF4AII 351 --------------------------------------------------
m-eIF4AI 350 -------------------------M-------T----------SI----
c-eIF4AII 401 MNVALDI
m-eIF4AII 401 -------
m-eIF4AI 400 L------
122 109
107
 
Figure 1. Comparison of the amino acid sequence for chicken eIF4AII (c-eIF4AII) predicted 
from full-length cDNA, mouse eIF4AII (m-eIF4AII) and mouse eIF4AI (m-eIF4AI). Amino acid 
sequences were aligned using MSA Version 2.1 provided on the World Wide Web server. 
Dashes indicate amino acids identical to that of the chicken eIF4AII. The dot indicates a 
gap inserted by the alignment program. The asterisks mark the start of the the amino acid 
sequences of the VP1-interacting bursae library clones pB42AD-eIF4AII(C-122aa), pB42AD-
eIF4AII(C-109aa) and pB42AD-eIF4AII(C-107aa). Bold letters indicate the start of the 
carboxyl-terminal domain of the “dumbbell” structure of eIF4A according to the published 
crystal structure of yeast eIF4A (Caruthers et al., 2000). Conserved motifs of eIF4A are 
boxed. The accession numbers are as follows: c-eIF4AII (AF515726), m-eIF4AII (S00985) and 
m-eIF4AI (S00986). 
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complete sequence identity. Some differences were, however, observed in its 612 
nt-3’ UTR, which lacked a stretch of 53 nucleotides, showed one transition (T to C), 
and contained an additional three nucleotides (CTT) at the extreme 3’ end (Fig. 2). 
The deduced amino acid sequence of chicken eIF4AII was compared to that of 
eIF4AII and eIF4AI from mouse (Fig. 1). The comparison indicates that the chicken 
protein is more similar to mouse eIF4AII (98% identity) than to mouse eIF4AI (91% 
identity). Both isoforms, eIF4AI and eIF4AII, are involved in translation initiation and 
are functionally interchangeable (Yoder-Hill et al., 1993). More recently, a third 
member of the eIF4A family, eIF4AIII, has been identified but this protein is more 
distantly related and its involvement in translation initiation has been questioned in 
view of its predominant nuclear occurrence (Holzmann et al., 2000; Li et al., 1999). 
 
 
3’-UTR
eIF4AII(full-length) 1 TAATCCCTGGAGAGGAGATGGTTTGAATGCAGTGCTCGCTGTTGCTGAATAGGCGATTCA
eIF4AII(C-122aa) 1 ------------------------------------------------------------
eIF4AII(full-length) 61 CTTGCATTGTGCTTCTTTCTTTGGGGATATATTGAATCTTGTCTCAATGCTCATAACGGA
eIF4AII(C-122aa) 61 ------------------------------------------------------------
eIF4AII(full-length) 121 TCAGAAATACAGATTTTTGATAAGCGAAGCGACTTTTTGTCGTGAGCTCTTGTGGGGAAA
eIF4AII(C-122aa) 121 ------------------------------------------------------------
eIF4AII(full-length) 181 GCCATTGGCTTTATCCACTTTAGGGTTAGA******************************
eIF4AII(C-122aa) 181 ------------------------------CTGTTGGGGTTGGGTGGAAAGTCATGGGGT
eIF4AII(full-length) 211 ***********************AATTTATTTCCTAGTTCCATAGAAGTGGTTGTATTAG
eIF4AII(C-122aa) 241 CTGTAAATTTTTTCTTTATTAGA-------------------------------------
eIF4AII(full-length) 248 ATGTTCTTTATCATTTAATAATTTACTTATGGACTAAAAGATATAAGTGCTGTATAAAAT
eIF4AII(C-122aa) 301 ------------------------------------------------------------
eIF4AII(full-length) 308 CAGCCAATTATGTTAAACTAGCCTACCTTCCTTTATTGTATGTACTTACCCTTCAGATTG
eIF4AII(C-122aa) 361 ------------------------------------------------------------
eIF4AII(full-length) 368 AATTGGAAAGGCCTTTCAAAATCTCAAAACTTTTATAAGAGCATTAAAATGCATTTTCGT
eIF4AII(C-122aa) 421 ---------------------------------------------------------T--
eIF4AII(full-length) 428 TTGATATGTATTTATTCAATAAAGTATTTAATTAGTGGTAAGTGTGATCTGGACCCTGTT
eIF4AII(C-122aa) 481 ------------------------------------------------------------
eIF4AII(full-length) 488 GCTAAGCCCCAGCAAGCAAGCAATCATACTATTGTCTTAGTTAGGGTTAAACCCAGTAAA
eIF4AII(C-122aa) 541 ------------------------------------------------------------
eIF4AII(full-length) 548 ATTTGCCATATTGCACATGTCTTAATGAAGTTTGAATGTTCAATAAAATACTTCTATATT
eIF4AII(C-122aa) 601 ------------------------------------------------------------
eIF4AII(full-length) 608 CACTTAAA
eIF4AII(C-122aa) 661 --***AAA
∆
 
Figure 2. Sequence alignment of the 3’ UTRs of chicken bursa eIF4AII full-length cDNA and 
the VP1-interacting chicken bursa eIF4AII(C-122aa) cDNA. The stop codon is given in bold 
letters. Dashes indicate identical residues and asterisks mark missing nucleotides. The 
polyadenylation signals are underlined and the position of poly(A) addition for both cDNAs 
is indicated by an open triangle beneath the sequence.  
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VP1 INTERACTS ONLY WITH THE C-TERMINUS OF eIF4AII IN THE YEAST TWO-HYBRID 
SYSTEM  
In order to check the specificity of our observed VP1-eIF4AII interaction, the VP1-
interacting eIF4AII library clones were retransformed back to yeast either alone or in 
combination with VP1, with the binding domain vector alone, or with different 
proteins unrelated to VP1: pVP2 and VP3 of IBDV, and Lamin C.  
In addition, full-length eIF4AII, termed c-eIF4AII(full-length), was assayed in 
the yeast two-hybrid system in the same way as the eIF4AII library clones, termed c-
eIF4AII(C-107aa), c-eIF4AII(C-109aa) and c-eIF4AII(C-122aa). All transformants failed 
to induce the reporter genes except for the combination of the three eIF4AII library 
clones with VP1 (Table 1). A similar result, although with a weaker interaction 
strength, was obtained for the reciprocal combinations of bait and prey fusion-
proteins (Table 1).  
These results demonstrate that eIF4AII(C-107aa), eIF4AII(C-109aa) and 
eIF4AII(C-122aa) are true positive VP1 interaction partners in the two-hybrid system. 
They also show that full-length eIF4AII did not interact with VP1 in this assay. 
 
CHARACTERIZATION OF THE VP1-INTERACTING DOMAINS OF eIF4AI AND eIF4AII  
The crystal structure of eIF4A has been reported as a “dumbbell” structure consisting 
of two compact domains connected by an extended linker (Caruthers et al., 2000). 
Since the VP1-interacting eIF4AII library clones encode almost the complete 
carboxyl-terminal domain of this “dumbbell” structure (Fig.1) it was of interest to 
know whether the interaction is indeed limited to this particular domain. To this end, 
the carboxyl-terminal domain (Fig. 1, c-eIF4AII residues 244-407) and the amino-
terminal domain (Fig. 1, c-eIF4AII residues 1-243) of the eIF4AII “dumbbell” structure 
were independently assayed for interaction with VP1 in the two-hybrid system.  
The assay confirmed that the carboxyl-terminal domain of eIF4AII, termed 
eIF4AII(C-domain),  but not its amino-terminal domain, termed eIF4AII(N-domain), 
was able to interact with VP1. It also appeared that the interaction of eIF4AII(C-
domain) with VP1 was weaker than that of the shorter C-terminal domains of the 
eIF4AII library clones (Table 1). The reciprocal combination of the respective bait 
and prey fusion-proteins gave the same result, although again, as was observed 
with the eIF4AII library clones, the interaction strength of this combination was 
weaker. 
We also investigated whether the interaction of eIF4AII with VP1 is isoform-II 
specific. To this end the two isoforms eIF4AI and eIF4AII of mouse (m-eIF4AI and m-
eIF4AII) had to be used because the existence and hence the sequence of a 
putative chicken eIF4AI is unknown. Along with these constructs we additionally  
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LexABD fusion  B42AD fusion  LEU
 a LacZ b 
 
VP1   c-eIF4AII(full-length)   −  − 
VP1   c-eIF4AII(C-107aa) +++ ++ 
VP1   c-eIF4AII(C-109aa) +++ ++ 
VP1   c-eIF4AII(C-122aa) +++ ++ 
VP1   c-eIF4AII(C-domainc)   +  + 
VP1   c-eIF4AII(N-domaind)   −  − 
c-eIF4AII(full-length) VP1     −  − 
c-eIF4AII(C-107aa) VP1     + +/− 
c-eIF4AII(C-109aa) VP1     + +/− 
c-eIF4AII(C-122aa) VP1     + +/− 
c-eIF4AII(C-domain) VP1    +/− +/− 
c-eIF4AII(N-domain) VP1     −  − 
 
VP1   m-eIF4AII(full-length)    −   − 
VP1   m-eIF4AII(C-107aa) +++  ++ 
VP1   m-eIF4AII(C-domain)    +   + 
VP1   m-eIF4AII(N-domain)   −   − 
m-eIF4AII(full-length) VP1     −   − 
m-eIF4AII(C-107aa) VP1     + +/− 
m-eIF4AII(C-domain) VP1    +/− +/− 
m-eIF4AII(N-domain) VP1     −   − 
 
VP1   m-eIF4AI(full-length)    −   − 
VP1   m-eIF4AI(C-107aa)   +   + 
VP1   m-eIF4AI(C-domain)  +/−   − 
VP1   m-eIF4AI(N-domain)   −   − 
m-eIF4AI (full-length) VP1     −   − 
m-eIF4AI(C-107aa) VP1     −   − 
m-eIF4AI(C-domain) VP1     −   − 
m-eIF4AI(N-domain) VP1     −   − 
 
Table 1. Interactions between IBDV VP1 and different lengths of chicken 
bursa-specific eIF4AII (ceIF4AII), mouse eIF4AII (meIF4AII) and mouse 
eIF4AI (meIF4AI) in the Yeast Two-Hybrid System  
a Interactions were assayed for leucine autotrophy (LEU): +++; clear 
growth (strong interaction); +, growth (interaction); +/−, limited 
growth (weak interaction); −, no growth (no interaction). All 
controls, including the fusion-proteins by themselves or in 
combination with Lamin C, or the viral proteins pVP2 and VP3, 
remained negative. 
b Interactions were assayed for β-galactosidase activity (LacZ): ++; 
deep-blue colonies (strong interaction); +, blue colonies 
(interaction); +/−, light-blue colonies (weak interaction); −, white 
colonies (no interaction). All controls, including the fusion-proteins 
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by themselves or in combination with Lamin C, or the viral proteins 
pVP2 and VP3, remained negative. 
c,d C-domain and N-domain encodes the carboxyl- and amino-
terminal domain of the “dumbbell” structure of eIF4AII (Caruthers et 
al., 2000). 
 
tested the N- and C-terminal domains of both these mouse-specific eIF4A isoforms, 
as well as a truncated form encoding 107 aa of the C-terminus resembling the 
shortest bursa-specific eIF4AII library clone. It is of interest to note that the amino 
acid sequence of m-eIF4AII(C-107aa) is 100% identical to that of c-eIF4AII(C-107aa) 
(Fig. 1). The results showed that for both mouse-specific eIF4A isoforms I and II the 
107 aa polypeptide bound to VP1, although the strength of the interaction with the 
isoform I polypeptide was weaker. In the reciprocal combination this truncated 
protein, m-eIF4AI(C-107aa), even failed to activate LEU or LacZ reporter activity. 
Consistently, also the C-terminal domains of both m-eIF4AII and m-eIF4AI were able 
to interact with VP1, although the isoform I interaction appeared to be very weak as 
only one of the two reporters was sensitive enough to allow detection of this 
interaction. Moreover, the C-domain of m-eIF4AI failed to interact with VP1 in its 
reciprocal combination of bait and prey. Finally, the N-terminal domain as well as 
the full-length form both of m-eIF4AI and of m-eIF4AII, were unable to interact with 
VP1. All these results are similar to those found for the chicken-specific eIF4AII(N-
domain) and eIF4AII(full-length).  
Altogether, these results indicate that the carboxy-terminal domain of both 
eIF4A isoform I and II is able to interact with VP1, but that isoform II has the strongest 
interaction. 
 
VP1-eIF4AII(C-TERMINUS) INTERACTION IS NOT DEPENDENT ON YEAST-SPECIFIC 
FACTORS 
Next we wanted to confirm the specificity of the interaction of eIF4AII(C-terminus) 
with VP1 in an independent manner. With this aim we co-expressed the VP1 protein 
with various forms of the eIF4A proteins in avian QM5 cells using a transient fowlpox 
virus expression system, and analysed association of the proteins by radio-
immunoprecipitation (RIP) assay. For this, cDNA of chicken eIF4AII and of mouse 
eIF4AI and eIF4AII, as well as derivates thereof (i.e. fragments encoding the 
polypeptides C-107aa, C-domain and N-domain) were cloned as a fusion protein 
with a c-myc epitope tag in a transcription plasmid behind a T7 RNA polymerase 
promoter. We fused the c-myc tag (N-terminally) to eIF4A because no antibody 
against eIF4A(C-terminus) was available. For the expression of VP1 we used plasmid 
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pHB34Z, in which the full-length genomic cDNA of segment B of IBDV is cloned 
between a T7 RNA polymerase promoter and the autocatalytic hepatitis delta virus 
ribozyme sequence (Boot et al., 1999). The eIF4A encoding plasmids were co-
transfected with plasmid pHB34Z into QM5 cells that were previously infected with a 
recombinant fowlpoxvirus expressing T7 RNA polymerase (Britton et al., 1996). Forty-
eight hours post-transfection, cells were metabolically labeled for 3 h with 
[35S]methionine, cell lysates were prepared and subjected to immunoprecipitation 
with either anti-VP1 or anti-c-myc serum. The immunoprecipitates obtained were 
analysed by SDS-PAGE and the labeled proteins visualized by autoradiography. 
Mock-transfected cells and cells transfected with either pHB34Z or the eIF4A-
encoding plasmids alone were used as controls for each immunoprecipitation.  
Both antibodies were found to precipitate only their cognate protein, 
indicating that they did not exhibit cross-reactivity (Fig. 3A, lanes 13-15 and Fig. 3B, 
lanes 6-8; data of eIF4A-derivatives not shown except for c-eIF4AII(C-107aa)). Using 
the anti VP1-serum, comparable amounts of VP1 were detected in the different 
transfected QM5 cells (Fig. 3A, lanes 1-12). Full-length c-eIF4AII, m-eIF4AI and m-
eIF4AII each failed to be co-precipitated with VP1 (Fig. 3A, lanes 1, 5 and 9). In 
contrast, all C-107aa constructs were co-precipitated with VP1, indicating that 
these polypeptides were interacting with VP1 (Fig. 3A, lanes 2, 6 and 11). Notably, 
the binding of m-eIF4AI(C-107aa) to VP1 (Fig. 3A, lane 6) appeared to be weaker 
than that of m-eIF4AII(C-107aa) (Fig. 3A, lane 11). Of the C-domain derivatives, m-
eIF4AI failed to be co-precipitated (Fig. 3A, lane 7), whereas both c-eIF4AII and m-
eIF4AII were co-precipitated though in much lower quantities than their C-107aa 
derivative (Fig. 3A, lane 3 and 10). No co-precipitation with VP1 was observed of 
any of the N-domain derivatives (Fig. 3A, lanes 4, 8 and 12). Using the anti-c-myc 
antiserum for the reciprocal immunoprecipitations, all tagged eIF4A-derivatives 
were clearly precipitated. However, in neither case could any co-precipitating VP1 
be detected (Fig. 3B, lanes 1-4; data of the m-eIF4A(-derivatives) not shown). This 
was equally the case when we tested the derivative c-eIF4AII(C-122aa) for 
interaction with VP1 (Fig. 3B, lane 5). 
 
eIF4A IS NOT CLEAVED IN IBDV-INFECTED CELLS  
The observation that only the carboxy-terminal domain of eIF4A, not the full-size 
protein was able to interact with VP1 prompted us to test the idea that in IBDV-
infected cells the eIF4A protein might be proteolytically cleaved to generate a 
carboxy-terminal polypeptide. Such a process would not be without precedent as a 
similar cleavage has been demonstrated for eIF4AI in foot-and-mouth disease virus 
(FMDV)-infected cells (Li et al., 2001). Thus, we assessed the effect of IBDV infection 
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on host eIF4A by immunoblotting of cell extracts with a polyclonal antibody specific 
for eIF4A.  
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Figure 3. Radio-immunoprecipitation analysis of VP1-eIF4A interaction in transfected QM5 
cells. QM5 cells were (co-)transfected with plasmids pHB34Z and/or pGBKT7-
eIF4A(derivatives) expressing the indicated polypeptides. At 48 h post transfection cells 
were metabolically labeled for 3 h with [35S]methionine. Subsequently, cells were lysed and 
immunoprecipitated with anti-VP1 serum (A) or with anti-c-myc serum (B) followed by SDS-
PAGE (18% polyacrylamide) and autoradiography. Mock-transfected cells were used as a 
control for each immunoprecipitation. Positions of the precipitated polypeptides and sizes 
of marker proteins (M) are indicated.  
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First, host cell protein synthesis and production of virus-encoded proteins were 
monitored as a function of time during infection (Fig. 4A). QM5 cells were infected 
with IBDV and labelled with [35S]-methionine for 15 min at various time points until 24 
h post-infection (p.i.). As controls, mock-infected cells were similarly labelled. Cell 
extracts were prepared, proteins were electrophoresed in a polyacrylamide gel and 
the labelling pattern visualized by autoradiography. No shut-off of host cell 
polypeptide synthesis was observed in infected cells indicating that the IBDV 
infection generally did not interfere with host protein translation. Virus-specific 
protein synthesis was first detected at 4 h and was maximal between 6 and 12 h p.i. 
The cells started to show cytopathic effect (CPE) by about 12 h p.i. while at 24 h p.i., 
when the experiment was terminated, nearly all cells appeared to have 
succumbed. At this stage almost no protein synthesis was detected.  
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Figure 4. Analysis of host cell protein synthesis within IBDV-infected cells. QM5 cells were 
infected with IBDV strain CEF94. (A) Fifteen min prior to the indicated times (hours post-
infection) cells were labeled for 15 min with [35S]methionine and subsequently lysed. The cell 
extracts were analysed by SDS-PAGE (12% polyacrylamide) and autoradiography (A). 
Alternatively, cells infected in parallel with those analysed in panel A were harvested at the 
same times without metabolic labelling. Cell extracts were prepared and analysed by SDS-
PAGE (12% polyacrylamide) and immunoblotting with polyclonal anti-eIF4A serum (B). 
Mock-infected QM5 cell extracts (lanes mock) were analysed in parallel at indicated times. 
Purified eIF4AI was used as a positive control for the immunoblotting (lane eIF4AI). Positions 
of viral proteins, eIF4A and molecular size markers are indicated.  
 
The effect of IBDV infection on eIF4A was assessed by immunoblotting of the gel 
followed by probing of the blotted proteins with a specific anti-eIF4A serum (Fig. 4B). 
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Full-length eIF4A migrated at about 46 kD as a doublet, most likely representing the 
eIF4AI and eIF4AII isoforms, which were present in both infected and mock-infected 
cells. It was apparent that the infection with IBDV did not result in a specific 
cleavage of eIF4A nor in a general proteolytic degradation of the protein as no 
cleavage products nor a significant loss of full-length eIF4A was detected during this 
time course under these conditions. The decrease of the overall quantity of full-
length eIF4A at 24 h p.i. was attributed to the severe CPE at this stage of infection. 
 
DISCUSSION 
 
It is becoming remarkably clear that the birnavirus VP1 protein is an impressively 
multifunctional viral component, exhibiting a range of activities throughout the viral 
life cycle. Firstly, as the RNA-dependent RNA polymerase, VP1 carries out all those 
diverse functions required for the replication and transcription of the binary dsRNA 
genome that occur within viral particles and in the cell’s cytoplasm (Spies et al., 
1987). Secondly, it acts as a primase in the generation of viral mRNAs, as a result 
becoming part of these mRNAs through covalent linkage at their 5’ end (Magyar et 
al., 1998). Furthermore, by its interaction with the inner capsid component VP3 
(Lombardo et al., 1999; Tacken et al., 2000; Tacken et al., 2002) the protein is also 
considered to be instrumental in the encapsidation of viral RNAs during particle 
morphogenesis. VP1 also associates with itself, but the significance of this interaction 
has not yet been established (Tacken et al., 2000). In the present study we focussed, 
for the first time, on interacting host cell partners of VP1 by using the yeast two-
hybrid system. Our observation that VP1 specifically binds to the C-terminus of 
eukaryotic translation initiation factor eIF4AII suggests an involvement of this protein 
in translation initiation. This interaction therefore further extends the list of potential 
functions of this viral protein.  
eIF4A is the prototypic member of the DEAD-box family of RNA helicases 
(Linder et al., 1989). Together with eIF4B it participates in the initiation of polypeptide 
synthesis by facilitating the melting of RNA secondary structures present in the 5’ UTR 
of mRNAs required for the efficient recruitment of the 40S ribosomal subunit 
(reviewed in Gingras et al., 1999). eIF4A is a loosely bound subunit of the eIF4F 
complex, of which eIF4E (cap-binding protein) and eIF4G (scaffold component) are 
the other subunits. Eukaryotic cytoplasmic mRNAs contain a cap structure at their 
5’-terminus. The cap structure is required for efficient attachment of the mRNA to 
the 40S ribosomal subunit. This attachment is mediated by eIF4F (through binding of 
eIF4E to the cap) and by ribosome-bound eIF3. eIF4A is an essential factor, required 
for both cap-dependent and cap-independent translation (Blum et al., 1992). 
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An interaction of VP1/VPg with eIF4AII is intriguing particularly because IBDV mRNAs 
are not capped but possess a covalently linked VPg at their 5’ ends. A direct 
interaction of eIF4A with VPg may be a key event in the establishment of IBDV 
infection. It may reveal a novel cap-independent mechanism for the initiation of 
translation in which the binding of eIF4A to VPg mediates the recruitment of the 40S 
ribosomal subunit to the 5’ end of the viral mRNA. Thus, while eIF4E is essential for 
initiation of translation of capped mRNAs, and proteolytically cleaved eIF4G for that 
of picornaviral uncapped mRNA (Lamphear et al., 1995), eIF4A may have a similar 
function for IBDV mRNA.  
For a subset of viral and cellular mRNAs, cap-independent initiation of 
translation is accomplished by internal binding of the ribosome at or upstream of the 
initiation codon mediated by an internal ribosomal entry site (IRES) in the 5’ UTR 
(reviewed in Martinez-Salas et al., 2001). The possibility of IRES-mediated cap-
independent translation has not been investigated for IBDV, nor for other 
birnaviruses, but is not unlikely to occur. Although the nucleotide sequence of the 5’ 
UTR of IBDV RNA is relatively short (segment A: 96 nt, segment B: 111 nt) compared 
to that of many viral IRES-containing mRNAs (about 200-500 nt), both segments have 
a theoretical potential to form Y-shaped or hairpin stem and loop secondary 
structures (Kibenge et al., 1996; Mundt & Muller, 1995). These structures resemble 
those proposed to occur in some cellular IRESes (Le & Maizel, 1997). However, there 
is no convincing evidence supporting the idea that these cellular IRES structures are 
of significance for translation initiation. More interestingly, it was found that some 
mRNAs may recruit ribosomes by base pairing with ribosomal RNA (Chappell et al., 
2000; Owens et al., 2001; Zhou et al., 2001). Sequences as short as 9 nt have been 
shown to possess such IRES activity (Chappell et al., 2000). These short IRES-modules 
have complementarity to the 18S rRNA occurring in 40S ribosomal subunits. A similar 
feature might be the case for IBDV mRNA. A highly conserved sequence of 13 nt in 
the 5’ UTR of both segments, located exactly 19 nt upstream of the respective start 
codons for the nearest ORF (VP5 gene in segment A, VP1 gene in segment B), has 
complementarity to the chicken reticulocyte 18S rRNA and could thus function as a 
binding site for the 40S ribosomal subunit (Mundt & Muller, 1995). A tenable 
hypothesis is that an interaction of the C-terminus of eIF4A with VPg might be 
required to open mRNA secondary structure to allow ribosome binding. 
The eIF4AII encoding cDNA clones that were identified in the yeast two-
hybrid screen all corresponded to the carboxy-terminal domain of the protein. The 
specific interaction of VP1 with this particular eIF4AII domain was confirmed in 
various experiments, not only in the two-hybrid system but also in the co-
immunoprecipitation assays. No association of VP1 was observed with full-length 
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eIF4AII, also not in IBDV-infected cells (data not shown) by different co-
immunoprecipitation assays. We then investigated whether in infected cells an 
eIF4AII carboxy-terminal fragment is generated by some kind of cleavage, similar to 
what has been found for eIF4AI in FMDV-infected cells (Li et al., 2001). No 
breakdown of eIF4AII was, however, observed, the protein appearing as stable as in 
non-infected cells. Our interpretation of these results is that the formation of VPg-
eIF4AII complexes might be conformation dependent and transient. In its free form 
the initiation factor does not expose its VP1 binding site. Only when engaging in the 
formation of a translation initiation complex this site becomes available as a result of 
conformational changes induced in the eIF4AII structure by its interaction with other 
partners involved in the assembly of the complex such as eIF4G or 3’ end mRNA 
elements. In fact, various studies suggest that eIF4A does indeed adopt different 
conformations. (i) Mammalian eIF4A undergoes a cycle of ligand-dependent 
conformational changes as it binds its substrates, hydrolyzes ATP, and releases 
products (Lorsch & Herschlag, 1998a; Lorsch & Herschlag, 1998b). (ii) In its crystallized 
form, eIF4A has a ‘dumbbell’ structure in which the amino- and carboxyl-terminal 
domains occur as separately folded entities connected by an extended, 11-residue 
linker (Caruthers et al., 2000). In solution, the linker between the domains is relatively 
flexible, allowing eIF4A to adopt many different conformations (Caruthers et al., 
2000). (iii) eIF4A is expected to interact only transiently with eIF4G, cycling in and out 
of the eIF4F complex, thereby changing its conformation (Pause et al., 1994). 
Altogether, these considerations support our interpretation, although we can of 
course not exclude that full-length eIF4A has an overall weak affinity for VP1.  
The immunoprecipitation analyses demonstrated that co-expressed VP1 
and c-myc-tagged carboxy-terminal eIF4AII polypeptides form stable complexes, 
particularly VP1/C-107aa complexes, that are efficiently immunoprecipitated with 
VP1 antibodies (Fig. 3A). Somewhat surprisingly, these complexes were not 
precipitable in the reciprocal assay using c-myc antibodies (Fig. 3B). The c-myc 
antibodies clearly recognized the tagged c-eIF4AII proteins but no VP1 was co-
precipitated. It seems feasible that the binding of antibody to the tag induces a 
conformational change in the eIF4AII polypeptide that destabilizes its complex with 
VP1. The tag was fused to the amino-terminus of the c-eIF4AII polypeptides. We 
have not tested whether attachment to the carboxy-terminus of the polypeptides 
would have made a difference. 
It is quite remarkable that our two-hybrid screening only yielded eIF4A-
derivatives of isoform type-II as VP1-interacting proteins and that no clones of the 
functionally equivalent isoform type-I were isolated. eIF4AII strongly resembles eIF4AI  
(in mice the two isoforms have 91% identity) though its tissue-specific expression 
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(Nielsen & Trachsel, 1988) and its developmental regulation (Morgan & Sargent, 
1997) differ from those of eIF4AI. While the carboxy-terminal polypeptides (C-107aa) 
of both the mouse-specific eIF4AI and eIF4AII isoforms were able to interact with 
VP1, the strength of the interaction with isoform type-I was consistently weaker. This 
suggests that VP1 preferentially associates with eIF4AII. Data indicate that this 
isoform is also held more strongly in the eIF4F complex than is eIF4AI (Conroy et al., 
1990).  
The interaction of VP1 with the carboxy-terminal domain of eIF4AII reported 
here suggests yet another viral strategy on the protein translation battlefield. Future 
studies will be required to confirm and establish the functional significance of this 
interaction for viral multiplication, particularly whether VP1, when linked to viral RNA 
(i.e. as VPg) can indeed bind the initiation factor and support translation initiation of 
viral RNA, without compromising host mRNA translation. Another interesting question 
relates to the possible occurrence of 5’-3’ interactions in the IBDV mRNAs and to the 
binding partners that mediate these interactions. These studies will undoubtedly 
reveal additional striking features of the biology of these fascinating viruses. 
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ABSTRACT 
 
Infectious bursal disease virus (IBDV), a non-enveloped double-stranded RNA virus of 
chicken, encodes five proteins. Of these, the RNA-dependent RNA polymerase 
(VP1) is specified by the smaller genome segment, while the large segment directs 
synthesis of a non-structural protein (VP5) and a structural protein precursor from 
which the capsid proteins pVP2 and VP3 as well as the viral protease VP4 are 
derived. Using the recently redefined processing sites of the precursor we have re-
evaluated the homotypic interactions of the viral proteins using the yeast two-hybrid 
system. Except for VP1, which interacted weakly, all proteins appeared to self-
associate strongly. Using a deletion mutagenesis approach we subsequently 
mapped the interacting domains in these polypeptides, where possible confirming 
the observations made in the two-hybrid system by performing co-
immunoprecipitation analyses of tagged protein constructs co-expressed in avian 
culture cells. The results revealed that pVP2 possesses multiple interaction domains, 
consistent with available structural information about this external capsid protein. 
VP3-VP3 interactions were mapped to the amino-terminal part of the polypeptide. 
Interestingly, this domain is distinct from two other interaction domains occurring in 
this internal capsid protein: while binding to VP1 has been mapped to the carboxy-
terminal end of the protein, interaction with the genomic dsRNA segments has been 
suggested to occur just upstream thereof. No interaction sites could be assigned to 
the VP4 protein; any deletion applied abolished its self-association. Finally, one 
interaction domain was detected in the central, most hydrophobic region of VP5, 
supporting the idea that this virulence determinant may function as a membrane 
pore-forming protein in infected cells.  
 
INTRODUCTION 
 
Infectious bursal disease (IBD), also known as Gumboro disease, is an acute 
contagious viral disease of young chickens that is of major importance for the 
poultry industry (Cheville, 1967). The IBD virus (IBDV) causes a severe 
immunosuppression by destroying B-lymphoid cells present in the bursa of Fabricius 
followed by bursal atrophy. The immunosuppression leads to an increased 
susceptibility to other pathogens and reduces the growth rate of surviving animals 
(Kibenge et al., 1988). To date, two distinct serotypes (I and II) of IBDV have been 
identified (Jackwood et al., 1982). The pathogenic serotype I viruses are isolated 
from chickens and vary in virulence. Serotype II viruses are nonpathogenic and 
occur in turkeys and chickens (Jackwood et al., 1982; McFerran et al., 1980).  
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IBDV belongs to the family Birnaviridae (Leong et al., 2000). Members of the family 
contain a double-stranded RNA (dsRNA) genome consisting of two segments, 
designated A and B, within an unenveloped single-shelled icosahedral capsid of 60 
nm in diameter (Dobos et al., 1979; Muller et al., 1979). The smaller segment B 
(approximately 2.9 kb) encodes viral protein 1 (VP1; 95 kDa), the putative RNA-
dependent RNA polymerase (RdRp) (Bruenn, 1991; Macreadie & Azad, 1993; Spies 
et al., 1987). This polypeptide is present in the virion both as a free protein and as a 
genome-linked protein, called VPg, attached to the 5’ end of the positive strands of 
the two genomic segments (Dobos, 1993; Spies & Muller, 1990). Segment A 
(approximately 3.3 kb) contains two partially overlapping open reading frames 
(ORFs). The first, smaller ORF encodes nonstructural protein VP5, which is not essential 
for viral replication in vitro but important for virus-induced pathogenicity (Mundt et 
al., 1997; Yao et al., 1998). The larger ORF encodes a 110 kDa polyprotein that is 
autocatalytically cleaved, rendering three polypeptides: pVP2 (48 kDa), VP3 (32 
kDa) and VP4 (28 kDa). VP4, a serine-lysine protease (Birghan et al., 2000), is 
responsible for this self-processing (Lejal et al., 2000; Sanchez & Rodriguez, 1999). It is 
a nonstructural protein mainly associated with type II tubules of 24 nm in diameter 
(Granzow et al., 1997). pVP2 is further processed at its carboxy terminus to become 
VP2 (40 kDa) (Da Costa et al., 2002; Lejal et al., 2000). VP2 and VP3 are the structural 
proteins forming the outer and inner layers of the virion, respectively (Bottcher et al., 
1997; Caston et al., 2001). Recently we showed that VP3 interacts not only with VP1 
but also with the genomic dsRNA segments A and B, the former interaction being of 
crucial importance for IBDV replication (Tacken et al., 2002). 
Interactions among viral proteins and between viral and host proteins play a 
central role in the infection process. These interactions include transient as well as 
long-lived associations. Often, these interactions establish essential functional 
complexes responsible for processes such as viral genome replication, RNA 
transcription and translation, virus assembly and virus release. Identification of such 
protein-protein interactions is therefore of vital importance for a better 
understanding of the dynamics of viral multiplication.  
We have recently been using the yeast two-hybrid system in various 
interaction studies of the IBDV proteins. Thus, we detected a number of candidate 
cellular interaction partners for the IBDV proteins VP1, pVP2, VP3 and VP5 (Tacken et 
al., 2001). One of these was further explored revealing an interaction between VP1 
and translational eukaryotic initiation factor 4AII (eIF4AII) (M.G.J. Tacken, A.A.M. 
Thomas, B.P.H. Peeters, P.J.M. Rottier and H.J. Boot, submitted). We also used this 
system to analyse the intermolecular interactions between the IBDV proteins 
themselves (Tacken et al., 2000). Though the yeast assays did not allow us to detect 
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an interaction between the two capsid proteins pVP2 and VP3, an interaction 
between the latter and VP1, presumed to draw the polymerase into assembling viral 
particles, was clearly demonstrated. Whereas these studies also revealed homotypic 
interactions of the IBDV structural proteins, the recent redefinition o processing 
scheme of the structural protein precursor (Lejal et al., 2000; Sanchez & Rodriguez, 
1999) now casts some doubt on these observations. In the present study we have 
first re-evaluated our earlier findings based on the newly established processing sites. 
This confirmed the homotypic interactions found for pVP2, VP3, VP4 and VP5, which 
we now also demonstrated by co-immunoprecipitation of co-expressed tagged 
and untagged forms of the proteins. We subsequently carried out deletion studies to 
map the self-interacting domains in each of these proteins. It appears that the 
different proteins interact through different domains which for the VP3 protein 
identified yet another domain in addition to the ones shown recently to be involved 
in associating with VP1 and with genomic dsRNA of both segment A and B.  
 
MATERIALS AND METHODS 
 
CELL LINE, VIRUS, PLASMID, AND BACTERIAL AND YEAST STRAINS 
QM5 cells (Antin & Ordahl, 1991) were cultured in QT35 medium (Gibco-BRL) 
supplemented with 5 % fetal calf serum (FCS) and 2% antibiotic solution ABII (1,000 U 
of penicillin [Yamanouchi], 1 mg of streptomycin [Radiumfarma], 20 µg of 
amphotericin B [Fungizone], 500 µg of polymixin B, and 10 mg of kanamycin/ml) in a 
CO2 (5%) incubator at 37°C. Recombinant fowlpox virus expressing the T7 
polymerase gene (FPV-T7) (Britton et al., 1996) was received from the laboratory of 
M. Skinner (Compton Laboratory, Berks, United Kingdom). The preparation of the 
plasmid pHB36W, which contains the full-length genomic cDNA of segment A of 
IBDV strain CEF94, has been described (Boot et al., 1999). Escherichia coli (E. coli) 
strain DH5-α (Life Technologies) was used during DNA manipulations. Yeast strain 
Saccharomyces cerevisiae (S. cerevisiae) EGY48 (MATα, his3, trp1, ura3, LexAop(x6)-
LEU2) was used for the yeast two-hybrid analyses. Yeast strain S. cerevisiae 
EGY48[p8oplacZ] is the host strain EGY48 transformed with the autonomously 
replicating reporter plasmid p8op-LacZ (Clontech).  
 
CONSTRUCTION OF TWO-HYBRID EXPRESSION PLASMIDS  
The plasmids pLexABD-VP1, pLexABD-VP5, pB42AD-VP1, pB42AD-VP5, containing the 
cDNA sequence encoding VP1 or VP5 of IBDV strain CEF94, have been described 
previously (Tacken et al., 2000). Copy DNA encoding the full-length sequences of 
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pVP2, VP3 and VP4 of IBDV strain CEF94, as well as defined parts of VP5, pVP2, VP3, 
and VP4 (see Fig. 2), were amplified by PCR by using the Expand high fidelity PCR 
system (Boehringer Mannheim). Plasmid pHB36W was used as a template. The sets of 
primers used were designed to introduce an EcoRI site at the upstream (5’) end and 
a stop codon plus either a SalI site or a XhoI site at the downstream (3’) end of each 
coding sequence (Table 1). The PCR products were precipitated, digested with 
EcoRI/SalI or EcoRI/XhoI, gel purified by the QIAEX-II method (QIAGEN), and ligated 
with T4 ligase (New England BioLabs) into the yeast expression vectors pLexABD and  
 
 
Primer  Nucleotide sequencea               Orientation Polypeptide 
 
p001 ccgGAATTCATGACAAACCTGCAAGATCAAACCC          + pVP2, pVP2∆C128 and pVP2∆C256  
p122 ccgGAATTCTTCCAAGGAAGCCTGAGTGAACTG + pVP2∆N128 and pVP2∆N128/C128 
p120 ccgGAATTCCTGGGCGCCACCATCTACCTC + pVP2∆N256 
p054 aagtGTCGACTCAGGCGAGAGTTAGCTGCCTTATGC − pVP2, pVP2∆N128 and pVP2∆N256 
p157 taaCTCGAGTCAAACCAGGTTCTTTGCTAGTTCAGG      − pVP2∆C128 and pVP2∆N128/C128 
p119 taaCTCGAGTCATACAAGGCCGTGGACGCTTGTTTG − pVP2∆C256 
p057 tcGAATTCGCTTCAGAGTTCAAAGAGACCCCC + VP3, VP3∆C64, VP3∆C129 and VP3∆C161 
p131 ccgGAATTCGTGTTCATGTGGCTGGAAGAGAATG + VP3∆N32/C64, VP3∆N32/C129, and  
   VP3∆N32/C161 
p062 ccgGAATTCAACGCACCACAAGCAGGCAGCAAG + VP3∆N64 and VP3∆N64/C64 
p060 ccgGAATTCGGCCAGCTAAAGTACTGGCAGAAC  + VP3∆N129 
p006 gatcGTCGACTCACTCAAGGTCCTCATCAGAGAC − VP3, VP3∆N64 and VP3∆N129 
p063 aagtGTCGACTCAATAGACTTTGGCAACTTCGTCTATG − VP3∆C64, VP3∆N64/C64 and VP3∆N32/C64 
p061 aagtGTCGACTCAGCTTGGCCCTCGGTGCCCATTG       − VP3∆C129 and VP3∆N32/C129 
p132 aagtGTCGACTCACCTCTGTGCTTCCTCTGGTGTGG − VP3∆N32/C161 and VP3∆C161 
p055 agGAATTCGCCGACAAGGGGTACGAGGTAGTC + VP4, VP4∆C61 and VP4∆C122 
p144 ccgGAATTCAAAGCATTGAACAGCAAAATG + VP4∆N60 and VP4∆N60/C61 
p124 ccgGAATTCTGGGACGACAGCATTATGCTGTCC + VP4∆N121 
p143 taaCTCGAGTCAGGCCATGGCCAGGTCGTAC − VP4, VP4∆N60 and VP4∆N121 
p125 taaCTCGAGTCAGGCGAGCTTGGTGCTTCTAAAGC − VP4∆C61 and VP4∆N60/C61 
p123 taaCTCGAGTCAGACATCATCTATTGGGACAACGGTG − VP1∆C122 
p007 ccgGAATTCATGGTCAGTAGAGATCAGACAAACG + VP5∆C37, VP5∆C73 and VP5∆C55 
p130 ccgGAATTCGGCGTCCATTCCGGACGACACC + VP5∆N36, VP5∆N36/C37 and VP5∆N36/C55 
p128 ccgGAATTCTGGATTCCCTGGCTCAATTGTGGG + VP5∆N72 and VP5∆N72/C37 
p145 ccgGAATTCCTACAAGTTCGATCAGATGCTCCTG          + VP5∆N90 
p008 gatcGTCGACTCACTCAGGCTTCCTTGGAAGGTC − VP5∆N36, VP5∆N72  and VP5∆N90 
p129 taaCTCGAGTCATTGTAACTGGCCGGTAGGTTCTG         − VP5∆C37, VP5∆N36/C37  and VP5∆N72/C37 
p146 ttgCTCGAGTCATTCCCATTGCTCTGCAGTGTGTAG       − VP5∆C55 and VP5∆N36/C55 
p127 taaCTCGAGTCAGGGAAAAAGACAATTAGCCCTGAC − VP5∆C73 
 
Table 1. Sequences of primers used for the construction of the yeast two-hybrid expression 
plasmids  
a The primer sequences are listed 5’ to 3’. Restriction sites are in italics. Nucleotides 5’ of a 
restriction site which are unable to hybridize with the IBDV cDNA are in lower case. Bold 
letters indicate an in-frame stop codon.  
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pB42AD (Clontech). These vectors had previously been digested with EcoRI/XhoI. The 
ligation mix was transformed into E. coli DH5-α cells, which were subsequently grown 
under ampicillin selection. Plasmid DNA prepared from several independent 
transformants was screened for the presence of the insert, and plasmids from 
positive clones were sequenced at the fusion junction by cycle sequencing using an 
ABI 310 sequencer (PE Applied Biosystems) to ensure correct reading frames. Control 
plasmids pLexABD-53 (human p53 gene in pLexABD), pB42AD-SV40 T (SV40 large T 
antigen in pB42AD) and pLexABD-Lamin C (human Lamin C gene in pLexABD) were 
from Clontech.  
 
TWO-HYBRID ANALYSIS 
All two-hybrid media, buffers, and protocols were as described in the Clontech 
Manual for the Matchmaker LexA Two-Hybrid System and in the Clontech Yeast 
Protocols Handbook (Clontech). The yeast strain S. cerevisiae EGY48[p8op-lacZ], 
which contains two reporter genes, LEU2 and LacZ, under the control of two 
independent promoters, was transformed by using the lithium acetate method with 
pLexABD (HIS3
+) and pB42AD (TRP1
+) constructs carrying VP1, pVP2, VP3, VP4 and VP5, 
in every possible pairwise combination. Control plasmids were pLexABD-Lamin C 
(Clontech), pLexABD-53 (Clontech), pB42AD-SV40 T (Clontech), and pB42AD-empty 
vector. This resulted in 37 pairwise transformations (see Table 2 and 3) that were 
plated onto SD/Glu/-His/-Ura/-Trp medium. About 10 His+ Ura+ Trp+ colonies from 
each transformation were subsequently plated onto SD/Gal/Raf/-His/-Ura/-Trp/-Leu 
medium to assess the transcriptional activation of the LEU2 reporter gene and onto 
SD/Gal/Raf/5-bromo-4-chloro-3-indolyl ß-D-galactopyranoside (X-gal)/-His/-Ura/-Trp 
medium to assess the transcriptional activation of the LacZ reporter gene.  
Stable expression of the hybrid proteins was verified by Western blot analysis 
according the manufacturer’s instructions (Clontech). The ability of the LexA fusions 
used in this study to bind operator DNA was confirmed by a repression assay. For 
this, yeast strain S. cerevisiae EGY48 was transformed with the URA3+ plasmid pJK101 
(OriGene) and, in parallel, with pJK101 together with one of the pLexABD constructs 
carrying VP1, pVP2, VP3, VP4, or VP5. Transformed yeast cells were plated onto 
SD/Glu/-Ura or SD/Glu/-His/-Ura medium, respectively. Plasmid pJK101 contains a 
LacZ reporter gene whose expression is driven by the yeast GAL1 promoter. 
However, two LexA operators have been placed between the GAL1 promoter and 
the lacZ gene. When a LexABD fusion protein binds to these operators there will be a 
decrease in the level of GAL1-driven lacZ expression. A liquid assay to quantify ß-
galactosidase activities was performed by growing transformants to mid log phase 
in the appropriate selection medium, SD/Gal/Raf/-Ura or SD/Gal/Raf/-His/-Ura, and 
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using O-nitrophenyl-ß-D-galactoside as the chromogenic substrate. Each enzyme 
activity assay was performed with at least five independent colonies and ß-
Galactosidase specific activities were calculated as described by Clontech. 
 
CONSTRUCTION OF THE EXPRESSION PLASMIDS FOR CO-IMMUNOPRECIPITATION 
ANALYSIS 
The c-Myc-tag and hemagglutinin (HA)-tag fusions were cloned as follows. The 
pVP2, VP3, VP4, VP5 (or defined parts thereof) containing inserts were excised from 
their respective pLexABD-vectors described above, through restiction enzyme 
digestion with either EcoRI/XhoI or EcoRI/SalI. These fragments were gel purified by 
the QIAEX-II method (QIAGEN) and ligated with T4 ligase (New England BioLabs) into 
the vectors pGBKT7 and pGADT7 (Clontech). The vector pGBKT7 had previously 
been digested with EcoRI/SalI and the vector pGADT7 with EcoRI/XhoI. The ligation 
mix was transformed into E. coli DH5-α cells, which were subsequently grown either 
under kanamycin (pGBKT7) or ampicillin (pGADT7) selection. Plasmid DNA prepared 
from several independent transformants was screened for the presence of the insert, 
and plasmids from positive clones were sequenced at the fusion junction by cycle 
sequencing using an ABI 310 sequencer (PE Applied Biosystems) to ensure correct 
reading frames.  
 
TRANSFECTION OF QM5 CELLS  
QM5 cells were grown to 80% confluency in 60-mm dishes and infected with FPV-T7 
(multiplicity of infection [MOI] = 3). After 1 h, the cells were washed once with 5 ml 
QT35 medium and covered with 5 ml of Optimem 1 (Gibco-BRL). In the meantime,  
2.0 µg of DNA was mixed with 25 µl Lipofectamine (Gibco-BRL) in 0.5 ml Optimem 1 
and kept at room temperature for at least 30 min. The QM5 cells were subsequently 
covered with 4 ml of fresh Optimem 1, and the DNA-Lipofectamine mixture was 
added. The transfection was performed overnight (18 h) in a 37°C incubator (5.0% 
CO2). The transfected monolayer was rinsed once with QT35 medium and fresh QT35 
medium supplemented with 5% FCS and 2% ABII was added, and the plates were 
incubated for another 24 h. 
 
RADIOLABELING OF TRANSFECTED CELLS AND IMMUNOPRECIPITATION 
At 48 h post-transfection, cells were starved for 1 h in methionine-free EMEM medium 
(Gibco-BRL). Cells were then labeled for 3 h with 20 µCi/ml of [35S]methionine 
(Amersham) in methionine-free EMEM medium. At the end of the labeling, the cell 
cultures were lysed on ice in 1x PBS-TDS lysis buffer, using a 5x PBS-TDS lysis buffer 
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stock solution (5 % Triton X-100, 2.5 % sodium deoxycholate, 0.5 % SDS, 0.7 M NaCl, 14 
mM KCl, 50 mM Na2HPO4, 7.5 mM KH2PO4). Cell debris was removed by 
centrifugation at 4°C for 20 min at 13,000 × g. All lysates were pretreated with Protein 
A Sepharose (Amersham) before they were used for immunoprecipitation with 
either monoclonal anti-c-Myc serum (Clontech) or polyclonal anti-HA serum 
(Clontech). Protein A Sepharose-bound immune complexes were washed three 
times in 1x PBS-TDS lysis buffer and eluted in 30 µl sodium dodecyl sulfate (SDS) 
sample buffer (60 mM Tris-HCl [pH 6.8], 2.5% SDS, 5% β-mercaptoethanol, 10% 
glycerol, 0.1% bromophenol blue). Proteins were resolved in 18% separating gels by 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and visualized by 
autoradiography.  
 
RESULTS 
 
INTERACTIONS OF pVP2, VP3, pVP4, VP1 AND VP5 WITH THEMSELVES AND EACH 
OTHER ASSAYED IN THE YEAST TWO-HYBRID SYSTEM 
The ability of the full-length viral proteins, VP1, pVP2, VP3, VP4 and VP5 to interact 
with themselves or with each other was re-evaluated using the polypeptides pVP2, 
VP3 and VP4 based on the corrected polyprotein cleavage sites (compare Fig. 1C 
with 1D). cDNA fragments of IBDV strain CEF94 encoding these polypeptides were 
generated by PCR and subcloned into the plasmids pLexABD and pB42AD for two-
hybrid analysis. The plasmid pLexABD constitutively expresses proteins as carboxy-
terminal fusions to a 202 amino acids sequence of the bacterial lexA DNA binding 
domain (BD). The plasmid pB42AD was used as the expression vector for all 
transcriptional activation domain (AD) fusion proteins. This plasmid expresses 
proteins under the control of the galactose-inducible GAL1 promoter as carboxy-
terminal fusions to a simian virus SV40 (SV40) nuclear localization sequence, an 
influenza virus hemagglutinin epitope tag, and the B42 AD. Protein expression of the 
fusion plasmids was verified by Western blot analysis (data not shown).  
Plasmids pLexABD and pB42AD expressing VP1, pVP2, VP3, VP4 and VP5 fusion 
proteins were co-transformed in all possible pairwise combinations into the yeast 
strain S. cerevisae EGY48[p8opLacZ]. This strain has the upstream activating 
sequences of the chromosomal LEU2 gene replaced with six LexA operators and 
contains the p8op-LacZ reporter plasmid encoding the LacZ gene under the control 
of eight LexA operators. Potential interactions were then scored by testing for 
growth in synthetic complete medium lacking leucine and for production of β- 
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Figure 1. Comparison of the previously and currently used two-hybrid fusion 
proteins encoding the viral proteins pVP2, VP4 and VP3 of IBDV.  (A and B) 
Schematic representation of the IBDV polyprotein; the pVP2-VP4 and VP4-VP3 
junctions of the polyprotein are indicated based (A) on the putative cleavage 
sites reported by Hudson et al. (Hudson et al., 1986) and (B) based on the recently 
corrected cleavage sites (Lejal et al., 2000; Sanchez and Rodriguez, 1999). (C and 
D) Schematic representation of the polypeptides used for the two-hybrid analysis; 
(C) previously used (Tacken et al., 2000) and (D) currently used. The first and last 
amino acid as well as the position of expressed regions are indicated.   
 
galactosidase (β-gal) as observed by the appearance of blue colonies on X-Gal-
containing medium. The strength of the protein-protein interaction was judged by 
the intensity of the bleu phenotype or by the time required for growth on 
mediumlacking leucine. At least seven independent transformants of each strain 
were screened. Additionally, all fusions were tested for intrinsic or nonspecific 
activation. The pB42AD fusion plasmids were co-transformed with LexA fused to the 
human Lamin C protein to test for specificity of interaction with each of the BD 
fusions while all the pLexABD fusion plasmids were co-transformed with an empty AD 
to test for intrinsic activation. None of the fusions did intrinsically or nonspecifically 
activate expression of the LEU2 and LacZ reporters, confirming the specificity of the 
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test system for IBDV proteins. Plasmids containing sequences encoding p53 fused to 
LexA and plasmids with sequences of SV40 large T antigen fused to B42, were co- 
 
 
           LexABD 
          fusion: 
  
   B42AD 
   fusion: 
 
VP1 
 
pVP2 
 
VP3 
 
VP4 
 
VP5 
 
Lamin C 
 
53 
 
     VP1 +/- - +++ - - - nd 
     pVP2 - +++ - - - - nd 
     VP3 +++ - +++ - - - nd 
     VP4 - - - +++ - - nd 
     VP5 - - - - +++ - nd 
  no insert - - - - - - nd 
   SV40 T nd nd nd nd nd nd +++ 
 
Table 2. Interactions between the viral proteins of IBDV strain CEF94 in the 
yeast two-hybrid system, assayed for leucine autotrophy. Growth was 
recorded after 1 day when the strain with LexABD-p53 and B42AD-SV40 T 
antigen (positive control) showed clear growth. +++, clear growth after 
one day (very strong interaction); +/-, limited growth (weak interaction); -, 
no growth (no interaction); nd, not determined. All results shown are 
representative of at least 7 independent transformants. 
 
 
          LexABD 
          fusion: 
  
   B42AD 
   fusion: 
 
VP1 
 
pVP2 
 
VP3 
 
VP4 
 
VP5 
 
Lamin C 
 
53 
 
     VP1 - - + - - - nd 
     pVP2 - +++ - - - - nd 
     VP3 +++ - +++ - - - nd 
     VP4 - - - +++ - - nd 
     VP5 - - - - +++ - nd 
   no insert - - - - - - nd 
   SV40 T nd nd nd nd nd nd +++ 
 
Table 3. Interactions between the viral proteins of IBDV strain CEF94 in the 
yeast two-hybrid system, assayed for β-galactosidase activity. The relative 
strength of the interaction was judged by intensity of the blue phenotype 
after 1 day when the strain with LexABD-p53 and B42AD-SV40 T antigen 
(positive control) had deep blue colonies. +++, deep blue colonies (very 
strong interaction); +, light blue colonies (interaction); -, white colonies (no 
interaction); nd, not determined. All results shown are representative of at 
least 7 independent transformants.  
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transformed into EGY48[p8oplacZ] and used as a positive control. Strains containing 
these fusion proteins showed visible growth in Leu⎯ medium after 2 days, and deep 
blue colonies on X-Gal containing medium after 1 day. We observed strong 
homologous interactions for the viral proteins pVP2, VP3, VP4 and VP5, a possible 
though weak homologous interaction for VP1 and one heterologous interaction 
between VP1 and VP3 (Tables 2 and 3). 
When we compare these results with those obtained previously (Tacken et 
al., 2000), there is one apparent difference. The homologous interaction of VP4, 
which we clearly observe in our present study, was not detected in our earlier work. 
Apparently, the amino-terminal extension abolished the protein’s ability to interact 
with itself. 
 
DELETION MAPPING OF THE SELF-INTERACTING DOMAINS OF THE IBDV PROTEINS 
USING THE YEAST TWO-HYBRID SYSTEM 
To study the domains involved in the homotypic interactions of the pVP2, VP3, VP4 
and VP5 proteins, five different deletion mutants were initially generated for each 
protein (Fig. 2A-D, no. 2-6; dark grey depicted polypeptides). To simplify 
interpretation of the results, we divided each of the viral proteins into four regions, 
designated REGION I to IV, as shown in Fig. 2. All the deletion mutants were 
expressed by both the pLexABD and the pB42AD expression vectors and the fusion 
products were tested for their capability to interact with their respective full-length 
protein. To rule out the possibility of non-specific transactivation of the reporter 
genes, all constructs were additionally assayed for reporter gene activation when 
expressed either alone or together with the control plasmids pLexABD-Lamin C or 
pB42AD-empty. All constructs proved to be negative in these tests (data not shown).  
The results of the assays are presented in Fig. 2. Of the pVP2 deletion 
mutants all truncated fusion proteins scored positive in the β-gal and Leu⎯ growth 
tests, albeit with some variation in interaction strength (Fig. 2A, no. 2-6). The 
observation that both the amino-terminal and the carboxy-terminal half of the pVP2 
protein were able by themselves to interact with the full-size polypeptide suggests 
that the homotypic interactions between pVP2 molecules are based on more than 
one contact site. For VP3 the critical domains for interaction are located in the 
amino-terminal part. Carboxy-terminal deletion of one-fourth or half of the protein 
as in VP3∆C64 and VP3∆C129 was without measurable effect on the strength of the 
interaction with full-length VP3 (Fig. 2B, no. 2-3). Truncations, however, by 64 and 129 
amino acids at the amino terminus were detrimental for their interaction with full-
length VP3: the scores with these polypeptides were (very) weak or even negative 
(Fig. 2B, no. 4-6). VP4-VP4 interaction appeared to be extremely sensitive to 
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modifications. Any deletion that we applied appeared to be invariably lethal (Fig. 
2C, no. 2-6). VP5-VP5 association on the other hand was quite tolerant to deletions. 
All truncations except for the construct VP5∆C73 (Fig. 2D, no. 3), which lacks the 
sequence for the carboxy-terminal half of the protein, scored positive in both the β-
gal and Leu⎯ growth test (Fig. 2D, no. 2-6). These results suggest that REGION III is 
responsible for VP5 homomeric interaction. 
  
FINE MAPPING THE SELF-INTERACTION SITES OF VP3 AND VP5 USING THE YEAST TWO-
HYBRID SYSTEM 
To determine the putative self-interacting domain of VP3 and VP5 more precisely, 
we constructed and tested four additional progressive deletion mutants for each 
protein. For VP3 a series of constructs was generated encoding internal core protein 
fragments (Fig. 2B, no. 7-9) as well as an amino-terminal protein fragment (Fig. 2B, 
no. 10), each comprising a part of REGION I and/or II. When these constructs were 
assayed in the yeast two-hybrid system homotypic interactions were observed for all 
these polypeptides, though for three of them the interaction strength measured in 
the pairing of pLexABD-VP3(deletion mutant) with pB42AD-VP3(full-length) was 
significantly lower than that in the reciprocal pairing of pB42AD-VP3(deletion mutant) 
with pLexABD-VP3(full-length) (Fig. 2B, no. 7, 9 and 10). Such polarity of two-hybrid  
 
 
Figure 2. Deletion mapping of the regions in pVP2, VP3, VP4 and VP5 responsible for 
homologous interaction by using the yeast two-hybrid system. All of the deletion mutants 
were cloned into pLexABD and pB42AD yeast expression vectors and tested for their ability to 
interact with full-length pVP2 (A), VP3 (B), VP4 (C) or VP5 (D). Left: Overview of the deletion 
mutants that were assayed. The graded line above each panel denotes the amino acid 
(AA) positions of the primary full-length sequence of each viral protein. A breakdown of 
the polypeptides into REGIONS I-IV is shown by shaded areas. Polypeptides depicted dark 
grey were used for an initial mapping; polypeptides depicted light grey were assayed 
subsequently for fine mapping. The polypeptides denoted in bold-face type were 
additionally assayed for interaction with their full-length cognate protein in vivo by co-
immunoprecipitation analysis (see text). Right: Interaction data obtained with double 
transformants. Interactions were assayed for leucine autotrophy (Leu) and for β-
galactosidase activity (LacZ). Leu: +++, clear growth after one day (very strong 
interaction); ++, clear growth after two days (strong interaction); +, growth (interaction); 
+/–, limited growth (weak interaction); –, no growth (no interaction). LacZ: +++, deep blue 
colonies (very strong interaction); ++, blue colonies (strong interaction); +, light blue 
colonies (interaction); +/–, very light blue (weak interaction); –, white colonies (no 
interaction). All results shown are representative of at least 7 independent transformants.   
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interactions has frequently been observed (Cuconati et al., 1998; Xiang et al., 1995) 
and is most likely an inherent consequence of the two-hybrid assay. The fused 
LexABD- or B42AD-domain might partly occlude the site of interaction, or the fusion 
proteins may be folded improperly, be unstable or poorly expressed. The VP3 
mutant termed VP3∆N32/C129, however, interacted in both its polarities with the full-
length VP3 (Fig. 2B, no. 8) as strongly as full-length VP3 interacted with itself (Fig. 2B, 
no. 1). Based on these results we conclude the internal core protein fragment 
encompassing residues 33 to 129 (i.e. REGION II and half of REGION I) to be essential 
for VP3 homomeric interaction (Fig. 2B, region between dotted lines). 
The constructs that were generated for the further mapping of the 
interaction site in VP5 consisted either of the complete REGION III (Fig. 2D, no. 7) or 
of half of it, extended on one side with REGION IV, REGION II, or REGION I + II (Fig. 
2D, no. 8-10). When the combined results of the assays are considered it is clear that 
the REGION III amino-terminal half (residues 73-90; Fig. 2D, region between dotted 
lines) is essential for homotypic VP5 association, with flanking domains additionally 
contributing to the interaction. This is seen most convincingly by looking at the effect 
of extending the non-functional amino-terminal half of VP5 (REGION I + II; VP5∆C73; 
Fig. 2D, no. 3) with the residue 73-90 fragment (VP5∆C55; no. 9), which renders the 
polypeptide strongly association-competent. Extending this construct further with 
the remaining part of REGION III (no. 2) does not increase the interaction strength 
any further. Conversely, the mere addition of the residue 73-90 fragment to the 
virtually inactive carboxy-terminal 55-residue polypeptide VP5∆N90 (no. 8) 
generates a highly interactive polypeptide VP5∆N72 (no. 5) to which further amino-
terminal extension (VP5∆N36; no. 4) does not seem to add much. Though we did not 
test the residue 73-90 fragment independently it is clear that the strength of its 
interaction with full-size VP5 would not be very high and that it requires the flanking 
regions as illustrated by the extended polypeptides VP5∆N72/C37 (no. 7) and 
VP5∆N36/C55 (no. 10) each of which binds with moderate strength.  
 
HOMOLOGOUS INTERACTIONS OF THE FULL-LENGTH IBDV PROTEINS pVP2, VP3 AND 
VP4 ASSAYED BY CO-IMMUNOPRECIPITATION ANALYSIS  
To obtain corroborating evidence for the interactions detected by the two-hybrid 
analyses, we employed a radio-immunoprecipitation (RIP) assay using a co-
transfection system in which the respective proteins are transiently co-expressed in 
QM5 cells. To this end, we used plasmid pHB36W, in which the full-length genomic 
cDNA of segment A of IBDV is cloned in a transcription plasmid between a T7 RNA 
polymerase promoter and the autocatalytic hepatitis delta virus ribozyme sequence 
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(Boot et al., 1999). Furthermore, for the co-expression of the viral proteins we used 
the transcription plasmid pGBKT7, in which the cDNA of each of the viral proteins, 
pVP2, VP3, VP4 and VP5, was cloned behind a T7 RNA polymerase promoter 
sequence, in fusion with a sequence encoding the c-Myc epitope tag. By using 
these tagged fusion proteins and anti-c-Myc antibodies, it was possible to 
specifically precipitate only one of the two homologous interacting proteins and to 
distinguish these proteins by a difference in their electrophoretic mobility (i.e. 
comparing the tagged and the untagged protein) when analysing the (co-) 
precipitates by SDS-PAGE. The molecular size of the fused c-Myc tag, including a 
small linker-peptide, is approximately 12 kDa.  
The plasmids encoding the c-Myc-tagged proteins were co-transfected 
with plasmid pHB36W into QM5 cells that had previously been infected with a 
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Figure 3. Radio-immunoprecipitation analysis of homologous interactions of the full-length 
viral proteins pVP2, VP3, VP4 and VP5 of IBDV in transfected QM5 cells. QM5 cells were 
(co-)transfected with the indicated plasmids expressing either the full-length untagged 
viral proteins pVP2, VP3, VP4 and VP5 (pHB36W) or a full-length viral protein, pVP2, VP3, 
VP4 or VP5, fused to a c-Myc-tag (pGBKT7). At 48 h post transfection cells were 
metabolically labeled for 3 h with [35S]methionine. Subsequently, cells were lysed and 
immunoprecipitated with anti c-Myc serum, followed by SDS-PAGE. Positions of the viral 
(fusion-) proteins and sizes of marker proteins (in kDa) are indicated.  
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recombinant fowlpox virus that expresses T7 RNA polymerase (Britton et al., 1996). 
Forty-eight hours post-transfection, cells were metabolically labeled for 3 hours with 
[35S]methionine and subsequently subjected to immunoprecipitation with anti-c-Myc 
serum. The immunoprecipitates obtained were analyzed by SDS-PAGE and the 
labeled proteins visualized by autoradiography. Mock-transfected cells and cells 
transfected with either pHB36W or the c-Myc encoding plasmids alone, were used 
as controls for each immunoprecipitation.  
As is clear from the results shown in Fig. 3, the c-Myc antibody precipitated 
only the c-Myc-tagged fusion proteins, indicating that it had no cross-reactivity 
(lanes 5-10). Furthermore, in the immunoprecipitations of the cell lysates of the co-
transfected cells, the full-length untagged viral proteins pVP2, VP3 and VP4, were 
each clearly co-precipitated with their cognate c-Myc-tagged fusion protein (lanes 
1-3). However, untagged full-length VP5 failed to be co-precipitated with c-Myc-
tagged VP5 (lane 4). The observation that the relative amounts of tagged pVP2 and 
VP3 versus untagged pVP2 and VP3 are substantially different, whereas tagged and 
untagged VP4 showed nearly equivalent amounts, may be a consequence of 
different transfection efficiencies. It is also possible that the tagged pVP2 and VP3 
proteins additionally interacted with themselves, whereas tagged VP4 did not, or to 
a lesser extent. 
 
FINE MAPPING OF HOMOTYPIC INTERACTIONS OF VP3 AND VP5 BY CO-
IMMUNOPRECIPITATION ANALYSIS 
Using this in vivo co-immunoprecipitation assay, we additionally analyzed several 
VP3 and VP5 truncation mutants assayed earlier in the two-hybrid system (Fig. 2B, 
no. 3, 5, 6 and 8-10; Fig. 2D, no. 3 and 5-8; polypeptides denoted in bold-faced 
type) for their ability to be co-precipitated with their full-length cognate protein. For 
this purpose, the pGBKT7 plasmids coding for the c-Myc-tagged VP3 or VP5 full-
length protein were co-expressed with a plasmid, pGADT7, encoding a VP3- or VP5-
deletion mutant protein in fusion with an influenza virus hemagglutinin (HA) epitope 
tag. By using two different tags we were able to assay for protein-protein interaction 
with two different antibodies, specifically precipitating either the c-Myc-tagged full-
length protein or the HA-tagged deletion mutant. Furthermore, by swapping the c-
Myc- and HA-fusions, the assay was additionally performed reciprocally, namely by 
co-expressing HA-tagged full-length VP3 or VP5 together with c-Myc-tagged VP3 or 
VP5 deletion mutant proteins.  
  Control experiments performed for each immunoprecipitation using 
radiolabeled lysates of mock-transfected cells and of cells transfected with either 
the pGBKT7 or the pGADT7 plasmid alone, demonstrated that both the c-Myc-  
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Figure 4. Radio-immunoprecipitation analysis of truncated VP3 proteins in transfected QM5 cells. 
The VP3 mutant constructs (typed in bold-face in Fig. 2B) were cloned into pGBKT7 and pGADT7 
expression vectors and the expressed polypeptides were tested for their ability to interact with 
full-length VP3. QM5 cells were co-transfected with the indicated plasmids expressing either the 
full-length, c-Myc-tagged VP3 protein (pGBKT7) together with a HA-tagged VP3 mutant 
polypeptide (pGADT7) (A), or a c-Myc-tagged VP3 mutant polypeptide together with the full-
length HA-tagged VP3 protein (B). At 48 h post transfection cells were metabolically labeled for 
3 h with [35S]methionine. Subsequently, cells were lysed and proteins were immunoprecipitated 
with anti c-Myc serum or anti HA serum, followed by SDS-PAGE. Positions of the viral (fusion-) 
proteins and sizes of marker proteins (in kDa) are indicated.  
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and the HA-antibodies lacked cross-reactivity against the respective fusion-proteins 
(data not shown). When using the c-Myc antibodies for the precipitation of c-Myc-
tagged VP3, only the HA-tagged mutant proteins VP3∆C129 and VP3∆C161 were 
found to be co-precipitated (Fig. 4A, lanes 1 and 6). The same result was observed 
when using the HA-antibodies, where c-Myc-tagged full-length VP3 was only co-
precipitated with the HA-tagged VP3∆C129 and VP3∆C161 proteins (Fig. 4A, lanes 8 
and 13). Furthermore, reversing the c-Myc- and HA-tags did not affect the observed 
interactions, thus confirming the results (Fig. 4B, lanes 1, 6, 8 and 13). In addition, an 
interaction was observed for mutant protein VP3∆N32/C129, though weak and only 
in one orientation. When using the c-Myc antibodies, HA-tagged full-length VP3 was 
observed to be co-precipitated with the HA-tagged VP3∆N32/C129 (Fig. 4B, lane 4). 
For VP5, none of the deletion mutants tested was found to be co-precipitated with 
full-length VP5, either way and irrespective of the orientation of the tags (data not 
shown).  
 
 
DISCUSSION 
 
In the present study we confirmed and extended our earlier analysis of the 
homotypic interactions of the IBDV proteins. The use of the recently refined 
cleavage map of the structural protein precursor allowed the detection of a novel 
homologous interaction for VP4 by the yeast two-hybrid system, in addition to the 
self-association observed earlier for pVP2, VP3 and VP5 as well as – though weakly – 
for VP1.  
A further characterization of the strongly interacting pVP2, VP3, VP4 and 
VP5 proteins was undertaken both by using the yeast two-hybrid system and by 
performing co-immunoprecipitation analyses of co-expressed cDNA constructs. 
Through deletion mutagenesis we were able to map the self-interacting regions in all 
of the proteins except for VP4 which appeared to be very sensitive to modifications. 
The data on VP3 allow us now to design a domain map in which the different 
regions of the protein involved in homomeric and heteromeric interactions can be 
assigned. 
The IBDV capsid is an icosahedron with a T=13 lattice composed of trimeric 
subunits (Bottcher et al., 1997; Caston et al., 2001). The outer face of the particle is 
composed of 260 trimeric VP2 clusters. Closely apposed to the inside of this protein 
layer are 200 Y-shaped trimeric VP3 structures. This arrangement not only predicts 
the existence of homomeric interactions of the two capsid proteins, their intimate 
association dictates the occurrence of heteromeric contacts as well. However, 
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while the self-association of both proteins came out convincingly, we failed to 
detect pVP2/VP3 interactions in our assays. The reasons for this most likely relate to 
the assay systems that we used. The two-hybrid system, for instance, would be 
inadequate if we assume that the interactions only occur between the trimeric units. 
Also, if such heteromeric complexes would have been formed in the co-expression 
system, they may not have been sufficiently stable to survive the 
immunoprecipitation conditions, e.g. due to the low concentration of SDS present. It 
is of note that VP2/VP3 complexes were also not detected in infected cell lysates 
(Tacken et al., 2000) and that the assembly of virus-like particles from these proteins 
somehow requires the VP3 protein to be ‘activated’, as their formation could only 
be achieved after modification of its carboxy terminus (Chevalier et al., 2002). 
We observed strong interactions between full-length VP3 molecules in our 
two-hybrid assays. These interactions were subsequently narrowed down by protein 
truncation to the amino-terminal region of the molecule. Specifically, a polypeptide 
comprising residues 1-97 was identified as the domain responsible for homomeric 
interaction, since this region proved to interact with its full-length cognate protein in 
both the yeast two-hybrid and the co-immunoprecipitation assay. Interestingly, this 
domain is clearly distinct from the regions in the VP3 molecule known to interact 
with other components in the virion. VP3 has been shown by us (Tacken et al., 2000) 
as well as by others (Lombardo et al., 1999) to bind to the viral RNA-dependent RNA 
polymerase, VP1. We were able to map the domain in VP3 responsible for this 
interaction to the very carboxy-terminal 10 residues (Tacken et al., 2002). In the 
same study we additionally demonstrated, that VP3 also interacts with both dsRNA 
segments of the viral genome. The domain responsible for this association has not 
been determined yet, but has been implicated to occur in the carboxy-terminal 
region as well, in a domain spanning residues 221-247, a highly basic region with 
interspersed proline residues (Bottcher et al., 1997; Hudson et al., 1986; Tacken et al., 
2002). Importantly, deletion of the VP1-binding domain in VP3 did not abolish VP3-
dsRNA interactions (Tacken et al., 2002) nor did it affect VP3-VP3 interaction 
(unpublished results). Conversely, deletion of the self-interacting domain of VP3 did 
not affect the VP1 binding activity (unpublished results). Altogether, these data are 
consistent with the independent functioning of three domains in the VP3 protein as 
we depicted in the domain model of the protein presented in figure 5. The drawing 
shows the homomeric association function localized in the amino-terminal one-third 
of the molecule, the VP1-binding segment at the opposite end of the molecule, and 
the dsRNA-binding domain just preceding the latter. 
Unlike VP3 (Martinez-Torrecuadrada et al., 2000b), (p)VP2 has been shown 
to have a strong tendency to self-assemble giving rise to different types of particles 
CHAPTER 6  HOMOLOGOUS INTERACTIONS OF IBDV PROTEINS 
 
 
166
depending on the conditions, varying from rigid, flexible and twisted tubules to 
smaller or larger virus-like particles (Caston et al., 2001; Chevalier et al., 2002; 
Fernandez-Arias et al., 1998; Lombardo et al., 1999; Martinez-Torrecuadrada et al., 
2000a; Martinez-Torrecuadrada et al., 2000b). Detailed electron cryomicroscopy 
and image processing analyses of different types of particles clearly revealed the 
trimeric VP2 structures in which each molecule can be subdivided into three 
subdomains, each able of interacting in a non-equivalent fashion with another VP2 
molecule of the same or of an adjoining trimer (Caston et al., 2001). This 
constellation would predict that removal of one such subdomain does not 
necessarily disable the interactions by the others. Our observations support this view, 
as the deletions of different domains of the pVP2 molecule appeared not to abolish 
the association capacity of the remaining polypeptides. This was also not the case 
after truncation of a carboxy-terminal 128-residue segment, which contains the 50-
60 residues tail supposed to play a crucial role in the control of the interactions 
between trimers of VP2 as well as between trimers of VP2 and VP3 (Caston et al., 
2001). Without this tail domain independently expressed VP2 assembles into T=1  
 
 
1 50 100 150 258200
AA:
VP3
VP3-binding domain 
(aa 1-97)
dsRNA-
binding domain
VP1-
binding domain
(aa 249-258)(postulated region: aa 221-247)  
 
Figure 5. A domain model for VP3. Functional binding domains are indicated as shaded 
boxes. The binding site for VP1 has been mapped previously to the extreme carboxy 
terminus (Tacken et al., 2002), while the approximate one-third amino-terminal region was 
presently shown to be responsible for homomeric interaction. The site for dsRNA interaction 
has not been precisely defined yet though has been postulated to comprise the indicated 
stretch of amino acids (Caston et al., 2001; Hudson et al., 1986; Tacken et al., 2002). The 
graded line above the upper bar representing the VP3 polypeptide indicates the amino 
acid (AA) residue numbers.   
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capsids (Caston et al., 2001), while this domain is essential for normal virion 
morphogenesis in IBDV infected cells (Da Costa et al., 2002).  
VP4, the viral protease, was anticipated to exhibit homologous interaction. 
In IBDV infected cells this protein assembles into distinct tubular aggregates, 24-26 
nm in diameter, known as type II tubules (Granzow et al., 1997). Though the function 
of these structures in viral infection is still unclear, they might serve to inactivate 
excess protease activity, thereby preventing lethal damage to the virus or to the 
cells. Attempts to identify interacting domain(s) in the polypeptide failed; none of 
the deletions tested preserved the ability of the protein to associate with its full-
length counterpart in the yeast two-hybrid assay. Negative results in the two-hybrid 
assay often result from protein instability, but that appeared not to be the case 
here. All described fusion proteins were analyzed by immunoblotting and appeared 
to accumulate in high amounts and with the expected size (data not shown). Our 
observations are therefore most compatible with the terminal domains interacting 
with each other to stabilize a conformation that is required for homotypic 
association. Deletion of either terminus disrupts this conformation and abolishes the 
interaction. This is also consistent with our initial inability to detect the homotypic 
interaction of VP4 in the yeast two-hybrid system (Tacken et al., 2000). The VP4 
protein that we tested in those studies carried a 61 residue amino-terminal extension 
while lacking 34 residues at its carboxy-terminal, both due to the use of incorrect 
precursor cleavage sites (Fig. 1C). Either or both these defects apparently interfered 
with self-association.  
The exact function of VP5 is still unknown. The protein is highly basic, 
cysteine-rich, and its sequence is conserved among all serotype I IBDV strains (>95% 
identity). A VP5 deficient virus can replicate in the bursa of inoculated chickens but 
does not induce bursal lesions (Yao et al., 1998). It has also been demonstrated that 
this VP5 deficient mutant IBDV remains closely associated with and is not efficiently 
released from infected cells (Yao & Vakharia, 2001). The protein has therefore been 
speculated to somehow facilitate progeny virus release (Yao & Vakharia, 2001). 
Recently, it was shown that VP5 accumulates within the host cell plasma membrane 
(Lombardo et al., 2000). Expression of VP5 resulted in alteration of cell morphology, 
disruption of the plasma membrane, and in a drastic reduction of cell viability 
(Lombardo et al., 2000). Furthermore, the protein is capable of inducing a 
programmed cell death response in culture cells (Yao & Vakharia, 2001). Sequence-
based topology predictions indicated that VP5 is a class II membrane protein, 
having an intracellular amino-terminal tail, a transmembrane helix and an 
extracellular carboxy-terminal region (Lombardo et al., 2000). Interestingly, the 
putative self-interacting domain of VP5 that we mapped in our two-hybrid analysis 
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to the domain comprising residues 73-90 corresponds almost exactly to the 
predicted transmembrane region (residues 69-88) of the protein. Due to the 
common α-helical structure of transmembrane domains, many are considered to 
form channels or pores in the membrane by a so-called ‘barrel-stave’ mechanism 
(reviewed in (Ojcius & Young, 1991)). The observation that the plasma membrane of 
VP5 expressing cells was permeable not only to small molecules, but also to 
macromolecules such as lectin and IgG molecules (Lombardo et al., 2000) strongly 
supports the hypothesis that VP5 molecules indeed form pore structures within the 
plasma membrane. In addition, these observed changes in membrane permeability 
are similar to those produced in E. coli by the viral proteins E1 of hepatitis C virus, M2 
of influenza virus, gp41of human immunodeficiency virus and 3AB of poliovirus, 
whose transmembrane domains are also thought to cause pore formation (Arroyo et 
al., 1995; Ciccaglione et al., 2001; Guinea & Carrasco, 1994; Lama & Carrasco, 1992; 
Lama & Carrasco, 1995). The ‘barrel-stave’ mechanism involves three major steps: (i) 
binding of monomers to the membrane; (ii) insertion into the membrane to form a 
pore; and (iii) progressive recruitment of additional monomers to increase the pore 
size (Shai, 1995). Initial assembly of monomers on the surface of the membrane must 
occur before the peptide is inserted, since it is energetically unfavourable for an 
amphipatic α-helix to traverse the membrane as a monomer. A homotypic 
interaction of VP5 through a self-interacting domain located within its predicted 
membrane-spanning region is therefore consistent with the hypothesis that VP5 
molecules co-assemble at the host plasma membrane to form a pore structure. It 
would hence be interesting to evaluate whether mutations of conserved amino 
acids in the putative transmembrane region of VP5 would affect its membrane-
permeabilizing activity. 
Shortcomings of the individual methods used in this study necessitate a 
cautious interpretation of data observed just by one type of assay. This is for 
instance obvious from those cases where we were unable to confirm protein 
interactions by the co-immunoprecipitation assay that had been convincingly 
demonstrated in the yeast system, as exemplified by some of the VP3 and all VP5 
truncation constructs that were tested by both approaches. Such inconsistencies 
between the two techniques are frequently observed (Vidal & Legrain, 1999; 
Warbrick, 1997). Our yeast two-hybrid deletion analysis of amino- and carboxy- 
terminally truncated VP3 molecules showed that neither the first 32 nor the last 129 
amino acids of VP3 were necessary for VP3-VP3 interaction. However, the strongly 
interacting deletion mutant VP3∆N32/C129, which lacks both these terminal 
domains, was found not to be efficiently co-immunoprecipitated when co-
expressed with full-length VP3. On the other hand, the VP3 deletion mutant 
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VP3∆C161, which differs from mutant VP3∆N32/C129 only by having its amino 
terminus intact, clearly interacted with full-length VP3 in both the two-hybrid and the 
co-immunoprecipitation assays. Because the two-hybrid LexABD and B42AD fusion 
proteins were stably expressed and negative for self-activation of the LEU2 and LacZ 
reporter genes, we attach much value to the positive results obtained with the yeast 
two-hybrid system. Thus, the deletion mutant VP3∆N32/C129 most likely behaved as 
a bona fide VP3 partner in the yeast two-hybrid system. In contrast, there are many 
possible causes for negative results in the immunoprecipitation assay. One is the 
effect of the c-Myc or HA tags used in this assay. These extensions might sterically 
hinder interaction of the fusion proteins or reduce their interaction strength. 
Alternatively, their interaction might become destabilized by the binding of 
antibodies to the tags. While these considerations leave us with uncertainties about 
some of our – unconfirmed – observations and at the same time ask for additional, 
independent interaction assays, the combined results of our study provide a good 
basis for the further analysis of these important interactions in the future. 
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SUMMARY AND GENERAL DISCUSSION  
 
The research described in this thesis was carried out in order to contribute to a 
better understanding of all interactions that the viral proteins of IBDV have with 
themselves, with each other, and with host cell proteins. At the time this project was 
started, very little was known about the interactions among the viral proteins of IBDV 
and between the viral and host cell proteins. What was known was a partly 
incorrect composition of the viral particle and a first cryoelectron microscopic study 
of the virion (Bottcher et al., 1997), on the basis of which some interactions could be 
predicted. No host components interacting with viral proteins had been reported 
yet. 
To obtain a better insight into the different interactions essential in the IBDV 
life cycle, we employed the, at that time, recently developed yeast two-hybrid 
system. The generation of interaction maps in this way showed to be a valuable first 
tool for the analysis of protein interactions present within the virion or during 
infection.  
The next paragraphs summarise and discuss the studies as described in the 
various chapters (2-6). At the end a brief description of future perspectives is given.   
 
HOMOMERIC INTERACTIONS BETWEEN THE VIRAL PROTEINS OF IBDV 
The first experiments were set up to identify interactions between the known proteins 
of IBDV themselves. The IBDV capsid is an icosahedron with a T=13 lattice composed 
of trimeric subunits (Bottcher et al., 1997; Caston et al., 2001). The outer face of the 
particle is composed of 260 trimeric VP2 clusters. Closely apposed to the inside of 
this protein layer are 200 Y-shaped trimeric VP3 structures. This arrangement not only 
predicts the existence of homomeric interactions of the two capsid proteins, their 
intimate association dictates the occurrence of heteromeric contacts as well. In this 
thesis, we showed that both capsid proteins appeared to self-associate strongly, 
though a heteromeric interaction of these two proteins was not found (Chapter 2 
and 6). However, if this heteromeric interaction only occurs between the trimeric 
units of VP2 and VP3, the yeast two-hybrid system might simply have been 
inadequate to detect this interaction. Furthermore, it was shown recently that the 
assembly of virus-like particles (VLPs) from VP2 and VP3 somehow requires the VP3 
protein to be ‘activated’ as the formation of VLPs could only be achieved after 
modification of the carboxy terminus of VP3 (Chevalier et al., 2002).  
Deletion mapping of the regions in VP2 responsible for homologous 
interaction revealed that VP2 possesses multiple interaction domains (Chapter 6). 
This is consistent with available structural information about this external capsid 
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protein. Detailed electron cryomicroscopy and image processing analyses of 
different types of particles clearly revealed the trimeric VP2 structures in which each 
molecule can be subdivided into three subdomains, each capable of interacting in 
a nonequivalent fashion with another VP2 molecule of the same or an adjoining 
trimer (Caston et al., 2001).   
The amino-terminal 97 amino acids of VP3, was identified as the domain 
responsible for VP3 homomeric interaction (Chapter 6). The functional relevance of 
this binding domain is discussed below (see The interacting domains of VP3). 
VP4, the viral protease, was anticipated to exhibit homologous interaction. 
In IBDV-infected cells this protein assembles into distinct tubular aggregates, 24-26 
nm in diameter, known as type II tubules (Granzow et al., 1997). In our initial yeast 
two-hybrid screening we made use of a VP4 two-hybrid fusion protein that was 
based on the presumed cleavage sites of the structural protein precursor reported 
by Hudson et al. in 1986. Here, we failed to detect the homomeric interaction of 
these VP4 molecules (Chapter 2). However, later these processing sites appeared to 
be incorrect and the exact cleavage sites were newly established in 1999 and 2000 
by Sanchez & Rodriguez and Lejal et al., respectively. We therefore re-evaluated our 
findings and this allowed the detection of the homologous interaction of VP4 
(Chapter 6). Attempts to identify interacting domain(s) in this polypeptide failed; 
VP4-VP4 interaction appeared to be very sensitive to modifications in the 
polypeptide (Chapter 6).  
The exact function of VP5 is still unknown. The protein is dispensable for virus 
replication in vitro but important for pathogenicity (Mundt et al., 1997; Yao et al., 
1998). It has recently been shown that VP5 is a cytolytic protein that accumulates 
within the plasma membrane of infected cells and promotes the egress of progeny 
virions (Lombardo et al., 2000; Yao & Vakharia, 2001). It was hypothesized by 
Lombardo et al. (2000) that VP5 molecules might form pore structures within the host 
plasma membrane. Hence, the homotypic interaction of VP5 that we have 
described in this thesis (Chapters 2 and 6) would fit in this hypothesis. Interestingly, 
the putative self-interacting domain of VP5 that we mapped in our two-hybrid 
analysis to the domain comprising residues 73-90, corresponds almost exactly to the 
predicted transmembrane region (residues 69-88) of the protein (Lombardo et al., 
2000). Due to the common α-helical structure of transmembrane domains, many are 
considered to form channels or pores in the membrane by a so-called “barrel-
stave” mechanism (reviewed in Ojcius & Young, 1991). The barrel-stave mechanism 
involves three major steps: (i) binding of monomers to the membrane; (ii) insertion 
into the membrane to form a pore; and (iii) progressive recruitment of additional 
monomers to increase the pore size (Shai, 1995). Initial assembly of monomers on the 
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surface of the membrane must occur before the peptide is inserted, since it is 
energetically unfavorable for an amphipatic α-helix to traverse the membrane as a 
monomer. A homotypic interaction of VP5 through a self-interacting domain 
located within its predicted membrane-spanning region is therefore consistent with 
the hypothesis that VP5 molecules co-assemble at the host plasma membrane to 
form a pore structure. It would hence be interesting to evaluate whether mutations 
of conserved amino acids in the putative transmembrane region of VP5 would 
affect its membrane-permeabilizing activity. 
VP1 also associates with itself but the significance of this interaction has not 
yet been established (Chapters 2 and 6). It is conceivable that a homologous 
interaction of VP1 can occur. Xiang et al. (1998) reported an interaction between 
VPg and the polymerase 3Dpol of poliovirus. The poliovirus protein VPg is covalently 
linked to the 5’ end of both genomic and antigenomic viral RNA and 3Dpol is the 
RdRp. These authors suggested that a direct interaction between these molecules is 
involved in the mechanism of initiation of viral RNA synthesis. VP1 of IBDV also exists 
as a genome-linked protein (VPg) (Muller & Nitschke, 1987). Therefore, an interaction 
between VPg and VP1 of IBDV may have a similar function. Moreover, it has been 
suggested that the initiation of viral RNA synthesis of birnaviruses may involve two 
VP1 molecules, one serving as a primer and the other as polymerase for chain 
elongation (Dobos, 1995b).   
 
HETEROMERIC INTERACTIONS BETWEEN THE VIRAL PROTEINS OF IBDV 
We found that a heterologous complex between VP1 and VP3 can be formed in 
yeast cells (Chapter 2). This heteromeric interaction was also detected in vivo in 
IBDV infected cells (Chapter 2). Our results are consistent with the results described 
by Lombardo et al. (1999), who observed the interaction of VP1 with VP3 by co-
localization and co-immunoprecipitation studies of vaccinia virus-expressed VP1 
and VP3. Their and our results raised several interesting possibilities regarding the 
function of the VP1-VP3 interaction. We therefore have followed up on this 
supposed essential interaction. By using the yeast two-hybrid system as well as by 
mutagenesis of an infectious cDNA clone of IBDV we mapped the domain in VP3 
interacting with VP1 to the extreme carboxy-terminal tail of the polypeptide 
(Chapter 3).  
Recently, Maraver et al. (2003a) reported similar results. They established the 
VP1 binding motif of VP3 to be present within the highly charged 16-amino-acid 
stretch on the C terminus of VP3. These results are comparable with ours; the VP3 
domain interacting with VP1 in our yeast two-hybrid analyses was mapped to its 
carboxy-terminal 10 amino acids (Chapter 3). Unfortunately, Maraver et al. (2003a) 
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did not test a VP3 deletion mutant lacking its 10 carboxy-terminal residues in their 
assay. In spite of this, there is one other obvious difference between these two 
studies. The domain mapping of VP3 that Maraver et al. used to identify the VP1 
binding motif was based on co-immunoprecipitation analysis of vaccinia virus-
expressed VP1 and VP3(-mutants), whereas the co-immunoprecipitation analysis 
that we used to confirm our yeast-two hybrid analysis was based on an IBDV reverse 
genetics system. This allowed us to analyze the interaction of carboxy-terminally 
truncated VP3 molecules with VP1 in infected cells. By using this strategy we found 
that in vivo the removal of just the terminal residue was already sufficient to affect its 
association with VP1 and also to fully abolish the production of infectious progeny 
(Chapter 3). Maraver et al., on the other hand, studied the role of the VP1 binding 
motif in vivo using only the complete 16-amino-acid stretch of the extreme C 
terminus of VP3 (Maraver et al., 2003a). They analyzed the effect of Trojan peptides 
(synthetic peptides) containing this 16-amino-acid stretch of the C terminus of VP3, 
on virus replication. They showed that the presence of these Trojan peptides in IBDV-
infected cells specifically reduced infective virus production. 
Altogether, their and our results demonstrate that the formation of VP1-VP3 
complexes plays a crucial role during virus morphogenesis. 
 
INTERACTIONS BETWEEN THE VIRAL COMPONENTS OF IBDV: PROTEIN-dsRNA 
INTERACTIONS 
In 1986 Hudson et al. (1986) already suggested that VP3, by virtue of its basic 
carboxy-terminal domain, might interact with the packaged viral dsRNA genome. 
Later, in 1999, studies performed with the aquabirnavirus infectious pancreatic 
necrosis virus (IPNV) showed the presence of VP3 in ribonucleoprotein complexes 
isolated from virus particles (Hjalmarsson et al., 1999). These complexes were shown 
to contain VP3 and RNA. However, it was not determined whether VP3 directly 
bound to RNA molecules or to VP1 complexed to dsRNA (Hjalmarsson et al., 1999). 
Additionally, VP3-RNA complexes could also be purified from supernatants of IPNV-
infected cell cultures, although the nature of the bound RNA was not determined 
(Hjalmarsson & Everitt, 1999). These observations along with the fact that VP3 coats 
the inner surface of the virus particle (Bottcher et al., 1997; Caston et al., 2001) 
emphasized the possibility that VP3 indeed establishes direct interactions with the 
virus genome. 
In this thesis, we provided the first experimental evidence for this long-
anticipated role of VP3 in binding to viral nucleic acids (Chapter 3). RNase 
treatments and reverse transcription-PCR analyses of VP1- and VP3-
immunoprecipitates (i.e. prepared from lysates of cells undergoing infection) 
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demonstrated that VP3 interacts with dsRNA of both viral genome segments 
(Chapter 3). Additionally, we showed that this interaction is not mediated by the 
extreme carboxy-terminal end of VP3 since C-terminal truncations of 1, 5, or 10 
residues did not prevent formation of the VP3-dsRNA complexes (Chapter 3). 
Recently, Kochan et al. (2003) further characterized the RNA-binding 
activity of VP3 and showed that VP3 interacts with RNA in a sequence-independent 
fashion. The lack of any binding specificity for ssRNA probes that they used in their 
study might indicate that, as is the case with other virus-encoded nucleoproteins 
(Gott et al., 1993; Klein et al., 2000; Muriaux et al., 2001; Skuzeski & Morris, 1995), other 
factor(s) could be necessary to confer specificity. VP1 is the most likely candidate 
for this role. Interestingly, VP3 also bound dsRNA and ssDNA, but not dsDNA. These 
binding characteristics are usually found in RNA-binding proteins, especially in 
dsRNA-binding proteins (Draper, 1999). Furthermore, according to the results of 
Kochan et al. (2003) the VP3 ssRNA-binding domain is located within a highly 
conserved 69-amino-acid stretch close to the N-terminus of the protein. Whether this 
domain also comprises the dsRNA-binding motif is currently under investigation by 
this group. It is, however, obvious that this domain is different from the highly basic 
carboxy-terminal domain that was predicted by Hudson et al. (1986) to be involved 
in binding to viral nucleic acids. As VP3 does not comprise any of the known RNA or 
DNA binding motifs that have previously been described in the literature such as 
zinc fingers, arginine-rich regions or RGG-box sequences (Burd & Dreyfuss, 1994; 
Kochan et al., 2003), the exact domain of VP3 that comprises the dsRNA-binding 
motif therefore still remains a subject for further investigation.  
 
THE INTERACTING DOMAINS OF VP3 
It is now clear that VP3 entertains interactions with itself (Chapters 2 and 6), with VP2 
(Bottcher et al., 1997; Caston et al., 2001), with free VP1 molecules (Chapters 2 and 
3; and Lombardo et al., 1999; Maraver et al., 2003a), most likely also with genome-
bound VP1 (Chapter 3), and with dsRNA segments A and B (Chapter 3; and Kochan 
et al., 2003). Different domains in the protein are responsible for these different 
interactions. The carboxy-terminal domain binding to VP1, for instance, proved to 
be distinct from the region binding to the dsRNAs (Chapter 3; and Kochan et al., 
2003) and from the region responsible for homomeric interaction (Chapter 6). These 
data indicate that these three domains of VP3 can function independently from 
each other.  
In this thesis, the amino-terminal part of VP3 comprising residues 1-97, was 
identified as the domain responsible for homomeric interaction (Chapter 6). 
Maraver et al. (2003b), on the contrary, recently mapped an oligomerization 
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domain of VP3 within a 24-amino-acid stretch near the carboxy-terminal end of the 
polypeptide, which partially overlaps the VP1 binding domain. Their results are 
(solely) based on the existence of a ladder of high-molecular mass VP3-specific 
protein bands, ranging from 65 to 170 kDa, in samples prepared from insect cells 
expressing His-tagged VP3 fusion proteins that proved to be resistant to 
denaturation. Comparing this study to the data presented in this thesis indicates that 
there are obviously some discrepancies. For instance, we have never seen such a 
ladder of high-molecular mass, denaturation resistant, VP3-specific protein bands in 
similar experiments, when expressing influenza virus hemagglutinin (HA)- and/or c-
Myc-tagged VP3 fusion proteins in avian cells (Chapter 6). In contrast, we showed 
that, under denaturating conditions, all of the existing viral component interactions, 
with the exception of the VPg-dsRNA interactions, were completely disrupted 
(Chapters 2, 3 and 6). Furthermore, we showed that deletion of the VP1-binding 
domain in VP3, comprising the 10-amino-acids stretch at its carboxy-terminal end, or 
even a deletion of the complete carboxy-terminal half of the protein (hence, in 
addition comprising the VP3 oligomerization domain mapped by Maraver et al., 
2003b), did not affect the VP3-VP3 interaction in two of our different and 
independent assays (Chapter 6 and unpublished results). It is difficult to speculate 
about the reasons underlying these conflicting results. Understanding the 
discrepancies between these two different studies on the mapping of the 
homomeric interaction domain of VP3 will thus need further research.  
It has frequently been seen, by us as well as by others, that VP3 occurs in (at 
least) two electrophoretic forms in IBDV-infected cells (Chapter 2). One of these 
bands has the expected size of VP3 (32 kDa) while the other seems to be smaller (28 
kDa). The existence of two VP3 species has also been reported for IPNV (Dobos & 
Rowe, 1977; Hjalmarsson & Everitt, 1999; Dobos, 1995a). The nature of the smaller 
VP3 species, however, remained unclear. Pulse-chase analyses indicated that only 
full-length VP3 is incorporated in IBDV virions (Chapter 2). Additionally, mass 
spectrometry of purified IBDV particles revealed the presence of only the full-length 
VP3 (M.G.J. Tacken, H.J. Boot, B.P.H. Peeters, P.J.M. Rottier, B. Delmas and E. Mundt, 
unpublished results). This suggests that the shorter form might have additional, non-
structural, functions. We speculated that it could be generated by internal initiation 
of translation at an AUG codon located 17 residues downstream from the bona fide 
initiator codon. Alternatively, the full-length protein might undergo a proteolytic 
trimming. The importance of the AUG codon was assessed by reverse genetics 
(M.G.J. Tacken, H.J. Boot, B.P.H. Peeters, P.J.M. Rottier, B. Delmas and E. Mundt, 
unpublished results). Our results showed that the IBDV mutants having the AUG 
codon (Methionine) exchanged for a CTC codon (Leucine) or an ATT codon 
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(Isoleucine) were reduced in their efficiency to generate recombinant IBDV (Table 
1), though still able to accumulate both VP3 species in infected cells (Fig. 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Effect of substituting methionine at position 772 of the 
polyprotein on replication. The effect was assessed by reverse 
genetics; derivates of either plasmids pHB-36W (A-segment of 
serotype I strain CEF94; Boot et al., 1999) or p2A (A-segment of 
serotype I of strain P2; Mundt et al., 1996) were transfected in 
combination with plasmids pHB-34Z (B-segment of strain 
CEF94; Boot et al., 1999) or p2B (B-segment of strain P2; Mundt 
et al., 1996) respectively, into IBDV susceptible cells and the 
resulting IBDV titer was determined 24 h after transfection. 
a 50% tissue culture infective doses (TCID50) is as Log 10 values 
b rIBDV; unmodified rescued IBDV (positive control) 
c only the IBDV-segment A was transfected (negative control) 
d mIBDV; mutagenized IBDV having the methionine at position 
772 of the polyprotein exchanged for the amino acid as 
indicated 
 
Unfortunately, attempts to N-terminally sequence both VP3 species to determine 
whether the smaller VP3 species had been proteolytically trimmed at its N-terminus 
have failed as it turned out that these proteins were blocked  (M.G.J. Tacken, H.J. 
Boot, B.P.H. Peeters, P.J.M. Rottier, B. Delmas and E. Mundt, unpublished results). 
Interestingly, Maraver et al. (2003b) recently showed that the VP3 protein 
synthesized by recombinant baculoviruses (rBVs) in insect cells, is proteolytically  
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Figure 1. Western blot analysis of VP3 in rIBDV, 
mIBDV-M772L and mIBDV-M772I (see Table 1) 
infected avian cells. VP3 proteins (indicated 
by arrows) were visualized using a VP3 
specific monoclonal antibody. The position of 
marker proteins and their sizes (kDa) are 
indicated on the left. 
 
cleaved at the C-terminal end of the protein, leading to the accumulation of a 
product lacking the 13 C-terminal residues. It would be interesting to determine 
whether this VP3-derived product is identical to the smaller VP3 species observed in 
IBDV-infected cells. If so, it would be additionally interesting to analyze its possible 
role during virus replication. This VP3-derivative lacking its 13 C-terminal residues 
undoubtedly has lost its VP1-binding activity, though, does it still possess its 
homomeric and dsRNA-binding activities? Maraver et al. (2003b) additionally 
showed that coexpression of VP1 prevents VP3 trimming and restores virus like 
particle (VLP) formation in insect cells. They speculated that the formation of VP3-
VP1 complexes might hinder the VP3 cleavage site, and thus protect the VP3 C-
terminal tail against proteolysis.  
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INTERACTIONS BETWEEN VIRAL AND HOST CELL PROTEINS 
Identification of cellular interaction partners of the viral proteins of IBDV could 
provide a more complete understanding of the dynamics of RNA replication, virus-
mediated cellular modulation and host-range restriction. In this thesis, we presented 
a yeast two-hybrid search for candidate cellular proteins interacting with the IBDV 
proteins VP1, pVP2, VP3, and VP5 (Chapter 4). We used the inducible LexA-
dependent yeast two-hybrid system to screen a cDNA library from bursae of 
Fabricius of 3-weeks-old chickens. We found that several host cell proteins were able 
to form complexes with the IBDV proteins in yeast cells (Chapter 4). The putative 
biological implications for some of the interactions found were discussed in Chapter 
4. A first step to demonstrate biological relevance was to verify these interactions by 
a different biochemical assay. For this purpose, we performed a series of co-
immunoprecipitations using different antibodies that were kindly provided by several 
groups (Table 2). However, as yet, only one of these virus-host interactions found in 
yeast could be convincingly confirmed by co-immunoprecipitation analysis, i.e. the 
interaction between VP1 and the carboxy-terminal domain of translation eukaryotic 
initiation factor 4AII (eIF4AII). Therefore, we have followed up on this supposedly 
essential interaction in Chapter 5. 
 
CHARACTERIZATION OF THE PUTATIVE INTERACTION BETWEEN VP1 AND eIF4AII  
Eukaryotic initiation factor 4A is an essential component of the translation initiation 
system. Normally it binds to the initiation complex in a cap-mediated way (Fig. 2A) 
(Gingras et al., 1999). An interaction of VP1 (or VPg) with eIF4AII is intriguing 
particularly because IBDV mRNAs are not capped but possess a covalently linked 
VPg at their 5’ end. A direct interaction of eIF4A with VPg may therefore be a key 
event in the establishment of IBDV infection. Possibly, it represents a novel cap-
independent mechanism for the initiation of translation in which the binding of eIF4A 
to VPg mediates the recruitment of the 40S ribosomal subunit to the 5’ end of the 
viral mRNA. Whereas an interaction between the cap-structure and eIF4E is required 
for normal capped translation, an interaction between proteolytically cleaved 
eIF4G and an internal ribosome entry site for uncapped picornaviral mRNA 
 
 
Table 2. Antibodies used for co-immunoprecipitation analysis. The following antibodies 
were used for co-immunoprecipitation analysis, in order to verify the biological relevance 
of some of the interactions found in yeast between IBDV and host cell proteins described 
in chapter 3. Other antibodies used in these co-immunoprecipitation analyses which are 
not listed as they were achieved from our own laboratory, were anti-VP1, anti-VP2, anti-
VP3 and anti-VP5. 
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Potential cellular interactors of VP1 
  
Paladin   
anti-paladin polyclonal (rabbit) Dr. J. Pearce, Wellcome CRC Institute, University of 
Cambridge, UK. 
 
NAD(+) Isocitrate dehydrogenase  
anti-Idh polyclonal (rabbit) Dr. H. van der Spek, Swammerdam Institute for Life 
Sciences, University of Amsterdam, The Netherlands. 
 
RAN binding protein 1 (RanBP1) 
anti-RanBP1 polyclonal (goat) Santa Cruz Biotechnology, Inc. 
 
Eukaryotic translation initiation factor 4A, isoform 2 (eIF4AII) 
anti-eIF4AII polyclonal (rabbit) Dr. C. Kuhlemeier, University of Berne, Switserland 
anti-eIF4AII monoclonal (mouse) Dr. H. Trachsel, University of Berne, Switserland 
 
Potential cellular interactors of VP2 
 
Ornithine decarboxylase antizyme (ODC-AZ) 
anti-ODC-AZ polyclonal (rabbit)  Dr. J.L.A. Mitchell, Center for Biochemical and Biophysical 
Studies, Northern Illinois University, USA 
anti-ODC-AZ polyclonal (rabbit) Dr. O.A. Jänne, Biomedicum Helsinki, University of Helsinki, 
Finland 
anti-ODC-AZ polyclonal (rabbit) Dr. S. Matsufuji, Jikei University School of Medicine, Minato-
ku, Tokyo, Japan 
anti-ODC-AZ monoclonal (mouse) Dr. S. Matsufuji, Jikei University School of Medicine, Minato-
ku, Tokyo, Japan 
 
Sin3-associated polypeptide 18 (Sap18) 
anti-SAP18 polyclonal (rabbit) Dr. A. Kuzmichev and Dr. D. Reinberg, Howard Hughes 
Medical Institute, University of Medicine and Dentistry of 
New Jersey, Piscataway, New Jersey, USA 
anti-SAP18 polyclonal (rabbit) Dr. S. Hanes, New York State Department of Health  & State 
University of New York-Albany, USA 
 
 
Potential cellular interactors of VP3 
 
RAN binding protein 1 (RanBP1) 
anti-ranbp1 polyclonal (goat) Santa Cruz Biotechnology, Inc. 
 
Thymocyte protein cThy28kD 
anti-cThy28 polyclonal (rabbit) Dr. M.M. Compton, Department of Poultry Science, 
University of Georgia, Athens, Greece 
 
Embryonic ectoderm development protein (EED) 
anti-EED polyclonal (rabbit)  Dr. A.P. Otte, BioCentrum Amsterdam, University of 
Amsterdam, The Netherlands 
 
 
Potential cellular interactor of VP5 
 
Ornithine decarboxylase antizyme (ODC-AZ) 
anti-ODC-AZ polyclonal (rabbit)  Dr. J.L.A. Mitchell, Center for Biochemical and Biophysical 
Studies, Northern Illinois University, USA 
anti-ODC-AZ polyclonal (rabbit) Dr. O.A. Jänne, Biomedicum Helsinki, University of Helsinki, 
Finland 
anti-ODC-AZ polyclonal (rabbit) Dr. S. Matsufuji, Jikei University School of Medicine, Minato-
ku, Tokyo, Japan 
 
anti-ODC-AZ monoclonal (mouse) Dr. S. Matsufuji, Jikei University School of Medicine, Minato-ku, 
Tokyo, Japan Tokyo, Japan 
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translation (Lamphear et al., 1995), an interaction between VPg and eIF4A may 
have a similar function in translating uncapped IBDV mRNA. Two possible models 
describing how an eIF4A-VPg interaction might induce the recruitment of the 40S 
ribosomal subunit for IBDV initiation of translation are dicussed below (see also figure 
2).  
The association of VP1 with the carboxy-terminal domain of eIF4AII was 
found in yeast (Chapters 4 and 5) and confirmed by co-immunoprecipitation 
analyses (Chapter 5). Interestingly, no interaction was observed between VP1 and 
full-length eIF4AII, nor with its functionally equivalent isotype eIF4AI. We also 
investigated whether in infected cells an eIF4AII carboxy-terminal fragment is 
generated by some kind of cleavage, similar to what has been found for eIF4AI in 
foot-and-mouth disease virus (FMDV)-infected cells (Li et al., 2001). No breakdown of 
eIF4AII was, however, observed, the protein being as stable as in non-infected cells 
(Chapter 5).  
In view of the known two-domain structure of the eIF4AII protein (Caruthers 
et al., 2000) it is conceivable that the interaction of VP1 with the full-length molecule 
requires collaborating proteins that open up its structure and expose the VP1-
binding site in the carboxy-terminal domain. Based on our observations described in 
Chapter 5 and on published information we propose two possible models for the 
initiation of translation of IBDV mRNAs, which may hold as well for other birnaviridae 
(Fig. 2). We postulate that binding of VP1 to eIF4A is required for the recruitment of 
the translational machinery, which in turn promotes 43S pre-initiation complex 
binding to the mRNA. The molecular interactions that enable the incoming 43S pre-
initiation complex to bind mRNA are thought to involve interaction of the eIF3 
component of 43S complexes with eIF4G. However, in yeast a direct eIF3-eIF4G 
interaction has not been reported. The two models we propose differ primarily in the 
role played by eIF4G. Model 1 (Fig. 2B) states that eIF4A bound to VPg attracts 
eIF4G. In this model, binding of the 43S pre-initiation complex is mediated by an 
interaction of eIF3 with eIF4G. It is assumed that eIF4G is not preassembled in the 
eIF4F complex but, rather, interacts with the 43S pre-initiation complex prior to mRNA 
recruitment. This has been postulated before (Gingras et al., 1999; Joshi et al., 1994; 
Lamphear et al., 1995) and is based on the documented interaction of in vitro 
synthesized eIF4G with the 43S pre-initiation complex in the absence of mRNA (Joshi 
et al., 1994). The second model, which we favor, proposes that VPg executes the 
pivotal functions of both eIF4E and eIF4G by delivering eIF4A to the 5’ end of the 
viral mRNA, where it is appropriately positioned to unwind secondary structure and 
provide a single-stranded RNA region as a landing pad for the 43S pre-initiation 
complex (Fig. 2B; Model 2). This model suggests that due to the unwound secondary 
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Figure 2. Hypothetical models for cap-independent initiation of translation of IBDV mRNA, 
in comparison with cap-dependent initiation of translation of its host cell mRNAs. (A) A 
typical capped mRNA of the eukaryotic host cell. eIF4F (i.e. eIF4E, eIF4G and eIF4A) binds 
to the 5’ cap and eIF4B joins eIF4A to unwind secondary structure of the mRNA. eIF3, eIF1A 
and the ternary complex (i.e. eIF2, GTP and initiator methionyl-tRNA (Met-tRNAi)), all 
bound to the 40S ribosomal subunit, form the 43S pre-initiation complex. This complex binds 
downstream of the cap and then scans the 5’ leader to locate the first AUG initiation 
codon. Subsequently the 60S subunit joins to form the translationally competent 80S 
ribosome. (B) Uncapped IBDV mRNA with VPg covalently linked at the 5’ end. Model 1: 
eIF4A bound to VPg attracts eIF4G that serves as landing platform for the 43S pre-initiation 
complex. The binding of the 43S pre-initiation complex to mRNA presumably occurs via 
eIF3-eIF4G interaction. Model 2: VPg interacts with eIF4A and executes the function of 
both eIF4E and eIF4G in cap-dependent translation, by bridging eIF4A to the mRNA. After 
sufficient mRNA secondary structure is unwound, the 43S pre-initiation complex binds the 
mRNA, possibly by base pairing between the putative 18S rRNA binding site (a 32 nt 
consensus sequence present in both IBDV segments; depicted as a dashed box) and its 
complement within the 40S ribosomal subunit. 
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structure in the 5’ region of the mRNA, the 43S pre-initiation complex is able to bind 
to the mRNA, presumably by base pairing between the putative binding site for 18S 
rRNA, present in both IBDV segments (Mundt & Muller, 1995), and its complement 
within the ribosomal RNA in the 40S ribosomal subunit. Alternatively, the binding of 
the 43S pre-initiation complex to the mRNA could be mediated by an eIF3-RNA 
interaction. Functional eIF3-mRNA interactions for translation initiation have been 
described for foot-and-mouth disease virus (FMDV), hepatitis C virus (HCV) and 
classical swine fever virus (CSFV) (reviewed in Martinez-Salas et al., 2001). However, 
these interactions involve extended tertiary RNA structures which do not seem to 
occur in the 5’ UTR of IBDV mRNAs. This model is based on the fact that the activity 
of eIF4G for IBDV translation may be redundant. Various activities of eIF4G are not 
required such as its binding to eIF4E, its docking to MAP kinase-interacting protein 
kinase-1 (Mnk1) to allow eIF4E phosphorylation, and its interaction with poly(A)-
binding protein (PABP) to bridge the 5’ cap structure to the 3’ poly(A) sequence 
(Gingras et al., 1999). Interestingly, during FMDV-infection eIF4G is proteolytically 
cleaved, thereby separating the eIF4E- and PABP-binding domain from the eIF4A- 
and eIF3-binding domain (Lamphear et al., 1995). As we assessed by Western blot 
analysis, a similar cleavage of eIF4G did not take place in IBDV infected cells (data 
not shown). 
It has been argued that communication between the 5' and 3' ends of 
mRNAs is important for regulation and efficiency of mRNA translation (Sachs, 2000). 
This view gained support by the demonstrated circularisation of a large number of 
viral and nonviral mRNAs that lack a cap or a poly(A) tail (Guo et al., 2001 and 
references therein). It is therefore expected that also the uncapped and non-
polyadenylated IBDV mRNAs require a functional interaction between terminal RNA 
elements similar to that observed between the canonical 5’ cap and 3’ poly(A) tail. 
It is exciting to speculate that the predicted stem-loop structure of the 3’ terminus of 
the IBDV mRNAs (Boot et al., 1999), might be involved in such a closed loop 
complex, operating as a surrogate for the poly(A) tail in enhancing the translation of 
viral mRNAs. Our finding that VP3 interacts both with VP1 and with the genomic 
dsRNA segments of IBDV (Chapter 3), and hence possibly also with the dsRNA 
region of the stem-loop structure, adds to the interest of this hypothesis.  
In contrast to many viruses that induce host translational shut-off, IBDV 
infection is not associated with a decrease in host protein synthesis (Chapter 5). 
How, then, do IBDV mRNAs adequately compete for available translation factors? 
The supposed binding of eIF4A to VPg most likely occurs transiently, where bound 
eIF4A is expected to be readily exchanged with free eIF4A, similar to when it 
recycles through the eIF4F complex (Pause et al., 1994). As eIF4A is the most 
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abundant of the translation initiation factors present in cells (three- to sixfold in 
relative excess over other initiation factors; Duncan & Hershey, 1983), a possible 
sequestering of eIF4A by VPg would not be detrimental for cellular translation. 
Moreover, a possible partial depletion of available eIF4A, sequestered by VPg, 
mainly affects the eIF4AII isoform, leaving the pool of ubiquitous and functionally 
equivalent eIF4AI accessible for host translation. Furthermore, in both our proposed 
models the cap-binding protein eIF4E, the least abundant of the initiation factors 
(Duncan et al., 1987), is supposed not to be required for the translation of the 
uncapped IBDV mRNAs, leaving host translation unaffected. Finally, phosphorylated 
eIF4E-binding protein 1 (4E-BP1), which liberates and activates eIF4E (Gingras et al., 
1999), remained unaffected upon IBDV infection (data not shown), consistent with 
our observed lack of inhibition of host cell protein synthesis by IBDV infection. 
 
CLOSING REMARKS AND FUTURE PROSPECTIVES 
In conclusion, the experiments described in this thesis showed that yeast two-hybrid 
interaction mapping provided a valuable (first) tool for the identification and 
molecular characterization of different interactions occurring in the IBDV life cycle.  
An association of eIF4AII with IBDV VP1 or, rather, with viral mRNA-linked VPg 
points to an important function of this viral protein in IBDV mRNA translation. 
However, future studies will be required to confirm and establish the functional 
significance of this interaction for viral multiplication. It would be interesting to know 
whether VP1, when linked to viral RNA (i.e. as VPg) can indeed bind the initiation 
factor and support translation initiation of viral RNA, without compromising host 
mRNA translation. Another interesting question relates to the occurrence of 5’-3’ 
interactions in the IBDV mRNAs and to the binding partners that mediate these 
interactions.  
The VP3 protein seems to be the key organizer in birnavirus morphogenesis. 
By its interactions with all the structural components in the virion it appears to create 
the interior architecture that is required for the proper execution of replication, 
transcription and assembly activities of these viruses. Nevertheless, knowledge about 
the morphogenesis of birnaviruses is still very limited and, while finishing the 
manuscript of this thesis, many questions remain. For instance, as VP1 resides inside 
the viral particle and VP3 forms trimeric subunits located at the inner surface of the 
virion shell, it is an intruiging question of how the VP1 binding activity of VP3 is 
regulated, given that only a few VP1 molecules are encapsidated into a virion. It will 
also be interesting to find out if and how the virus regulates the numbers of free and 
genome-bound VP1 molecules assembled in each viral particle. Furthermore, it is still 
an unresolved issue how the two genomic dsRNA segments are correctly assorted 
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during particle assembly. A role for the VPg moiety in the selection of the genome 
segments is conceivable. Alternatively, this selection might be achieved by VP3 
through its capacity to bind dsRNA. However, this capacity might of course also only 
assist in the proper positioning of the two dsRNA segments within the virion. 
Nevertheless, if this dsRNA binding activity would indeed operate at the level of 
segment selection during particle assembly we should assume that VP3 binds to 
specific double-stranded regions within the viral mRNAs, as all dsRNA viruses are 
assumed to synthesize their negative RNA strand only after the packaging of their 
mRNAs. The specific encapsidation of IBDV mRNAs might thus resemble the 
mechanism by which the hepatitis B virus assembles its pregenomic RNA. Here the 
viral polymerase binds to a specific stem-loop structure present in viral mRNAs which 
subsequently leads to the polymerase-dependent encapsidation of the viral nucleic 
acid (Bartenschlager & Schaller, 1992; Ziermann & Ganem). Much work will be 
needed to resolve these issues, not only for IBDV but as well for other dsRNA viruses. 
Continued molecular virological studies in combination with ultrastructural 
analyses are likely to be required to answer the many outstanding questions 
concerning the biology of these viruses.  
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Het infectious bursal disease virus (IBDV), ook wel het Gumboro virus genoemd, 
veroorzaakt de zeer besmettelijke ziekte infectieuze bursitis (IBD) bij kippen. De ziekte 
werd voor het eerst in 1957 waargenomen in de Amerikaanse plaats Gumboro 
(Delaware), vandaar het eponiem “De ziekte van Gumboro”. Het virus heeft zich 
inmiddels wereldwijd verspreid. De ziekte komt uitsluitend voor bij gevogelte (kippen 
en kalkoenen) en wordt gekenmerkt door de vernietiging van de lymphoide 
organen, met name de bursa van Fabricius, waar het virus de actief delende en 
differentiërende B-lymphocyten infecteert. De ziekte kan fataal zijn of een 
immunosuppressie veroorzaken die dan vaak van tijdelijke aard is, afhankelijk van 
de dosis en virulentie van de IBDV stam, de leeftijd van de dieren en het dierenras, 
en van de aan- of afwezigheid van passieve immuniteit. Het IBDV is een 
dubbelstengs RNA (dsRNA)-virus dat twee segmenten (A en B) bevat en daardoor 
behoort tot de familie Birnaviridae en het geslacht avibirnavirus. Tot deze familie 
behoren ook het infectious pancreatic necrosis virus (IPNV), voorkomend bij vissen, 
het tellina virus (TV) en het oyster virus (OV), voorkomend bij tweekleppige 
schelpdieren, en het Drosophila X virus (DXV), voorkomend bij fruitvliegjes.  
Het virus is zeer stabiel en persistent, dat wil zeggen moeilijk te verwijderen 
met desinfecterende middelen. De ziekte vormt een grote bedreiging voor de 
kippenhouderij en is alleen beheersbaar door middel van een strict en intensief 
vaccinatieprogramma. IBD is al enkele decennia endemisch in Nederland en 
Europa, waarbij een evenwicht bleek te bestaan tussen de weerstand van 
gevaccineerde dieren en het veldvirus. Vanaf 1988 veroorzaakte het voorkomen 
van “very virulent” (vv) IBD virussen uitbraken met een zeer hoge uitval, ondanks 
vaccineren. Elders in de wereld (U.S.A.) zijn variantstammen geisoleerd die in 
antigene eigenschappen verschillen van de eerder circulerende (klassieke) 
virusstammen en waartegen de klassieke vaccins minder bescherming bieden. 
Er is weinig bekend over de biochemische gebeurtenissen tijdens de 
replicatie van birnavirussen in het algemeen en van IBDV in het bijzonder. Om meer 
te weten te komen over dit proces is het onder andere van belang om meer inzicht 
te krijgen in de verschillende interacties die plaatsvinden tijdens de virale 
levenscyclus van IBDV. Bij aanvang van dit onderzoek was hierover nog weinig 
bekend. Wel werden er enkele interacties voorspeld op basis van een cryo-
electronenmicroscopische structuur van het viron, maar over eiwit-eiwit interacties 
tussen virus en gastheer was nog helemaal niets bekend. Het doel van dit 
onderzoek was daarom een inventarisatie te maken van de interacties die 
plaatsvinden tussen de virale eiwitten van IBDV onderling en tussen virus en gastheer 
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eiwitten. Hiertoe werd gebruik gemaakt van het destijds net ontwikkelde yeast two-
hybrid systeem. Dit is een techniek waarmee op een relatief eenvoudige manier in 
vivo specifieke eiwit-eiwit interacties in gist aangetoond kunnen worden. De 
techniek kan gebruikt worden om na te gaan of er interacties bestaan tussen twee 
bekende eiwitten of om een bibliotheek van eiwitten te screenen op interactie met 
een bekend targeteiwit. Vervolgens kan er met behulp van plaatsgerichte 
mutagenese achterhaald worden waar zich de precieze bindingsdomeinen van 
één of beide eiwitten bevinden.  
Allereerst werden de interacties tussen de virale eiwitten van IBDV onderling 
geanalyseerd. Het genoom van IBDV codeert voor een vijftal virale eiwitten, VP1-
VP5; drie hiervan zijn structureel, dat wil zeggen komen voor in rijpe virus deeltjes 
(VP1, VP2 en VP3), en twee zijn niet-structureel (VP4 en VP5). VP2, VP3 (beide 
capside eiwitten) en VP4 (een protease) worden gevormd door autoproteolytische 
klieving van een precursor (het polyproteine) die gecodeerd wordt door segment 
A. VP5 (exacte functie onbekend) wordt ook gecodeerd door segment A, maar 
vanaf een apart open leesraam. VP1 tenslotte, RNA polymerase, wordt gecodeerd 
door segment B. Het yeast two-hybrid systeem werd gebruikt om alle mogelijke 
combinates tussen deze vijf eiwitten te testen op interactie. Uit deze experimenten 
bleek dat verschillende complexen in gist gevormd kunnen worden, enkele 
homologe interacties, van VP2, VP3, VP5 en mogelijk van VP1, en één heterologe 
interactie tussen VP1 en VP3. De homologe interactie van VP1 was zeer zwak en 
werd om die reden niet als overtuigend positief gerekend. Aanvankelijk werd er 
geen homologe interactie voor VP4 waargenomen. Echter, in deze eerste two-
hybrid screening werd gebruik gemaakt van hybride constructen welke gebaseerd 
waren op de tot dan toe veronderstelde klievingsplaatsen in het IBDV polyproteine. 
Later bleek dat deze processing sites afweken van de onlangs opnieuw bepaalde 
klievingsplaatsen. Om die reden is daarna nog een tweede two-hybrid screening 
uitgevoerd met nieuwe hybride constructen gebaseerd op deze nieuw bepaalde 
klievingsplaatsen. Hieruit bleek dat, naast de al eerder aangetoonde interacties, 
ook VP4 in staat was tot het vormen van een homologe interactie. 
Vervolgens werd het bestaan van de heterologe interactie VP1-VP3 verder 
geanalyseerd in IBDV-geinfecteerde cellen door middel van co-immunoprecipitatie 
studies. Hieruit bleek dat de VP1-VP3 complexen worden gevormd in het 
cytoplasma van de gastheercel en later tijdens de infectie in het celculture medium 
terecht komen, hetgeen erop duidt dat deze interactie ook plaatsvindt in mature 
virions. Om de functie van deze interactie nader op te kunnen helderen werd 
daarna met behulp van plaatsgerichte mutagenese achterhaald waar zich de 
precieze bindingsdomeinen van deze twee eiwitten bevinden. Deze mapping-
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studie werd gedaan door verschillende VP1 en VP3 deletie-constructen te testen op 
interactie met respectievelijk full-length VP3 en VP1 in het yeast two-hybrid systeem. 
Hieruit bleek dat het VP3-bindingsdomein van VP1 zich in een intern gelegen 
domein van het eiwit bevindt, en dat VP3 uitsluitend via zijn 10 meest carboxy-
terminaal gelegen aminozuren met VP1 interacteert.  
Om de functionaliteit van de VP1-VP3 interactie te bepalen werd gebruik 
gemaakt van IBDV reverse genetics. Bij reverse genetics wordt gebruik gemaakt 
van een infectieuze cDNA kloon van het virus. Met behulp van recombinant DNA 
technieken kunnen mutaties in deze cDNA kloon worden aangebracht. Door 
middel van een reverse genetic systeem wordt vervolgens dit cDNA omgezet in 
mRNA zodat het virus kan repliceren. Het recombinante IBDV kan uit een celkweek 
gezuiverd en geanalyseerd worden. Van dit systeem werd gebruik gemaakt voor 
het testen van een drietal verschillende VP3 mutanten. Het bleek dat bij een 
verwijdering van 1 aminozuur (het meest carboxy-terminale aminozuur van VP3; 
VP3∆C1) de VP1-VP3 interactie in vivo nog wel, hetzij verzwakt, mogelijk was, maar 
dat bij een deletie van 5 of 10 aminozuren van de carboxy-terminus van VP3 
(VP3∆C5 en VP3∆C10) deze interactie niet meer mogelijk was. Verder bleek dat 
geen enkele van deze drie mutanten in staat was om (infectieuze) virusdeeltjes te 
vormen in het reverse genetics systeem. Geheel onverwacht leidde dit onderzoek 
tevens tot het aantonen van de in de literatuur al lang gesuggereerde interactie 
van VP3 met het virale dsRNA genoom van IBDV. Door middel van RNase- en 
reverse transcriptase PCR analyse kon aangetoond worden dat VP3 in staat was om 
zowel segment A als B van het IBDV genoom te binden. Omdat ook VP3∆C1, 
VP3∆C5 en VP3∆C10 in staat waren het virale dsRNA te binden bleek dat het dsRNA 
bindind domein van VP3 onafhankelijk functioneert van het VP1-bindingsdomein. Uit 
deze resultaten blijkt dat VP3 een essentiële rol speelt in de virus morfogenese, 
waarbij het niet alleen betrokken is bij de vorming van de capside struktuur maar 
ook bij de incorporatie van het genoom en het virale RNA polymerase, VP1. 
 Ook de homologe interacties, gevonden voor VP2, VP3, VP4 en VP5, 
werden verder gekarakteriseerd door middel van domein mapping, volgens 
eenzelfde strategie als voor de mapping van de VP1-VP3 interactie. De resultaten 
van deze mappings studie werden daarna, althans daar waar dat mogelijk was, 
bevestigd in een niet yeast two-hybrid gerelateerd systeem, door middel van co-
immunoprecipitatie studies. Uit dit onderzoek is gebleken dat VP2 meerdere, van 
elkaar onafhankelijke, bindingsdomeinen heeft voor homologe interactie, hetgeen 
overeenkomt met de structurele informatie die over dit capside eiwit bekend is 
(gebaseerd op een cryo-electronenmicroscopische studie van virus-like particles). 
De VP3-VP3 interactie werd gemapt op het amino-terminale deel van het eiwit. 
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Tevens is gebleken dat dit domein voor homologe interactie onafhankelijk kan 
functioneren van het VP1-bindingsdomein dat op het carboxy-terminale uiteinde 
van het eiwit gelegen is. Hiermee is duidelijk dat de drie bindingsdomeinen van VP3, 
het VP1-bindingsdomein, het dsRNA bindingsdomein en het homologe interactie 
domein, verschillend zijn gesitueerd in het eiwit en waarschijnlijk ook allemaal 
onafhankelijk van elkaar kunnen functioneren. Voor VP4 bleek het niet mogelijk om 
volgens deze strategie een domein voor homologe interactie te mappen. Dit eiwit 
bleek namelijk zeer gevoelig voor deleties. Tenslotte werd er voor VP5 een centraal 
gelegen domein gemapt als bindingssite voor homologe interactie. Dit domein 
omvat het meest hydrofobe gebied van VP5, een verondersteld transmembraan 
gebied. Omdat onlangs aangetoond is dat VP5 accumuleert in het 
plasmamembraan van de gastheercel en ook betrokken is bij het vrijkomen van 
nieuw gevormde virusdeeltjes, is het mogelijk dat dit domein voor homologe 
interactie betrokken is bij de vorming van een plasma membraan-porie in de 
gastheercel. 
 Voor het identificeren van interacties tussen virus- en gastheer-eiwitten werd 
een bibliotheek van eiwitten die tot expressie komen in de bursa van Fabricius van 
jonge kippen (3 weken oud), gescreend op interactie met de virale eiwitten VP1, 
VP2, VP3 en VP5 van IBDV. Hierbij werd voor ieder van deze virale eiwitten een 
aantal mogelijke, zowel bekende als nog onbekende, cellulaire interactoren 
gevonden. Hoewel voor de meeste van deze interacties nog aangetoond dient te 
worden of ze daadwerkellijk plaatsvinden tijdens een IBDV infectie, werd de 
biologische betekenis van sommige van deze veronderstelde interacties uitgebreid 
bediscussieerd in dit proefschrift.  
Voor een van de gevonden virus-gastheer interacties werd de associatie 
bevestigd. Dit betrof de interactie tussen VP1 en het carboxy-terminale 1/3 deel van 
de eukaryotische translatie initiatie factor 4A-isovorm 2 (eIF4AII). Dit cellulaire eiwit is 
een essentieel component bij de initiatie van translatie, waarbij mRNA vertaald 
wordt in eiwit. Vrijwel alle eukaryotisch cytoplasmatische mRNAs hebben een cap 
struktuur aan hun 5’ uiteinde en normaal gesproken bindt eIF4AII voor eiwitsynthese 
aan het initiatie complex op een cap-afhankelijke wijze. Een interactie tussen VP1 
en eIF4AII is daarom heel interessant omdat de virale mRNAs van IBDV geen cap-
structuur hebben aan het 5’ uiteinde maar een covalent gebonden VP1 molecuul 
(VPg genaamd). Een directe interactie tussen VPg en eIF4AII zou daarom een 
essentiele stap kunnen zijn voor de initiatie van virale eiwitsynthese. Opvallend was 
echter dat alleen het carboxy-terminale 1/3 deel van eIF4AII, en dus niet het 
volledige eiwit, interactie vertoonde met VP1. Omdat het eIF4AII eiwit een 
kenmerkende struktuur heeft, bestaande uit twee domeinen, lijkt het aannemelijk 
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dat een interactie tussen VP1 en volledig eIF4AII mogelijk alleen kan plaatsvinden 
wanneer andere eiwitten helpen om deze struktuur zodanig te openen dat de VP1-
bindingssite gelegen in het carboxy-terminale domein van dit eiwit vrij komt te 
liggen. In dit proefschrift zijn twee mogelijke modellen beschreven over hoe een 
VPg-eIF4AII interactie zou kunnen plaatsvinden en daarmee betrokken zou zijn bij 
de initiatie van de virale mRNA translatie. 
Samenvattend heeft het yeast two-hybrid systeem bewezen een 
waardevolle techniek te zijn voor het in kaart brengen van de interacties die 
plaatsvinden in de virale levenscyclus van IBDV. Met name de specifieke interacties 
die plaatsvinden tussen de virale componenten onderling zijn goed in kaart 
gebracht. Tevens zijn er verscheidene cellulaire kandidaat eiwitten gevonden die 
mogelijk een essentiele interactie aangaan met de virale eiwitten. Het is te 
verwachten dat deze kennis verder onderzoek naar IBDV zal stimuleren. De 
verwachting is dat zal deze kennis in de toekomst zal kunnen bijdragen aan 
preventie en controle van IBD. 
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ABBREVIATIONS 
 
aa   amino acid 
Ab   Antibody 
AD   Activation Domain  
AlMV   Alfalfa Mosaic Virus  
amp   ampicillin 
ATP  Adenosine Triphosphate 
AZ   Antizyme 
β-Gal   β-Galactosidase 
BD  Binding Domain  
BSA  Bovine Serum Albumin 
bp   base pair 
C  Carboxy 
cDNA  copy DNA 
CEF   chicken embryo fibroblast  
CFU   Colony-Forming unit  
CMV  Cytomegalovirus  
co-IP  co-Immunoprecipitation  
CPE   Cytopathic effect 
CSFV   Classical Swine Fever Virus 
CThy28kD  Thymocyte protein  
DAP5  Deatch Associated Protein 5 
DNA  Deoxyribonucleic Acid 
DNAse  Deoxyribonuclease 
dsDNA  double-stranded DNA 
dsRNA   double-stranded RNA 
DXV   Drosophila X Virus  
4E-BP1   eIF4E-Binding Protein 1 
E. coli   Escherichia coli  
EED   Embryonic Ectoderm Developmental protein  
eIF   eukaryotic Initiation Factor  
EM  Electron Microscopy  
EV   European Eels Virus 
FCS   Foetal Calf Serum 
FMDV   Foot and Mouth Disease Virus  
FPV-T7  Fowlpox Virus expressing the T7 polymerase gene  
Gal  Galactose  
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Glu  Glucose  
GTP  Guanosine Triphosphate 
HA   Haemagglutinin 
HCV   Hepatitis C Virus  
HDR   Hepatitis Delta Ribozyme   
IBD  Infectious Bursal Disease  
IBDV  Infectious Bursal Disease Virus  
Ig  Immunoglobulin  
IP  Immunoprecipitation  
IPMA   Immunoperoxidase Monolayer Assay  
IPNV  Infectious Pancreatic Necrosis Virus 
IRES   Internal Ribosomal Entry Site  
ITR  Inverted Terminal Repeat  
kb  kilobase 
kDa  kilo Dalton 
Mab   Monoclonal antibody  
Met-tRNAi initiator methionyl-tRNA 
mIBDV   mutagenized IBDV 
Mnk1   MAP kinase-interacting protein kinase-1 
m.o.i.   multiplicity of infection 
mRNA  messenger RNA 
N  Amino 
NADH  reduced form of the Nicotinamide Adenine Dinucleotide  
ND   Not Determined 
nt   nucleotide 
ODC   Ornithine Decarboxylase  
ODC-AZ  Ornithine Decarboxylase Antizyme  
OIE   Office International des Epizooties 
ORF  Open Reading Frame 
OV   Oyster Virus 
PABP   Poly(A)-Binding Protein 
PBS  Phosphate-Buffered Saline 
PBS-TDS  Phosphate-Buffered Saline - Triton-sodium Deoxycholate-SDS  
PcG protein Polycomb-Group protein 
PCR  Polymerase Chain Reaction 
PGK   Phosphoglycerate Kinase  
p.i.  post-infection 
Raf  Raffinose 
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RanBP1   RanGTP-binding protein 1 
RdRp  RNA-dependent RNA polymerase  
RGG box  Arginine-Glycine-Glycine (Arg-Gly-Gly) box 
rIBDV   rescued IBDV 
RIP   Radio-Immunoprecipitation  
RNA   Riboucleic acid  
RNAse  Ribonuclease 
RRL   Rabbit Reticulocyte Lysate  
rRNA  ribosomal RNA  
RT  Reverse Transcriptase 
RT-PCR  Reverse Transcriptase - Polymerase Chain Reaction  
Sap18   Sin3-associated polypeptide 18 
S. cerevisiae Saccharomyces cerevisae 
SDS  Sodium Dodecyl Sulphate 
SDS-PAGE  Sodium Dodecyl Sulphate - Polyacrylamide Gel Electrophoresis 
SPF   Specific Pathogen Free  
ssDNA  single-stranded DNA 
ssRNA  single-stranded RNA 
SV40  Simian Virus 40 
TCID50   50% Tissue Culture Infective Dose  
tRNA  transfer RNA 
TV   Tellina Virus 
UTR   Untranslated Region  
VLP  Virus-Like Particle 
VP   Viral Protein 
VPg   genome-linked Viral Protein  
vvIBDV   very virulent IBDV 
wt  wild-type 
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DANKWOORD 
 
De Finish! Eindelijk, de eindstreep is in zicht! Het was een ware marathon, of zeg 
maar gerust een ultraloop. Tijdens mijn onderzoeksperiode zijn er momenten 
geweest dat ik dacht nooit aan het schrijven/afronden van mijn proefschrift toe te 
komen. Het was een leerzame maar vooral drukke tijd welke vaak gepaard ging 
met vallen en opstaan. Maar eindelijk is het nu dan toch zover gekomen en is het 
moment aangebroken om de laatste regels te vullen en er daadwerkelijk een punt 
achter te zetten. 
 
Veruit de meeste mensen van de afdeling Aviaire Virologie waren al ‘gevlogen’ 
voordat ik het einde van mijn promotieonderzoek bereikt had. Toch wil ik graag hen 
bedanken die een steentje hebben bijgedragen aan het onderzoek beschreven in 
dit proefschrift. Dit geld zeker voor mijn directe collega’s destijds op ‘ons’ kleine 
moleculaire AV-labje. Olav de Leeuw (onze reorganisatie-survivor c.q. -diehard), 
Erwin Claassen (drinken we er nog eens ‘n 10% SDS-je op?), Fräncis Balk (onze vaste 
labgast!), Hans Ovelgönne, Yvonne Gruijthuijsen (alvast succes met jouw 
proefschrift), Stephanie Vastenhouw (de route naar een succesvol labuitje: neem 
de A6 tot knooppunt Joure en ga dan weer terug), Heng Zhao, Helmi (kan ook in 
meervoud) Fijten, Marc Hulst, Jos Dekker, Bart Kooi en Maarten van den Burg. 
Allemaal bedankt voor de hulp en gezelligheid op het lab! Maar uiteraard ook dank 
aan al die andere AV’ers van destijds, met bovenaan de lijst onze aanvoerder Arno 
Gielkens!! Daarnaast heb ik in mijn laatste jaar veel steun en plezier gehad aan het 
‘IBDV-team’: Arjan Hoekman (zónder bubbelbad), Sylvia Pritz-Verschuren (mét 
bubbelbad), Marion Tieman (onze kappertjes-deskundige), Dirk van Roozelaar (ook 
al zo fotogeniek als ik) en ja, ook (kort maar krachtig) Ben van Schaijk. Dan, niet te 
vergeten, mijn stagiaires: Eduard (‘Eddy’) Verbruggen en Patricia van den Beuken, 
bedankt voor jullie inzet. Ik vond het leuk om jullie te mogen begeleiden. Het was 
leerzaam en reuze gezellig. Natuurlijk ook dank aan alle andere stagiaires die in de 
loop van de tijd op ons lab werkten, het kwam de sfeer altijd ten goede. Behalve 
lab- en IBDV-genoten had ik uiteraard ook andere collega’s in de high-containment 
unit van de Houtribweg. Zowel ‘binnen’ als ‘buiten’, iedereen bedankt! Houtribweg 
39 was een beetje mijn 2e thuis (met tegen zevenen het bekende telefoontje van 
Jeanine of ik er nog was: ‘Ja Jeanine, ik ben er nog, ik zal de lampen wel uit doen 
als ik wegga’). En dan, last but not least, wil ik graag mijn beide co-promotoren 
bedanken: Ben Peeters en Hein Boot. Ik geloof dat jullie altijd meer vertrouwen 
hadden in het welslagen van deze onderneming dan ik zelf. Ik heb veel van jullie 
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geleerd en jullie bijdrage aan dit proefschrift is mij meer dan zeer waardevol. 
Hartstikke bedankt! 
 
Van Lelystad nu even naar Utrecht. Dank allereerst aan mijn promotor, professor 
Peter Rottier. Peter, bedankt voor het in mij gestelde vertrouwen, en voor de 
kritische belangstelling in mijn werk. De discussies met jouw waren zeer nuttig om het 
overzicht te behouden en om op de juiste momenten de knopen door te hakken. 
Adri Thomas, ik wil jouw op deze plek bedanken omdat ik je altijd beschouwd heb 
als mijn derde co-promotor. Ik had jouw heldere kijk op de wetenschap en jouw 
suggesties op de manuscripten niet willen missen, maar bovenal kon ik altijd bij je 
aankloppen voor advies. Ik hoop onze samenwerking op deze prima manier door te 
blijven zetten. 
 
Sylvia en Olav, enorm leuk dat jullie mijn paranimf willen zijn!! Mijn hardloopcollega’s 
van ID-Lelystad: Olav, van 4 km zuigerplasbos op donderdagmiddag tot New York 
Marathon 2004!, Frank Nelissen, John Voermans, Theo Hegeman, Harry Stoorvogel 
en Frank Proost, bedankt voor alle gezellige kilometers. Erik van Weezep, wat ben ik 
je nog altijd dankbaar voor de deskundige printplaat-transplantatie en het weer tot 
leven wekken van mijn harde schijf. Dank ook aan mijn huidige collega’s in A’dam: 
Jan Pronk, Gert Scheper, Barbara van Kollenburg, Ilja Boor, Carola van Berkel, Koen 
de Groot en Gesina Bertrand, en met name aan Marjo van der Knaap, voor de 
gelegenheid die je me gaf voor het afronden van mijn proefschrift. Dat er maar 
spoedig een VWM-muis over de catwalk mag gaan lopen!  
 
Naast de mensen op de werkplek hebben ook familie, vrienden en bekenden een 
heel belangrijke rol gespeeld. Het leven van een AIO is soms maar moeilijk te 
bevatten: een hectische tijd waarbij er (te) weinig tijd overblijft voor het 
onderhouden van contacten. Clemens, Karel, Rixt, Mariëlle, Suzy, Lotte en Irene, 
eindelijk ben ik zover, de volgende Benno-reünie is in L’stad, en nu écht, oké!? Karen 
en Charlotte, met z’n drieën in Nijmegen begonnen en uiteindelijk alle drie in 
Lelystad beland, een unicum! Mijn vriendinnen in Horst: Riet, Monique, Marij, Rianne 
en Evelyn, leuk om de contacten weer op te halen!! Michiel, lief, maar helaas ook 
leed hebben we meegemaakt, het ga je goed! Cindy & Erwin, bedankt voor jullie 
steun in moeilijke tijden, en dit geld zeker ook voor Sylvia & Marco (Bastion 382 
bevalt nog altijd prima!). Dank ook aan Marian & Keimpe voor de gouden tip: een 
lidmaatschap bij AV Spirit. Ronald, bedankt voor alle kneepjes van het vak 
hardlopen! Het gaf mij de afgelopen twee jaar de broodnodige afleiding en 
ontspanning. Alle ‘exafferente’ en ‘reafferente input’ heeft mijn ‘contractiel’ en 
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‘elastisch element’ (‘cec’ en ‘pec deel’) inmiddels al aardig ontwikkeld ;-). En Ron, 
ik ben alleen bang dat Lissabon–Moskou toch nog even op zich laat wachten.  
Dan tot slot, dank aan mijn allertrouwste maatjes, mijn ouders. Lieve paps 
en mams, dat ik altijd op jullie steun kan rekenen weet ik, maar dit was STEUN met 
hoofdletters. Ontzettend bedankt voor alles…..hou van jullie! Dank ook aan Frank & 
Daniëlle, voor jullie begrip, gezelligheid en hulp bij de laatste loodjes. 
  
Het zit er nu écht op, soms zeggen woorden niet genoeg, iedereen bedankt! 
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CURRICULUM VITAE 
 
Mirriam Tacken zag haar eerste daglicht op 18 april 1970 in Horst (Noord-Limburg) en 
bracht haar jeugd door in dit prachtige dorpje. Zij volgde de MAVO opleiding aan 
de ‘Jacob Merlo Horstius’ te Horst, waarna de Middelbare Laboratorium Opleiding 
(MLO) werd voltooid aan het MBO-college Noord-Limburg te Venlo.  
In 1989 is zij begonnen met het Hoger Laboratorium Onderwijs (HLO) aan de 
Hogeschool Eindhoven. Tijdens deze opleiding werd gekozen voor de studierichting 
algemene microbiologie met moleculaire biologie en biochemie als specialisatie. 
De stage en afstudeeropdracht werden uitgevoerd bij, respectievelijk, de research 
groepen moleculaire biologie en biochemie, van de afdeling Animal Health 
Research van het concern Ciba-Geigy (huidige naam: Novartis) te Bazel, 
Zwitserland, onder leiding van Dr. B. Suri. In juli 1993 werd de studie afgerond met het 
behalen van de Ingenieurs titel (Ing.).  
Datzelfde jaar is zij begonnen met de studie Biologie, fysiologisch-
biochemische richting, aan de Faculteit der Natuurwetenschappen van de 
Katholieke Universiteit van Nijmegen. Tijdens de doctoraalfase verrichtte zij haar 
bijvakstage binnen de afdeling Endocrinologie van de firma Organon Akzo-Nobel 
te Oss, onder begeleiding van Dr. R.G.J.M. Hanssen en Dr. A. Wiersma, en Prof. Dr. 
E.W. Roubos van de Katholieke Universiteit van Nijmegen. De hoofdvakstage werd 
verricht bij de afdeling Experimentele Plantkunde, onderzoeksgroep Celbiologie van 
de Plant, onder leiding van Prof. Dr. C. Mariani en onder begeleiding van Dr. B.H.J. 
de Graaf. Het doctoraal examen in de Biologie werd in maart 1997 met genoegen 
afgelegd waarbij de daarbij behorende Doctorandus titel (Drs.) werd verkregen. 
Van juni 1997 tot maart 2002 was zij aangesteld als Assistant In Opleiding 
(AIO) bij de toenmalige afdeling Aviaire Virologie van het DLO-Instituut voor 
Dierhouderij en Diergezondheid, het ID-DLO (huidige naam: Animal Sciences Group 
WUR), te Lelystad, onder leiding van Dr. A.L.J. Gielkens. Hier werd, onder 
begeleiding van Dr. B.P.H. Peeters en Dr. H.J. Boot, en Prof. Dr. P.J.M. Rottier van de 
faculteit Diergeneeskunde van Universiteit Utrecht, het in dit proefschrift beschreven 
onderzoek uitgevoerd. Naast het begeleiden van studenten en het bezoeken van 
verschillende congressen, volgde zij een AIO opleidingsprogramma aan de 
onderzoeksschool ‘Eijkman Graduate School for Immunology and Infectious 
Diseases’ (voorheen ‘Graduate School Infection and Immunity’) van de faculteit 
Diergeneeskunde van Universiteit Utrecht. 
Sinds september 2002 is zij werkzaam als postdoc bij de afdeling 
Kindergeneeskunde van het VU Medisch Centrum te Amsterdam onder leiding van 
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Prof. Dr. M.S. van der Knaap. Hier wordt onderzoek gedaan aan ziekten van de 
witte stof van de hersenen bij kinderen. 
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